{
    "testId": 374146510,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 14,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 20,
    "correctToIncorrect": 2,
    "incorrectToCorrect": 1,
    "incorrectToIncorrect": 7,
    "timeInSeconds": 2802,
    "averageTimeSpentInSeconds": 110,
    "otherAverageTimeSpentInSeconds": 58,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 11044,
            "questionIndex": 12185,
            "questionText": "<p>A 32-year-old woman comes to the office due to &#x22;feeling anxious and down&#x22; for the past 2 weeks.&nbsp; The patient cries frequently and has been making mistakes in her accounting job due to poor concentration.&nbsp; She feels tense throughout the day and has difficulty staying asleep most nights because she is awakened by episodes of palpitations, shortness of breath, and sweating.&nbsp; The patient was mugged 3 weeks ago while walking home from work but is reluctant to discuss what happened.&nbsp; She does not use alcohol or illicit drugs and takes no medication.&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 125/70 mm Hg, pulse is 88/min, and respirations are 14/min.&nbsp; Physical examination shows no abnormalities.&nbsp; On mental status examination, the patient makes minimal eye contact, looks down at the floor, and wrings her hands repeatedly.&nbsp; She tearfully says, &#x22;I feel like I&#39;m in a daze, and I can&#39;t snap out of it.&#x22;&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33515\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute stress disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Duration &ge;3 days &amp; &le;1 month</li><li>Exposure to actual or threatened trauma</li><li>Symptoms from following categories:<ul style=\"list-style-type:circle;\"><li>Avoidance of internal memories or external reminders</li><li>Intrusion (eg, nightmares, flashbacks)</li><li>Dissociation (eg, amnesia for event, derealization)</li><li>Arousal (eg, insomnia, hypervigilance, startle)</li><li>Negative mood</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Trauma-focused, brief CBT</li><li>Consider medication for insomnia, intense anxiety</li><li>Monitor for PTSD (symptom duration &gt;1 month)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CBT</strong> = cognitive-behavioral therapy; <strong>PTSD</strong> = posttraumatic stress disorder.</p></td></tr></tbody></table></div><p>This patient who recently experienced trauma (a mugging event) has a&nbsp;2-week history of anxiety, impaired concentration, insomnia, dissociative symptoms (eg, being in a &#x22;daze&#x22;), and avoidance of discussing the traumatic event, consistent with <strong>acute stress disorder</strong> (ASD).&nbsp; Her negative mood and tearfulness are also characteristic.&nbsp; Other ASD symptoms include intrusive memories, nightmares, and flashbacks.&nbsp; Symptoms must last for <strong>&#8805;3 days and &#8804;1 month following trauma exposure</strong>.</p><p>If the symptoms persist for &gt;1 month and meet criteria for posttraumatic stress disorder (PTSD), the diagnosis is changed from ASD to PTSD <strong>(Choice F)</strong>.&nbsp; Early recognition and intervention (eg, trauma-focused cognitive behavioral therapy)&nbsp;are important because patients with ASD are at a higher risk for subsequent PTSD.</p><p><strong>(Choice B)</strong>&nbsp; Depersonalization/derealization disorder is characterized by a sense of unreality of self or environment.&nbsp; If symptoms occur as part of an acute or posttraumatic stress reaction, a separate diagnosis is not required.</p><p><strong>(Choice C)</strong>&nbsp; Individuals with generalized anxiety disorder (GAD) also have insomnia, tension, and difficulty concentrating.&nbsp; However, anxiety in GAD is about multiple everyday concerns (rather than being trauma related) and has a duration of &#8805;6 months.</p><p><strong>(Choice D)</strong>&nbsp; This patient&#39;s sad mood, sleep disturbance, and impaired concentration are a response to trauma and better explained as symptoms of ASD rather than major depressive disorder.</p><p><strong>(Choice E)</strong>&nbsp; This patient&#39;s panic symptoms are likely triggered by bad dreams resulting from the trauma.&nbsp; She does not experience recurrent, unexpected panic attacks necessary for the diagnosis of panic disorder.</p><p><strong>Educational objective:</strong><br>Acute stress disorder is a severe anxiety response characterized by re-experiencing of trauma, dissociation, negative mood, avoidance, and hyperarousal lasting &#8805;3 days and &#8804;1 month after exposure to a traumatic event.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17235,
            "topic": "Post traumatic stress disorder",
            "titleId": 17235,
            "title": "Post traumatic stress disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "1",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute stress disorder",
                    "choiceNumber": 1,
                    "correctTaken": 14032,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Depersonalization/derealization disorder",
                    "choiceNumber": 2,
                    "correctTaken": 350,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 58,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 185,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic disorder",
                    "choiceNumber": 5,
                    "correctTaken": 185,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Posttraumatic stress disorder",
                    "choiceNumber": 6,
                    "correctTaken": 2242,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1217,1383,true,-1,1*1757,1760,true,-1,1*1842,1863,true,-1,1*467,510,true,-1,1*70,97,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30089232",
                    "mediaDataId": 0,
                    "title": "Treatment of acute stress disorder for victims of violent crime.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30089232",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23062092",
                    "mediaDataId": 0,
                    "title": "The physician&#39;s role in managing acute stress disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23062092",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 96,
            "othersAvgTimeSpent": 43,
            "notes": null,
            "peopleTaken": 17052,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 82,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 639,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 2502,
            "questionIndex": 2502,
            "questionText": "<p>A 20-year-old college student comes to the office due to anxiety.&nbsp; She is very worried because she has an important presentation coming up in a few weeks and is afraid that &#x22;everyone will see how anxious I am.&#x22;&nbsp; The patient reports that she had to leave in the middle of her last presentation because her heart suddenly began racing, her voice started to crack, and her face turned bright red.&nbsp; The patient says school has been stressful due to a heavy class load.&nbsp; She recently ended a relationship with her boyfriend of 6 months but feels supported by her friends.&nbsp; She drinks alcohol and uses marijuana socially.&nbsp; Family history is significant for anxiety, depression, and alcohol dependence in her mother.&nbsp; Blood pressure is 134/82 mm Hg, pulse is 86/min, and respirations are 12/min.&nbsp; Physical examination is unremarkable.&nbsp; Mental status examination shows an initially tense patient who relaxes as the interview progresses.&nbsp; The patient requests medication to help with her symptoms.&nbsp; Which of the following is the most appropriate pharmacotherapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T34093\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Social anxiety disorder (social phobia)</strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Diagnosis</strong></p></td><td><ul><li>Marked anxiety about &#8805;1 social situations for &#8805;6 months</li><li>Fear of scrutiny by others, humiliation, embarrassment</li><li>Social situations avoided or endured with intense distress</li><li>Marked impairment (social, academic, occupational)</li><li>Subtype specifier: performance only</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Treatment</strong></p></td><td><ul><li>SSRI/SNRI</li><li>Cognitive-behavioral therapy</li><li>Beta blocker or benzodiazepine for performance-only subtype</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRI</strong> = serotonin-norepinephrine reuptake inhibitor; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>This patient has performance anxiety, which is classified in DSM-5 as <strong>social anxiety disorder, performance-only</strong>.&nbsp; Individuals with performance-only social anxiety disorder do not fear nonperformance social situations and are not socially avoidant in general.</p><p>The pharmacologic treatment of performance-only social anxiety disorder includes as-needed <strong>beta blockers or benzodiazepines</strong> rather than maintenance medication.&nbsp; Beta blockers (eg, propranolol) on an as-needed basis help control the associated autonomic response (eg, tremors, tachycardia, diaphoresis).&nbsp; Due to their addictive potential, benzodiazepines (eg, diazepam, lorazepam) are generally avoided in patients with a personal or family history of substance use disorder.&nbsp; In addition, they are not preferred when performance could be impaired by sedation and cognitive side effects (eg, giving a presentation, as in this case) <strong>(Choices B and C)</strong>.&nbsp; Cognitive-behavioral therapy is an effective nonpharmacologic approach.</p><p><strong>(Choice A)</strong>&nbsp; Buspirone is used to treat generalized anxiety disorder, not social anxiety disorder.</p><p><strong>(Choices D and F)</strong>&nbsp; Selective serotonin reuptake inhibitors (eg, paroxetine) and serotonin-norepinephrine reuptake inhibitors (eg, venlafaxine) are used in the treatment of social anxiety disorder that is not limited to performance situations (ie, generalized) or if there is comorbid depression.&nbsp; It would be inappropriate to prescribe a daily medication to this patient because her anxiety is limited to performance situations and she has no depression.</p><p><strong>Educational objective:</strong><br>Performance anxiety is classified as performance-only social anxiety disorder in DSM-5.&nbsp; Pharmacologic treatments include as-needed beta blockers or benzodiazepines.&nbsp; Benzodiazepines should be avoided in patients with a personal or family history of substance use disorder or when cognitive and sedative side effects could impair performance.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24454,
            "topic": "Social anxiety disorder",
            "titleId": 24454,
            "title": "Social anxiety disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Buspirone",
                    "choiceNumber": 1,
                    "correctTaken": 524,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diazepam",
                    "choiceNumber": 2,
                    "correctTaken": 219,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lorazepam",
                    "choiceNumber": 3,
                    "correctTaken": 685,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Paroxetine",
                    "choiceNumber": 4,
                    "correctTaken": 2392,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Propranolol",
                    "choiceNumber": 5,
                    "correctTaken": 12711,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Venlafaxine",
                    "choiceNumber": 6,
                    "correctTaken": 444,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "659,803,true,-1,1*804,965,true,-1,1*1107,1526,true,-1,1*1643,1919,true,-1,1*386,445,true,-1,1*126,135,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23438729",
                    "mediaDataId": 0,
                    "title": "Non-antidepressant treatment of social anxiety disorder: a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23438729",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 79,
            "othersAvgTimeSpent": 46,
            "notes": null,
            "peopleTaken": 16975,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 640,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 14454,
            "questionIndex": 15863,
            "questionText": "<p>A 29-year-old man comes to the office because he is &#x22;worrying all the time.&#x22;&nbsp; The patient has a long history of anxiety and says, &#x22;It was manageable when I was allowed to work from home, but since I was promoted and have to come into the office, I&#39;m completely overwhelmed.&#x22;&nbsp; He spends hours rehearsing before meetings to find &#x22;the right words&#x22; to say and repeatedly edits emails until they are &#x22;good enough.&#x22;&nbsp; The patient also has difficulty leaving the house in the mornings because he spends 1-2 hours making sure all the appliances are unplugged.&nbsp; He shares, &#x22;I know it sounds crazy, but when I&#39;m at work, I constantly worry that there will be an electrical fire at home, and I can&#39;t concentrate.&#x22;&nbsp; Physical examination shows no abnormalities.&nbsp; On mental status examination, the patient describes his mood as &#x22;really anxious&#x22;; he is restless and makes poor eye contact.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33713\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Obsessive-compulsive disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li><strong>Obsessions </strong><ul style=\"list-style-type:circle;\"><li>Recurrent, intrusive, anxiety-provoking thoughts, urges, or images</li></ul></li><li><strong>Compulsions</strong><ul style=\"list-style-type:circle;\"><li>Response to obsessions with repeated behaviors or mental acts</li><li>Behaviors not connected realistically with preventing feared event</li></ul></li><li>Time-consuming (&gt;1 hr/day) or causing significant distress or impairment</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Selective serotonin reuptake inhibitor</li><li>Cognitive-behavioral therapy (exposure &amp; response prevention)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s long-standing anxiety related to <strong>intrusive thoughts</strong> and <strong>repetitive behaviors</strong> is characteristic of <strong>obsessive-compulsive disorder</strong> (OCD).&nbsp; <strong>Obsessions</strong> in OCD may include excessive worries about safety and an obsessive need to find just &#x22;the right words,&#x22; as seen in this patient.&nbsp; <strong>Compulsions</strong> are time-consuming, repetitive behaviors performed in response to the obsession, such as this patient&#39;s unplugging appliances and excessive checking, editing, and rehearsing.</p><p>Patients with OCD typically become more anxious when they are unable to perform or complete their compulsive rituals that are aimed at relieving their obsessions (eg, this patient&#39;s recent increase in anxiety associated with having to work out of the home).&nbsp; Most, but not all, patients with OCD have some insight that their concerns and behaviors are excessive (eg, patient says, &#x22;I know it sounds crazy&#x22;).</p><p><strong>(Choice A)</strong>&nbsp; In adjustment disorder, anxiety symptoms develop within three months of an identifiable stressor and do not meet criteria for another specific disorder.&nbsp; Although this patient&#39;s symptoms have increased with the stress of having to go into the office since he received a promotion, he has a long history consistent with OCD.</p><p><strong>(Choices B, C, and F)</strong>&nbsp; Agoraphobia is characterized by anxiety about and/or avoidance of certain situations (eg, closed spaces, crowds) and is frequently comorbid with panic attacks.&nbsp; Patients with generalized anxiety disorder worry about everyday concerns.&nbsp; In social anxiety disorder, anxiety is focused on fears of scrutiny and embarrassment in social situations.&nbsp; Although anxiety is a prominent feature of OCD, OCD can be differentiated from these primary anxiety disorders by unwanted obsessions and associated rituals that are not realistically connected to each other and are clearly excessive (eg, spending hours unplugging appliances).</p><p><strong>(Choice E)</strong>&nbsp; Schizoid personality disorder involves a lifelong pattern of behavior characterized by lack of desire for and detachment from social relationships and restricted emotions.</p><p><strong>Educational objective:</strong><br>Obsessive-compulsive disorder is characterized by intrusive, recurrent, and persistent unwanted thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) in response to the obsessions.&nbsp; Patients typically have prominent anxiety symptoms that must be differentiated from those of primary anxiety disorders.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17181,
            "topic": "Obsessive compulsive disorder",
            "titleId": 17181,
            "title": "Obsessive compulsive disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with anxiety",
                    "choiceNumber": 1,
                    "correctTaken": 267,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Agoraphobia",
                    "choiceNumber": 2,
                    "correctTaken": 138,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 4708,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obsessive-compulsive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 11709,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizoid personality disorder",
                    "choiceNumber": 5,
                    "correctTaken": 23,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Social anxiety disorder",
                    "choiceNumber": 6,
                    "correctTaken": 166,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "298,370,true,-1,1*150,156,true,-1,1*450,480,true,-1,1*1220,1368,true,-1,1*1728,1740,true,-1,1*1817,1839,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25150561",
                    "mediaDataId": 0,
                    "title": "Obsessive-compulsive disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25150561",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24576790",
                    "mediaDataId": 0,
                    "title": "Obsessive-compulsive disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24576790",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 110,
            "othersAvgTimeSpent": 45,
            "notes": null,
            "peopleTaken": 17011,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 770,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 13657,
            "questionIndex": 15047,
            "questionText": "<p>A 4-year-old girl is brought to the office by her adoptive mother due to concerns about her adjustment to preschool.&nbsp; She was placed in foster care at age 2 due to parental substance use disorder and was adopted by her current family 6 months ago.&nbsp; Prenatal history is unknown.&nbsp; At school, the patient does not interact with classmates and prefers to play by herself.&nbsp; She speaks infrequently at home and stays in her room; the mother has discovered that she hoards toys and food under the bed.&nbsp; The mother says, &#x22;She doesn&#39;t like being hugged or picked up; nothing I do seems to comfort her.&#x22;&nbsp; The patient can dress herself, copy a triangle, write the letters of her name, and walk down the stairs without aid.&nbsp; Vital signs are within normal limits; weight and height curves are at the 50th and 60th percentiles, respectively.&nbsp; On examination, the patient is sitting quietly, playing with various toys in the room.&nbsp; She interacts with the physician and makes occasional eye contact.&nbsp; Responses are brief and said with little facial expression, but speech is otherwise normal.&nbsp; Physical examination shows no other abnormalities.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T71060\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Reactive attachment disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p><p align=\"center\"><strong>(some evidence</strong></p><p align=\"center\"><strong>&lt;5 years)</strong></p></td><td><ul><li>Insufficient care (eg, neglect, abuse, inconsistent caregiving)</li><li>Does not seek or respond to comfort</li><li>Poor social responsiveness, limited positive affect</li><li>Unexplained irritability/fear/sadness even during safe encounters</li></ul></td></tr><tr><td><p align=\"center\"><strong>Associated features</strong></p></td><td><ul><li>Toileting &amp; sleep difficulties</li><li>Anxiety, aggression, hyperactivity/impulsivity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Differential diagnosis</strong></p></td><td><ul><li>Adjustment disorder, posttraumatic stress disorder</li><li>Global developmental delay, intellectual disability</li><li>Autism spectrum disorder</li><li>Anxiety disorders (eg, social anxiety disorder, selective mutism)</li><li>Depressive disorders</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Early intervention promoting:<ul style=\"list-style-type:circle;\"><li>safe, stable &amp; enriching environment</li><li>consistent, responsive caregiving</li></ul></li><li>Psychological services (eg, parenting skills, individual/family counseling)</li></ul></td></tr></tbody></table></div><p>This child&#39;s history of early foster care placement due to parental substance use, social withdrawal, lack of positive response to attempts to comfort, and poor emotional responsiveness is consistent with <strong>reactive attachment disorder (RAD)</strong>.&nbsp; RAD may develop in young children when abuse, <strong>neglect</strong>, prolonged institutionalization, or inconsistent care (eg, frequently moving between foster homes) disrupts the development of a healthy, secure attachment to caregivers.</p><p>Children with RAD <strong>seldom seek comfort</strong> and do not respond to attempts to comfort them.&nbsp; Other symptoms include <strong>lack</strong> of <strong>social responsiveness</strong>, lack of positive emotions, and episodes of unexpected irritability or sadness in response to nonthreatening encounters.&nbsp; Symptoms of RAD often improve when a child has access to consistent and responsive attachment figures.</p><p><strong>(Choice A)</strong>&nbsp; Adjustment disorder is diagnosed when the response to a stressor is out of proportion to the circumstances and is typically accompanied by either anxiety, depression, and/or a disturbance of conduct.&nbsp; Social disengagement both at school and at home, as well as lack of response to comfort, are not typical.&nbsp; Adjustment disorder should not be diagnosed when symptoms are better explained by another disorder, such as RAD in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Deficits in social and emotional interaction can be seen in both RAD and autism spectrum disorder (ASD).&nbsp; However, this girl interacts with the physician and does not display the restricted interests, stereotyped and repetitive motor mannerisms, and language impairment commonly seen in ASD.&nbsp; Her history of neglect and hoarding, which is common in children who have suffered neglect, makes RAD the more likely diagnosis.</p><p><strong>(Choice C)</strong>&nbsp; Disinhibited social engagement disorder is another possible outcome of severe, early neglect and is characterized by overfamiliarity with unfamiliar adults.&nbsp; Rather than a lack of seeking comfort, these children show a lack of boundaries when approaching adults (eg, sitting on another person&#39;s lap, leaving with a stranger).</p><p><strong>(Choice D)</strong>&nbsp; Young children with posttraumatic stress disorder (PTSD) may engage in constricted play, social withdrawal, and avoidance.&nbsp; However, they tend to avoid interactions reminiscent of the abuse, rather than interactions in general.&nbsp; Key features of PTSD include intrusive reexperiencing (eg, nightmares, dissociative flashbacks) and emotional hyperarousal (eg, irritability, aggression, startle response), both of which this girl&#39;s mother does not describe.&nbsp; A lack of response to comfort is not typical of PTSD.</p><p><strong>Educational objective:</strong><br>Early childhood abuse or neglect can result in disrupted attachment to caregivers and difficulty forming healthy relationships.&nbsp; Reactive attachment disorder is characterized by a pattern of emotional and social withdrawal as well as a lack of response to comfort.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 25309,
            "topic": "Reactive attachment disorder",
            "titleId": 25309,
            "title": "Reactive attachment disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 1,
                    "correctTaken": 1034,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autism spectrum disorder",
                    "choiceNumber": 2,
                    "correctTaken": 1484,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disinhibited social engagement disorder",
                    "choiceNumber": 3,
                    "correctTaken": 1976,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Posttraumatic stress disorder",
                    "choiceNumber": 4,
                    "correctTaken": 1030,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reactive attachment disorder",
                    "choiceNumber": 5,
                    "correctTaken": 11513,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2571,2896,true,-1,1*2429,2558,true,-1,1*569,634,true,-1,1*441,462,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28401844",
                    "mediaDataId": 0,
                    "title": "Signs of reactive attachment disorder and disinhibited social engagement disorder at age 12 years: effects of institutional care history and high-quality foster care.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28401844",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26310381",
                    "mediaDataId": 0,
                    "title": "Impaired neural reward processing in children and adolescents with reactive attachment disorder: a pilot study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26310381",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25359236",
                    "mediaDataId": 0,
                    "title": "Annual research review: attachment disorders in early childhoodâ€”clinical presentation, causes, correlates, and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25359236",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 118,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 17041,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1092,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 19771,
            "questionIndex": 21260,
            "questionText": "<p>A 22-year-old man comes to the office due to difficulty concentrating and sleeping.&nbsp; The patient lost his job and moved in with his parents 2 months ago.&nbsp; Although he has been looking for work and revising his resume, he gets distracted and easily loses focus.&nbsp; The patient has not received any interview invitations and is worried that he will be living with his parents for a long time.&nbsp; He feels that he has &#x22;reverted to my high school self,&#x22; playing video games most evenings and going out with friends on the weekends.&nbsp; The patient gets annoyed with his parents occasionally but states that he knows they are &#x22;just trying to be helpful.&#x22;&nbsp; He has been eating more than usual since moving, gaining 3 kg (6.6 lb) and feeling tired during the day.&nbsp; The patient takes 2-3 hours to fall asleep each night and frequently checks the time while in bed.&nbsp; He drinks 3 or 4 beers a week and does not use recreational substances.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows no abnormalities.&nbsp; The patient states that his mood is &#x22;okay,&#x22; and he has a full range of affect.&nbsp; He reports no suicidal ideation.&nbsp; In addition to recommending psychotherapy, which of the following is the most appropriate pharmacotherapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t70440\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Adjustment disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Mood &amp; behavioral symptom onset within 3 months of identifiable stressor</li><li>Marked distress &amp;/or functional impairment</li><li>Does not meet criteria for another DSM-5 disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Differential diagnosis</strong></p></td><td><ul><li>Normal stress response<ul style=\"list-style-type:circle;\"><li>Not excessive, no significant impairment</li></ul></li><li>Acute stress disorder<ul style=\"list-style-type:circle;\"><li>Traumatic event, intrusive reexperiencing</li></ul></li><li>Major depressive disorder<ul style=\"list-style-type:circle;\"><li>&ge;2 weeks, 5/9 symptoms:&nbsp;depressed mood + SIGECAPS</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Psychotherapy is treatment of choice</li><li>Adjunctive pharmacotherapy<ul style=\"list-style-type:circle;\"><li>Short-term, reserved for rapid relief of impairing symptoms (eg, sleep aid, anxiolytic)</li></ul></li></ul></td></tr><tr><td colspan=\"2\"><p style=\"margin-left:.25in;\"><strong>SIGECAPS</strong> = <strong>S</strong>leep disturbance, loss of <strong>I</strong>nterest, excessive <strong>G</strong>uilt, low <strong>E</strong>nergy, impaired <strong>C</strong>oncentration,&nbsp;<strong>A</strong>ppetite disturbance, <strong>P</strong>sychomotor agitation/retardation, &amp; <strong>S</strong>uicidal ideation.</p></td></tr></tbody></table></div><p>This patient&#39;s symptoms of insomnia and impaired concentration, developing within 3 months of an <strong>identifiable stressor</strong> (eg, job loss, moving back in with his parents), are consistent with an <strong>adjustment disorder</strong>.&nbsp; Patients with adjustment disorder experience an excessive response to a stressful life event that impairs daily functioning.&nbsp; <strong>Short-term psychotherapy</strong> is the <strong>primary form of treatment</strong> and focuses on stress reduction, cognitive reframing, definition of realistic goals, and coping skills enhancement.&nbsp; In general, pharmacotherapy is used as an adjunct to psychotherapy when more rapid symptom relief is desired.</p><p>In this patient, short-term or as-needed treatment with <strong>zolpidem</strong> can be used as an <strong>adjunct to sleep hygiene and psychotherapy</strong> to help obtain the restorative sleep needed to function.&nbsp; Zolpidem, a nonbenzodiazepine benzodiazepine receptor agonist, has demonstrated efficacy in the treatment of sleep-onset and sleep-maintenance insomnia.</p><p><strong>(Choice A)</strong>&nbsp; Alprazolam is a benzodiazepine that can be used for short-term management of generalized anxiety and panic disorders.&nbsp; Alprazolam has a fast onset and short duration of action; therefore, it is less likely than zolpidem to improve sleep hygiene.&nbsp; In addition, because of the risk of misuse, it is not recommended in the treatment of maladjustment to stressful life events.</p><p><strong>(Choice B)</strong>&nbsp; Lithium is a mood stabilizer that can be used to treat bipolar disorder.&nbsp; Although this patient has difficulty focusing, he has intermittent irritability and low energy; he is not experiencing the sustained affective symptoms (eg, persistent irritability, elevated mood) or excessive energy seen during a manic episode.</p><p><strong>(Choice C)</strong>&nbsp; Methylphenidate is a stimulant used to treat attention deficit hyperactivity disorder, which is characterized by childhood onset and chronic impairments in attention and concentration.&nbsp; This patient&#39;s recent onset of distractibility and inability to maintain focus following a stressful life event is more consistent with an adjustment disorder.</p><p><strong>(Choice D)</strong>&nbsp; Although quetiapine is sedating, an antipsychotic medication would not be appropriate as a sleep aid in a patient without a comorbid psychotic or mood disorder when safer choices are available.</p><p><strong>Educational objective:</strong><br>Patients with adjustment disorder experience an excessive response to a stressful life event that impairs daily functioning, including sleep.&nbsp; Short-term pharmacotherapy for insomnia can be used as an adjunct to psychotherapy when more rapid symptom relief is desired.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 396,
            "topic": "Adjustment disorders",
            "titleId": 396,
            "title": "Adjustment disorders",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alprazolam",
                    "choiceNumber": 1,
                    "correctTaken": 1732,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lithium",
                    "choiceNumber": 2,
                    "correctTaken": 307,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methylphenidate",
                    "choiceNumber": 3,
                    "correctTaken": 5114,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quetiapine",
                    "choiceNumber": 4,
                    "correctTaken": 1543,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Zolpidem",
                    "choiceNumber": 5,
                    "correctTaken": 10773,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1611,1763,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "130",
                    "mediaDataId": 0,
                    "title": "Adjustment disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22424586",
                    "mediaDataId": 0,
                    "title": "Zolpidem for insomnia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22424586",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 212,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 19469,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 510,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 13586,
            "questionIndex": 14970,
            "questionText": "<p>A 32-year-old man comes to the office due to recurrent episodes of chest pain, dizziness, and numbness.&nbsp; The patient says, &#x22;Suddenly, my heart starts pounding and I have trouble breathing.&nbsp; Then my whole body shakes, I start to sweat, and I feel like I&#39;m going to faint.&nbsp; Many times I also notice numbness and tingling in both arms.&nbsp; It only lasts for a few minutes, but it feels like hours.&#x22;&nbsp; The episodes occur 3 or 4 times a week.&nbsp; He is very worried that similar episodes will occur at work and that he will pass out.&nbsp; The patient has a history of occasional insomnia and hypertension treated with enalapril.&nbsp; His mood is good, and he enjoys his work and spending time with family and friends.&nbsp; The patient both smokes marijuana and drinks 2 or 3 glasses of wine daily.&nbsp; Family history is significant for hypertension, coronary artery disease, and seizure disorder.&nbsp; Physical examination is unremarkable, and laboratory results and ECG are normal.&nbsp; Which of the following is the most appropriate pharmacotherapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33491\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Panic disorder</strong></p></td></tr><tr><td style=\"width: 10%;\"><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td style=\"width: 90%;\"><ul><li>Recurrent &amp; unexpected panic attacks with &ge;4 of the following:<ul style=\"list-style-type:circle;\"><li>Chest pain, palpitations, shortness of breath, choking</li><li>Trembling, sweating, nausea, chills</li><li>Dizziness, paresthesia</li><li>Derealization, depersonalization</li><li>Fear of losing control or of dying</li></ul></li><li>Worry about additional attacks, avoidance behavior</li></ul></td></tr><tr><td style=\"width: 10%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width: 90%;\"><ul><li>First-line/maintenance: SSRI/SNRI &amp;/or cognitive-behavioral therapy</li><li>Acute distress: benzodiazepines</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRI</strong> = serotonin norepinephrine reuptake inhibitor; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p><strong>Recurrent, unexpected episodes</strong> of chest pain, shortness of breath, trembling, sweating, and dizziness lasting several minutes are consistent with <strong>panic disorder</strong>.&nbsp; This patient&#39;s paresthesia (eg, numbness, tingling) is also characteristic.&nbsp; <strong>First-line treatment</strong> options for panic disorder include selective serotonin reuptake inhibitors <strong>(SSRIs)</strong>, serotonin-norepinephrine reuptake inhibitors <strong>(SNRIs)</strong>, and/or <strong>cognitive-behavioral therapy</strong>.</p><p>Benzodiazepines (eg, alprazolam, diazepam) are also effective.&nbsp; However, due to the risks of abuse and addiction, they are typically reserved for short-term use in acutely symptomatic and functionally impaired patients who require rapid relief. They may also be used in patients who do not respond to or cannot tolerate antidepressants.&nbsp; Because benzodiazepines are best avoided in patients with a history of or suspicion for substance abuse, they should not be used as first-line treatment in this patient who smokes marijuana daily and exceeds the recommended limit of 14 alcoholic drinks per week <strong>(Choices A and C)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Buspirone is an antianxiety agent but is not effective for panic disorder.&nbsp; It has a role in the treatment of generalized anxiety disorder.</p><p><strong>(Choice D)</strong>&nbsp; Beta blockers as monotherapy are not effective in panic disorder but have been used to treat performance anxiety.</p><p><strong>Educational objective:</strong><br>Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors are first-line pharmacotherapy for panic disorder.&nbsp; Benzodiazepines are reserved for patients who require immediate relief and should be avoided in those with substance abuse.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 19090,
            "topic": "Panic disorder",
            "titleId": 19090,
            "title": "Panic disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alprazolam",
                    "choiceNumber": 1,
                    "correctTaken": 1851,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Buspirone",
                    "choiceNumber": 2,
                    "correctTaken": 749,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diazepam",
                    "choiceNumber": 3,
                    "correctTaken": 1109,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Propranolol",
                    "choiceNumber": 4,
                    "correctTaken": 2505,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline",
                    "choiceNumber": 5,
                    "correctTaken": 10778,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1340,1622,true,-1,1*369,468,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21733234",
                    "mediaDataId": 0,
                    "title": "Evidence-based pharmacotherapy of panic disorder: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21733234",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25955736",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of generalized anxiety disorder and panic disorder in adults.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25955736",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 110,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 17116,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 367,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 6978,
            "questionIndex": 6978,
            "questionText": "<p>A 32-year-old woman is brought to the office by her husband due to his concern about her increasing social withdrawal.&nbsp; The patient prefers to stay at home.&nbsp; When she must run errands, she insists that her husband accompany her.&nbsp; She stopped working 2 years ago due to severe episodes of anxiety that would occur unpredictably for no apparent reason.&nbsp; Since that time, the patient has continued to experience these episodes several times a week and has become more socially isolated due to fears of having another episode.&nbsp; She avoids seeing her friends except for the rare occasions when they come to her home.&nbsp; The patient feels badly that she is no longer working and contributing to the household finances.&nbsp; She has occasional difficulty falling asleep and problems with concentration.&nbsp; Although she is not looking for work, she keeps her home clean, cooks nightly, and enjoys watching television.&nbsp; Which of the following is the most likely cause of this patient&#39;s social withdrawal?</p>",
            "questionHeader": "",
            "explanationText": "<p>The patient&#39;s history of <strong>recurrent</strong>, <strong>spontaneous anxiety attacks</strong> and development of <strong>avoidance behavior</strong> are most consistent with <strong>panic disorder</strong>.&nbsp; Patients with panic attacks frequently develop <strong>agoraphobia</strong>, which is anxiety and avoidance of &#8805;2 situations in which it may be difficult to escape or get help (eg, being outside the home or in enclosed spaces, using transportation) in the event of a panic attack.</p><p>In severe cases, patients can become homebound or leave home only when accompanied by others, resulting in marked social and occupational impairment.&nbsp; Agoraphobia can also be diagnosed independently of panic disorder.&nbsp; Avoidance behavior and agoraphobia are best treated with cognitive behavioral approaches.</p><p><strong>(Choices A, B, and E)</strong>&nbsp; Although this patient has become socially avoidant and dependent on her husband, these behaviors are better explained as complications of her 2-year history of panic disorder.&nbsp; Personality disorders involve long-standing patterns of behavior dating back to adolescence.&nbsp; Patients with avoidant personality disorder fear negative evaluation and do not have panic attacks.&nbsp; Dependent personality disorder involves a pattern of submissive and clinging behavior in order to be cared for by others.&nbsp; Individuals with schizoid personality disorder are socially isolated by choice.</p><p><strong>(Choice D)</strong>&nbsp; This patient has insufficient symptoms to diagnose persistent depressive disorder.</p><p><strong>(Choice F)</strong>&nbsp; Although patients with social anxiety disorder may also avoid certain public places, their fear is of social humiliation and criticism and they do not experience spontaneous panic attacks.</p><p><strong>Educational objective:</strong><br>Panic disorder is characterized by recurrent, unexpected panic attacks and fears about future attacks and/or maladaptive behavior related to the attacks.&nbsp; Some patients will develop agoraphobia, which is the avoidance of &#8805;2 situations in which escape or obtaining help may not be possible.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 19090,
            "topic": "Panic disorder",
            "titleId": 19090,
            "title": "Panic disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Avoidant personality disorder",
                    "choiceNumber": 1,
                    "correctTaken": 654,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dependent personality disorder",
                    "choiceNumber": 2,
                    "correctTaken": 310,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic disorder",
                    "choiceNumber": 3,
                    "correctTaken": 12657,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 201,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizoid personality disorder",
                    "choiceNumber": 5,
                    "correctTaken": 143,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Social anxiety disorder",
                    "choiceNumber": 6,
                    "correctTaken": 2999,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1818,1953,true,-1,1*588,746,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24829902",
                    "mediaDataId": 0,
                    "title": "Disability and comorbidity: diagnoses and symptoms associated with disability in a clinical population with panic disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24829902",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27423353",
                    "mediaDataId": 0,
                    "title": "A discussion of various aspects of panic disorder depending on presence or absence of agoraphobia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27423353",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 131,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 16964,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 759,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 2506,
            "questionIndex": 2506,
            "questionText": "<p>A 19-year-old woman who is struggling academically comes to the university health clinic.&nbsp; The patient is assessed by a counselor and referred to the clinic&#39;s physician for symptoms of anxiety, insomnia, and fatigue.&nbsp; For the past year, the patient has worried excessively about whether her door is locked and the stove is turned off, so she checks the door and stove multiple times during the day and night.&nbsp; Although she knows she has locked the door and turned off the stove and that her fears &#x22;don&#39;t make sense,&#x22; she is unable to stop thinking about them until she checks.&nbsp; She also is concerned that spending so much time on these thoughts does not allow her time to complete assignments or get enough sleep.&nbsp; When the patient does complete assignments, she spends a great deal of time checking her work repeatedly.&nbsp; Her medications include daily oral contraceptives.&nbsp; She has no significant medical or psychiatric history.&nbsp; The patient does not use illicit drugs and has no feelings of depression or hopelessness.&nbsp; Physical examination is unremarkable.&nbsp; Which of the following would be the most appropriate treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33713\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Obsessive-compulsive disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li><strong>Obsessions </strong><ul style=\"list-style-type:circle;\"><li>Recurrent, intrusive, anxiety-provoking thoughts, urges, or images</li></ul></li><li><strong>Compulsions</strong><ul style=\"list-style-type:circle;\"><li>Response to obsessions with repeated behaviors or mental acts</li><li>Behaviors not connected realistically with preventing feared event</li></ul></li><li>Time-consuming (&gt;1 hr/day) or causing significant distress or impairment</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Selective serotonin reuptake inhibitor</li><li>Cognitive-behavioral therapy (exposure &amp; response prevention)</li></ul></td></tr></tbody></table></div><p>This patient has <strong>obsessive-compulsive disorder (OCD)</strong>, a condition characterized by time-consuming, recurrent, unwanted thoughts (obsessions) and repetitive behaviors that the patient feels compelled to perform (compulsions).&nbsp; <strong>First-line</strong> treatment includes <strong>cognitive-behavioral therapy</strong> based on exposure and response prevention (ERP) and/or pharmacotherapy with a <strong>selective serotonin reuptake inhibitor</strong> (eg, fluoxetine, fluvoxamine, paroxetine, sertraline).</p><p>ERP therapy involves repeated exposure to thoughts, images, and situations that provoke obsessional fears followed by prevention of the accompanying compulsion.&nbsp; For example, a therapist would guide this patient to practice leaving home after checking the stove and door once (<strong>exposure</strong>) and then prevent her from checking repeatedly (<strong>response prevention</strong>).&nbsp; Initially, anxiety increases, but with prolonged and repetitive exposure, habituation occurs and the anxiety subsides.</p><p><strong>(Choice A)</strong>&nbsp; Buspirone is used to treat generalized anxiety disorder; it does not have a role in OCD.</p><p><strong>(Choice B)</strong>&nbsp; Clomipramine is a tricyclic antidepressant that inhibits the reuptake of serotonin and norepinephrine.&nbsp; Although it has comparable efficacy to selective serotonin reuptake inhibitors in the treatment of OCD, it is not used first-line due to its unfavorable side-effect profile (eg, sedation, urinary hesitancy, orthostatic hypotension, cardiac conduction delay).</p><p><strong>(Choice D)</strong>&nbsp; Dialectical behavioral therapy is a type of psychotherapy developed for borderline personality disorder that integrates standard cognitive-behavioral therapy techniques with principles of mindfulness, distress tolerance, and emotion regulation.&nbsp; This patient&#39;s OCD symptoms are more likely to respond to ERP techniques.</p><p><strong>(Choices E and G)</strong>&nbsp; Psychodynamic psychotherapy, which traces problems back to their origins in childhood and unconscious conflict, may provide the patient with insight, but it is not effective in changing the compulsive behaviors seen in OCD.&nbsp; Supportive psychotherapy is a broadly applicable approach that helps to reduce stress, improve coping skills, and maintain hope.&nbsp; However, it does not specifically target obsessive and compulsive symptoms.</p><p><strong>(Choice F)</strong>&nbsp; The combination of a serotonergic agent (eg, sertraline) and an antipsychotic (eg, aripiprazole) is not a first-line treatment and would be reserved for patients who respond poorly to monotherapy.</p><p><strong>Educational objective:</strong><br>First-line treatments for obsessive-compulsive disorder are exposure and response prevention techniques based on cognitive-behavioral therapy and selective serotonin reuptake inhibitors.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17181,
            "topic": "Obsessive compulsive disorder",
            "titleId": 17181,
            "title": "Obsessive compulsive disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Buspirone",
                    "choiceNumber": 1,
                    "correctTaken": 437,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clomipramine",
                    "choiceNumber": 2,
                    "correctTaken": 1807,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cognitive-behavioral therapy",
                    "choiceNumber": 3,
                    "correctTaken": 12590,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dialectical behavioral therapy",
                    "choiceNumber": 4,
                    "correctTaken": 352,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Psychodynamic psychotherapy",
                    "choiceNumber": 5,
                    "correctTaken": 367,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline and aripiprazole",
                    "choiceNumber": 6,
                    "correctTaken": 1251,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Supportive psychotherapy",
                    "choiceNumber": 7,
                    "correctTaken": 119,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1527,1890,true,-1,1*381,481,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19635238",
                    "mediaDataId": 0,
                    "title": "Psychotherapy for obsessive-compulsive disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19635238",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25119610",
                    "mediaDataId": 0,
                    "title": "Clinical practice:  obsessive-compulsive disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25119610",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24576790",
                    "mediaDataId": 0,
                    "title": "Obsessive-compulsive disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24576790",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 100,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 16926,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 480,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 4063,
            "questionIndex": 4063,
            "questionText": "<p>A 16-year-old boy comes to the office due to concentration difficulties.&nbsp; The patient recently started working as a busboy in a restaurant and is afraid that he will be fired because he cannot focus or follow through on assigned tasks and is often late.&nbsp; He says, &#x22;I live close to work, but the drive takes me a long time&mdash;I have to make a lot of stops.&#x22;&nbsp; Every time the patient drives over a bump in the road, he is convinced that he has accidentally run over someone and immediately pulls over to check under the car.&nbsp; At work, he is unable to focus and must frequently scan through news articles to see if any hit-and-run accidents have been reported.&nbsp; The patient&#39;s grades have been slightly below average since elementary school; he plays football on the school team.&nbsp; His parents are divorced; he lives with his mother during the week and spends weekends with his father.&nbsp; The patient has no previous psychiatric history; family history is notable for attention deficit hyperactivity disorder in his brother, who responded to methylphenidate.&nbsp; The first-line pharmacotherapy for this patient&#39;s condition primarily affects which of the following neurotransmitters?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T33713\" style=\"overflow-x:auto;\" tid=\"3224\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Obsessive-compulsive disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li><strong>Obsessions</strong><ul style=\"list-style-type:circle;\"><li>Recurrent, intrusive, anxiety-provoking thoughts, urges, or images</li></ul></li><li><strong>Compulsions</strong><ul style=\"list-style-type:circle;\"><li>Response to obsessions with repeated behaviors or mental acts</li><li>Behaviors not connected realistically with preventing feared event</li></ul></li><li>Time-consuming (&gt;1 hr/day) or causing significant distress or impairment</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Selective serotonin reuptake inhibitor</li><li>Cognitive-behavioral therapy (exposure &amp; response prevention)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s behavior is highly suggestive of <strong>obsessive-compulsive disorder (OCD)</strong>.&nbsp; OCD often starts in childhood or adolescence and is characterized by the presence of <strong>persistent intrusive thoughts</strong>/urges/images and/or compulsive acts performed in response to obsessions.</p><p>Common themes in OCD involve fears of contamination, aggressive and sexual impulses, symmetry obsessions, and <strong>fears of harm</strong>.&nbsp; Images of horrific scenes (eg, running over a person) or violent urges (eg, to stab someone) can also occur.&nbsp; Related compulsions include cleaning rituals, <strong>checking behaviors</strong> (eg, this patient checking under his car and then scanning news articles), and mental acts performed in response to the obsession (eg, counting, repeating words silently, praying).&nbsp; Patients with OCD often perform multiple time-consuming rituals and recognize the irrational nature of their behavior, but they are unable to stop and are likely to suffer significant distress and functional impairment (eg, late to work, unable to concentrate on tasks).</p><p>Although multiple neurotransmitters and regulatory mechanisms are thought to contribute to the clinical expression of OCD, <strong>serotonin</strong> is the primary pharmacological target.&nbsp; <strong>First-line treatment</strong> is a <strong>selective serotonin reuptake inhibitor</strong> (SSRI) (eg, fluoxetine).&nbsp; The serotonergic tricyclic antidepressant clomipramine is generally considered second line due to potential adverse effects.</p><p><strong>(Choice A)</strong>&nbsp; Dopamine is the primary pharmacological target of stimulant medications used in the treatment of attention deficit hyperactivity disorder (ADHD).&nbsp; Although this patient has concentration concerns and a family history of ADHD, his inability to maintain focus is better attributed to the intrusive obsessions that keep him preoccupied.</p><p><strong>(Choice B)</strong>&nbsp; GABA is the major inhibitory neurotransmitter in the CNS and is the primary target of benzodiazepines.&nbsp; Benzodiazepines can be used short-term in treatment-resistant anxiety; however, they are not indicated for use in OCD.</p><p><strong>(Choice C)</strong>&nbsp; Glutamate is the major excitatory neurotransmitter in the CNS, and altered neurotransmission may contribute to OCD symptoms.&nbsp; Glutamate modulators (eg, topiramate) can be used as augmenting agents; however, serotonin is the primary pharmacological target, making SSRIs the initial treatment of choice.</p><p><strong>(Choice D)</strong>&nbsp; Norepinephrine is a catecholamine involved in mood, anxiety, alertness, learning, and memory.&nbsp; Although drugs that affect both serotonin and norepinephrine are used in the treatment of OCD (eg, serotonin-norepinephrine reuptake inhibitors), the role of serotonin is primary.</p><p><strong>Educational objective:</strong><br>Serotonin is the primary neurotransmitter targeted in pharmacotherapy of obsessive-compulsive disorder.&nbsp; Selective serotonin reuptake inhibitors are first-line treatment options.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17181,
            "topic": "Obsessive compulsive disorder",
            "titleId": 17181,
            "title": "Obsessive compulsive disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Dopamine",
                    "choiceNumber": 1,
                    "correctTaken": 322,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "GABA",
                    "choiceNumber": 2,
                    "correctTaken": 133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glutamate",
                    "choiceNumber": 3,
                    "correctTaken": 136,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Norepinephrine",
                    "choiceNumber": 4,
                    "correctTaken": 402,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serotonin",
                    "choiceNumber": 5,
                    "correctTaken": 4003,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "755,1508,true,-1,1*1772,1896,true,-1,1*2491,2792,true,-1,1*2805,3079,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30101713",
                    "mediaDataId": 0,
                    "title": "Psychopharmacological treatment of obsessive-compulsive disorder (ocd).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30101713",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 104,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 5083,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 527,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 19770,
            "questionIndex": 21259,
            "questionText": "<p>A 22-year-old woman comes to student health services for evaluation of low mood and anxiety.&nbsp; The patient received a rejection letter a week ago from her top choice for graduate school.&nbsp; Although she has received multiple acceptance letters from other programs, she feels like a &#x22;failure&#x22; and has not spoken to any of her friends or family for the past few days because she is too ashamed.&nbsp; The patient angrily states, &#x22;I have classmates that got much worse grades and have no publications, but they all got into better schools than I did.&#x22;&nbsp; She has been staying in bed instead of attending classes and has been eating large amounts of junk food.&nbsp; The patient says that her life is now &#x22;pointless&#x22; and that she would be &#x22;better off dead.&#x22;&nbsp; She has no medical or psychiatric history.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows no abnormalities.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t70440\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Adjustment disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Mood &amp; behavioral symptom onset within 3 months of identifiable stressor</li><li>Marked distress &amp;/or functional impairment</li><li>Does not meet criteria for another DSM-5 disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Differential diagnosis</strong></p></td><td><ul><li>Normal stress response<ul style=\"list-style-type:circle;\"><li>Not excessive, no significant impairment</li></ul></li><li>Acute stress disorder<ul style=\"list-style-type:circle;\"><li>Traumatic event, intrusive reexperiencing</li></ul></li><li>Major depressive disorder<ul style=\"list-style-type:circle;\"><li>&ge;2 weeks, 5/9 symptoms:&nbsp;depressed mood + SIGECAPS</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Psychotherapy is treatment of choice</li><li>Adjunctive pharmacotherapy<ul style=\"list-style-type:circle;\"><li>Short-term, reserved for rapid relief of impairing symptoms (eg, sleep aid, anxiolytic)</li></ul></li></ul></td></tr><tr><td colspan=\"2\"><p style=\"margin-left:.25in;\"><strong>SIGECAPS</strong> = <strong>S</strong>leep disturbance, loss of <strong>I</strong>nterest, excessive <strong>G</strong>uilt, low <strong>E</strong>nergy, impaired <strong>C</strong>oncentration,&nbsp;<strong>A</strong>ppetite disturbance, <strong>P</strong>sychomotor agitation/retardation, &amp; <strong>S</strong>uicidal ideation.</p></td></tr></tbody></table></div><p>This patient&#39;s 1-week history of mood symptoms in direct response to receiving a rejection letter is most consistent with an <strong>adjustment disorder</strong>.&nbsp; Adjustment disorder involves emotional or behavioral symptoms that develop <strong>within 3 months</strong> of an <strong>identifiable stressor</strong>.&nbsp; In contrast to a normal stress response, symptoms are excessive or out of proportion to the stressor and result in significant distress and functional impairment.</p><p>Although this patient is currently experiencing several depressive symptoms (ie, low mood, feelings of failure, increased appetite, passive suicidal ideation), her 1-week duration of symptoms is insufficient to meet diagnostic criteria for major depressive disorder (MDD) <strong>(Choice F)</strong>.&nbsp; In MDD, symptoms must persist for at least 2 weeks and include at least 5 of the following 9 symptoms: depressed mood plus <strong>SIGECAPS</strong> (<strong>S</strong>leep disturbance, loss of <strong>I</strong>nterest, excessive <strong>G</strong>uilt, low <strong>E</strong>nergy, impaired <strong>C</strong>oncentration, <strong>A</strong>ppetite disturbance, <strong>P</strong>sychomotor agitation/retardation, <strong>S</strong>uicidal ideation).</p><p><strong>(Choice A)</strong>&nbsp; Acute stress disorder requires exposure to a life-threatening traumatic event.&nbsp; It is characterized by reexperiencing events (ie, intrusive memories, flashbacks), avoidance, negative mood, dissociation, and hyperarousal lasting from 3 days to 1 month.</p><p><strong>(Choices C and E)</strong>&nbsp; This patient shows some features that are also seen in borderline personality disorder (eg, angry response to rejection, unstable mood, suicidality) and histrionic personality disorder (eg, excessive emotionality).&nbsp; However, diagnosis of personality disorders requires evidence of pervasive patterns of dysfunctional interpersonal behavior that are stable and of long duration.&nbsp; This patient&#39;s 1-week history of symptoms in direct response to a stressor is more consistent with adjustment disorder.</p><p><strong>(Choice D)</strong>&nbsp; Disruptive mood dysregulation disorder is a pediatric mood disorder characterized by persistent irritability (&#8805;1 year) and frequent temper outbursts that begin prior to age 10.</p><p><strong>Educational objective:</strong><br>Adjustment disorder is characterized by the development of emotional or behavioral symptoms in response to an identifiable stressor.&nbsp; Symptoms cause significant distress and functional impairment but do not meet the criteria for another mental disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 396,
            "topic": "Adjustment disorders",
            "titleId": 396,
            "title": "Adjustment disorders",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "2",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute stress disorder",
                    "choiceNumber": 1,
                    "correctTaken": 5832,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 2,
                    "correctTaken": 8991,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Borderline personality disorder",
                    "choiceNumber": 3,
                    "correctTaken": 2266,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disruptive mood dysregulation disorder",
                    "choiceNumber": 4,
                    "correctTaken": 722,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Histrionic personality disorder",
                    "choiceNumber": 5,
                    "correctTaken": 1230,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 6,
                    "correctTaken": 1362,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2611,2788,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31315203",
                    "mediaDataId": 0,
                    "title": "Adjustment disorder: current developments and future directions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31315203",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29107817",
                    "mediaDataId": 0,
                    "title": "Adjustment disorder: a diagnosis whose time has come.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29107817",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 212,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 20403,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 44,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 450,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 19444,
            "questionIndex": 20930,
            "questionText": "<p>A 13-year-old girl comes to the office with her mother due to concentration difficulties for the past month.&nbsp; The patient recently started at a new school and has been taking much longer to read through assignments and finish her homework.&nbsp; When called on by the teacher in class, her mind &#x22;goes blank,&#x22; and she is often unable to remember what she wanted to say.&nbsp; Although she has maintained average grades, the patient is concerned her recent lack of attention will cause her to fail out of school and not attend college.&nbsp; The mother says, &#x22;I have to constantly remind her to calm down and focus because she gets wound up so easily about everything and thinks the worst is going to happen.&nbsp; She&#39;s been like that since she was little.&#x22;&nbsp; Vital signs are within normal limits; growth curves are tracking consistently.&nbsp; Physical examination shows no abnormalities.&nbsp; On mental status examination, the patient is cooperative and friendly but sometimes fidgets in her seat.&nbsp; Which of the following is the most appropriate pharmacotherapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t69536\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Generalized anxiety disorder in children</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical&nbsp;features</strong></p></td><td><ul><li>Excessive, uncontrollable worry (multiple issues) &ge;6&nbsp;months</li><li>&ge;1 of the following symptoms:<ul><li>Restlessness; feeling on edge</li><li>Fatigue</li><li>Difficulty concentrating</li><li>Irritability</li><li>Muscle tension</li><li>Sleep disturbance</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Associated&nbsp;features</strong></p></td><td><ul><li>Physical symptoms: stomachaches, headaches</li><li>Perfectionism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Cognitive-behavioral therapy</li><li>SSRIs or SNRIs</li></ul></td></tr><tr><td><p align=\"center\"><strong>Differential&nbsp;diagnosis</strong></p></td><td><ul><li>Adjustment disorder (response to identifiable stressor)</li><li>Obsessive-compulsive disorder (intrusive thoughts; compulsive behaviors)</li><li>Separation anxiety disorder (anxiety focused on separation from caregiver)</li><li>Social anxiety disorder (fears of negative evaluation in social/performance situations)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRIs</strong>&nbsp;=&nbsp;serotonin-norepinephrine reuptake inhibitor; <strong>SSRIs</strong>&nbsp;=&nbsp;selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>This patient&#39;s concentration difficulties associated with chronic worry, tension, and restlessness are suggestive of <strong>generalized anxiety disorder</strong> (GAD), a common anxiety disorder of childhood and adolescence.&nbsp; <strong>Excessive worrying</strong> may frequently cause cognitive impairment, including feeling the mind is going blank, easy distractibility, and indecisiveness.&nbsp; <strong>Catastrophic fears</strong> of the worst-case scenario, muscle tension, and physical restlessness (eg, fidgeting, leg shaking) are characteristic features.&nbsp; Adolescents with GAD are often perfectionistic and worry excessively about academic performance.</p><p>When GAD symptoms are severe and impair social and academic functioning, <strong>pharmacotherapy</strong> is appropriate and is typically combined with <strong>cognitive-behavioral therapy</strong>.&nbsp; <strong>Selective serotonin reuptake inhibitors</strong> (eg, sertraline) are considered the first-line pharmacotherapy for GAD in children and adolescents.</p><p><strong>(Choice A)</strong>&nbsp; Although the sedating antihistamine hydroxyzine can be used short-term for situational anxiety in children (eg, preoperative anxiety), it is not considered a first-line treatment for pediatric GAD.</p><p><strong>(Choice B)</strong>&nbsp; The stimulant methylphenidate is a first-line pharmacotherapy for attention-deficit hyperactivity disorder (ADHD), which can cause impaired concentration and hyperactivity (eg, fidgeting) in different settings (eg, school, home).&nbsp; However, symptoms of impaired concentration must be present prior to age 12; in contrast, this patient has recent challenges with concentration (likely related to anxiety from starting at a new school) associated with a longstanding history of chronic anxiety (&#x22;thinks the worst is going to happen,&#x22; &#x22;since she was little&#x22;), which is more consistent with GAD.</p><p><strong>(Choice C)</strong>&nbsp; The beta blocker propranolol is used in the treatment of performance anxiety in adults.&nbsp; This patient&#39;s excessive worries are not limited to performing/speaking and being evaluated by others and are more consistent with GAD.</p><p><strong>(Choice E)</strong>&nbsp; Tetrabenazine, a vesicular monoamine transporter 2 inhibitor, has been used in the treatment of Tourette syndrome, a neurologic disorder manifested by motor and phonic tics with childhood onset.</p><p><strong>Educational objective:</strong><br>Generalized anxiety disorder (GAD) is a common anxiety disorder in children and adolescents characterized by persistent and excessive worry and tension.&nbsp; When GAD symptoms are severe and impairing, treatment with a selective serotonin reuptake inhibitor combined with cognitive-behavioral therapy is indicated.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 18230,
            "topic": "Generalized anxiety disorder",
            "titleId": 18230,
            "title": "Generalized anxiety disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hydroxyzine",
                    "choiceNumber": 1,
                    "correctTaken": 593,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methylphenidate",
                    "choiceNumber": 2,
                    "correctTaken": 7711,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Propranolol",
                    "choiceNumber": 3,
                    "correctTaken": 1015,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline",
                    "choiceNumber": 4,
                    "correctTaken": 11117,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tetrabenazine",
                    "choiceNumber": 5,
                    "correctTaken": 196,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "138,148,true,-1,1*209,216,true,-1,1*242,287,true,-1,1*308,364,true,-1,1*1045,1437,true,-1,1*1755,1889,true,-1,1*2196,2556,true,-1,1*2806,3000,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30699096",
                    "mediaDataId": 0,
                    "title": "Recognizing, diagnosing, and treating pediatric generalized anxiety disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30699096",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30056792",
                    "mediaDataId": 0,
                    "title": "Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30056792",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 115,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 20632,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1232,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 19604,
            "questionIndex": 21090,
            "questionText": "<p>A 28-year-old primigravida at 16 weeks gestation comes to the office for a routine prenatal visit.&nbsp; The patient has had muscle aches for the past 3 months.&nbsp; She did not think much of her soreness early in the pregnancy, but her symptoms have become more bothersome.&nbsp; The patient reports feeling fatigued and sleeping restlessly even before becoming pregnant and takes short naps most days.&nbsp; Throughout the past year, she has spent much of her time thinking about whether she can tolerate the pain of labor and if her marriage and health will be affected by having a baby.&nbsp; The patient usually feels comforted after talking to her mother but becomes overwhelmed again soon after.&nbsp; She has no chronic medical conditions and takes a prenatal vitamin.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows no abnormalities, and fetal heart tones are normal.&nbsp; Complete blood count, comprehensive metabolic panel, and TSH are normal.&nbsp; Which of the following is the most appropriate statement in response to this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t69535\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Generalized anxiety disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Excessive, uncontrollable worry (multiple issues) &ge;6 months</li><li>&ge;3 of the following symptoms (&ge;1 in children):<ul><li>Restlessness, feeling on edge</li><li>Fatigue</li><li>Difficulty concentrating</li><li>Irritability</li><li>Muscle tension</li><li>Sleep disturbance</li></ul></li></ul><ul><li>Chronic, fluctuating course; academic/occupational dysfunction</li></ul></td></tr><tr><td><p align=\"center\"><strong>Associated features</strong></p></td><td><ul><li>Physical symptoms related to tension (headaches, neck pain)</li><li>Comorbid depression, substance use common</li><li>Increased risk of high health care utilization, cardiovascular events</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Cognitive-behavioral therapy</li><li>SSRI or SNRI</li><li>Buspirone</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRI</strong> = serotonin-norepinephrine reuptake inhibitor; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>This patient&#39;s history of feeling easily overwhelmed by <strong>anxiety</strong> and multiple <strong>worries</strong> (eg, pain of labor, impact of baby on marriage and health), accompanied by nonspecific <strong>physical symptoms</strong> (eg, muscle aches, fatigue, and sleep disturbance that began before the pregnancy), is consistent with <strong>generalized anxiety disorder</strong> (GAD).&nbsp; GAD, a common anxiety disorder prevalent in the perinatal population, can negatively impact maternal and fetal health and mother-infant bonding.&nbsp; Treatment should be recommended when symptoms are distressing and interfering with functioning, as in this patient.</p><p>First-line treatment of GAD consists of <strong>psychotherapy</strong> (eg, cognitive-behavioral therapy [CBT]) and/or psychopharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).&nbsp; Although some SSRIs and SNRIs can be used in pregnancy (eg, in stable patients at high risk of psychiatric decompensation without pharmacotherapy, in patients with distressing symptoms), psychotherapy can often be considered first.&nbsp; <strong>CBT techniques</strong> include cognitive restructuring to reduce catastrophic thinking and relaxation training (eg, breathing, progressive muscle relaxation) to address physical symptoms such as muscle tension, restlessness, and poor sleep.&nbsp; Applying these techniques during anxiety-provoking situations is effective in reducing psychological and physiological anxiety symptoms.</p><p><strong>(Choice A)</strong>&nbsp; Normal pregnancy-related anxiety can be managed with reassurance and family support.&nbsp; It is differentiated from GAD by the absence of significant distress or functional impairment.&nbsp; This patient&#39;s anxiety symptoms were present before she became pregnant and are worsening, distressing, and impairing; treatment is warranted.</p><p><strong>(Choice B)</strong>&nbsp; Acetaminophen and relaxation training can target some pregnancy-related physical and emotional changes.&nbsp; They would also target physical symptoms of GAD.&nbsp; However, they would not address the psychological aspects of anxiety.&nbsp; Psychotherapy that also targets the emotional and cognitive aspects of anxiety is more likely to improve overall functioning.</p><p><strong>(Choice C)</strong>&nbsp; Restless legs syndrome is common during pregnancy and can contribute to poor sleep and fatigue.&nbsp; However, it is characterized by an uncomfortable feeling at rest that is relieved by movement rather than by muscle aches.&nbsp; It would not explain this patient&#39;s excessive and overwhelming anxiety.</p><p><strong>Educational objective:</strong><br>Perinatal generalized anxiety disorder is common and requires treatment when symptoms are distressing and impairing.&nbsp; Psychotherapy is a first-line treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 18230,
            "topic": "Generalized anxiety disorder",
            "titleId": 18230,
            "title": "Generalized anxiety disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;It&#39;s natural to be worried when it&#39;s your first pregnancy; I encourage you to keep talking with your mother who can be an important source of support for you.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 4108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;There are lots of physical and emotional changes that occur in pregnancy; scheduled acetaminophen and relaxation techniques may help decrease your symptoms.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 2869,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Your symptoms and sleep difficulty may be due to restless legs syndrome, which is very common in pregnancy.&nbsp; Are you experiencing an urge to move your legs at night?&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 1430,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Your symptoms may be due to a treatable anxiety disorder; psychotherapy can help relieve the physical symptoms and worries you are experiencing.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 8807,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2489,2592,true,-1,1*2645,2714,true,-1,1*137,182,true,-1,1*376,547,true,-1,1*600,609,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26125602",
                    "mediaDataId": 0,
                    "title": "Perinatal generalized anxiety disorder: assessment and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26125602",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30934083",
                    "mediaDataId": 0,
                    "title": "Generalized anxiety disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30934083",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 170,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 17214,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 908,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 11007,
            "questionIndex": 12146,
            "questionText": "<p>A 38-year-old woman is brought to the emergency department by her sister after developing acute anxiety, headache, nausea, and vomiting while eating dinner.&nbsp; The patient has no history of migraine, hypertension, or diabetes.&nbsp; She has no known food allergies but does have a history of seasonal allergies treated with diphenhydramine.&nbsp; The patient has a long history of major depressive disorder and panic attacks and has had poor response to several antidepressants.&nbsp; For the past year, she has been treated with escitalopram, which she discontinued a week ago.&nbsp; Yesterday, she started taking phenelzine for depressive symptoms.&nbsp; On arrival, the patient is agitated, disoriented, diaphoretic, and tremulous.&nbsp; Temperature is 38.9 C (102 F), blood pressure is 170/110 mm Hg, pulse is 115/min, and respirations are 24/min.&nbsp; Physical examination shows dilated pupils and bilateral tremors.&nbsp; Deep tendon reflexes are 3+ bilaterally.&nbsp; Which of the following is the most likely cause of these findings in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33501\"><table class=\"table-default-style table-header-footer-style\" style=\"width:100.0%\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Serotonin toxicity</strong></p></td></tr><tr><td><p align=\"center\"><strong>Causes</strong></p></td><td><ul><li>Serotonergic medications, especially in combination (eg, SSRI/SNRI, TCA, tramadol)</li><li>Drug interactions: serotonergic medication &amp; MAOI or linezolid</li><li>Intentional overdose of serotonergic medications</li><li>Serotonergic substances (eg, MDMA, dextromethorphan, amphetamines)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Mental status changes (eg, anxiety, agitation, delirium)</li><li>Autonomic dysregulation (eg, diaphoresis, hypertension, tachycardia, hyperthermia, vomiting, diarrhea)</li><li>Neuromuscular hyperactivity (eg, tremor, myoclonus, hyperreflexia)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Discontinuation of all serotonergic medications</li><li>Supportive care, sedation with benzodiazepines</li><li>Serotonin antagonist (cyproheptadine) if supportive measures fail</li><li>Immediate sedation, paralysis &amp; tracheal intubation if temperature &gt;41.1 C (106 F)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>MAOI</strong> = monoamine oxidase inhibitor; <strong>SNRI</strong> = serotonin-norepinephrine reuptake inhibitor; <strong>SSRI </strong>= selective serotonin reuptake inhibitor; <strong>TCA</strong> = tricyclic antidepressant.</p></td></tr></tbody></table></div><p>This patient is taking phenelzine, a monoamine oxidase inhibitor (MAOI) used in treatment-resistant depression.&nbsp; MAOIs irreversibly inhibit monoamine oxidase, preventing the oxidative deamination of serotonin, norepinephrine, and dopamine.&nbsp; Her acute symptoms (agitated delirium, diaphoresis, hyperthermia, hypertension, tachycardia, dilated pupils, vomiting, tremor, and hyperreflexia) are consistent with <strong>serotonin toxicity</strong>, most likely due to a <strong>drug-drug interaction</strong> between phenelzine and escitalopram, the selective serotonin reuptake inhibitor (SSRI) that she discontinued a week ago.&nbsp; <a href=\"1207\">Serotonin toxicity</a> is caused by excess serotonin levels and is characterized by a triad of <strong>mental status changes</strong>, <strong>autonomic dysregulation</strong>, and <strong>neuromuscular hyperactivity</strong>.</p><p>Most <strong>antidepressants</strong> should be <strong>discontinued 2 weeks before beginning an MAOI</strong> to avoid serotonin toxicity.&nbsp; The SSRI fluoxetine is an exception due to its long half-life and must be stopped 5 weeks before initiating an MAOI.</p><p><strong>(Choice A)</strong>&nbsp; Anticholinergic toxicity is characterized by hyperthermia, delirium, dilated pupils, dry mucous membranes, urinary retention, and decreased bowel sounds.&nbsp; It would not cause diaphoresis, hyperreflexia, and tremors, as seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Malignant hyperthermia presents with hyperthermia, tachycardia, rigidity, and rhabdomyolysis following the administration of succinylcholine or a volatile inhaled anesthetic (eg, halothane, sevoflurane).</p><p><strong>(Choice C)</strong>&nbsp; Neuroleptic malignant syndrome is characterized by hyperactive vital signs (eg, hyperthermia, tachycardia), altered mental status, and rigidity that develops in the context of antipsychotic use.&nbsp; The absence of an inciting medication, this patient&#39;s hyperreflexia, and the overall clinical picture make serotonin toxicity more likely.</p><p><strong>(Choice D)</strong>&nbsp; Abrupt discontinuation of short&ndash;half-life antidepressants can cause dizziness, fatigue, headache, nausea, anxiety, myalgia, and paresthesia.&nbsp; However, it would not cause agitated delirium, hyperthermia, hypertension, and hyperreflexia, which are more consistent with serotonin toxicity.</p><p><strong>(Choice F)</strong>&nbsp; A hypertensive crisis may occur in patients who consume foods rich in the sympathomimetic substance tyramine while taking an MAOI.&nbsp; Prohibited foods include aged cheeses and aged, smoked, pickled, or cured meats/fish/poultry.&nbsp; Although this patient&#39;s meal may have contained tyramine, her dilated pupils, hyperreflexia, and hyperthermia are consistent with serotonin toxicity and not an MAOI-associated hypertensive crisis.</p><p><strong>Educational objective:</strong><br>Switching antidepressants to or from a monoamine oxidase inhibitor (MAOI) must be done cautiously as drug-drug interactions can cause serotonin toxicity.&nbsp; Switching from most antidepressants to an MAOI requires a 2-week washout.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 8437,
            "topic": "Serotonin toxicity",
            "titleId": 8437,
            "title": "Serotonin toxicity",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anticholinergic toxicity",
                    "choiceNumber": 1,
                    "correctTaken": 184,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malignant hyperthermia",
                    "choiceNumber": 2,
                    "correctTaken": 18,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neuroleptic malignant syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 207,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selective serotonin reuptake inhibitor discontinuation syndrome",
                    "choiceNumber": 4,
                    "correctTaken": 220,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serotonin toxicity",
                    "choiceNumber": 5,
                    "correctTaken": 2837,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tyramine-induced hypertensive crisis",
                    "choiceNumber": 6,
                    "correctTaken": 1514,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1791,2014,true,-1,1*1050,1139,true,-1,1*124,138,true,-1,1*278,316,true,-1,1*669,817,true,-1,1*3139,3564,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22951238",
                    "mediaDataId": 0,
                    "title": "Dietary restrictions and drug interactions with monoamine oxidase inhibitors:  an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22951238",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24358002",
                    "mediaDataId": 0,
                    "title": "Serotonin syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24358002",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27824534",
                    "mediaDataId": 0,
                    "title": "Serotonin syndrome:  preventing, recognizing, and treating it.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27824534",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 142,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 5052,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1103,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 13674,
            "questionIndex": 15064,
            "questionText": "<p>An 18-year-old woman comes to the office due to difficulty sleeping and fatigue.&nbsp; The patient started attending college 2 months ago and lives alone in an apartment near campus.&nbsp; For the past month, she has been increasingly anxious at night and thinks that someone is going to break into her home despite living on the eighth floor in a safe neighborhood.&nbsp; The patient makes sure to check that the front and balcony doors are secure every night and locks her bedroom door before going to bed.&nbsp; She wakes up multiple times a night when her air conditioner turns on or when she hears street noises and often has difficulty falling back asleep.&nbsp; The patient struggles to stay awake during class and is worried that her lack of sleep is beginning to affect her grades.&nbsp; She feels tense when walking alone on campus and spends time with friends only during the day.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows no abnormalities.&nbsp; She appears anxious and reports that her mood has been okay.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s onset of anxiety and insomnia in response to a major life change (living alone for the first time) is most consistent with an <strong>adjustment disorder</strong>.&nbsp; Her insomnia and increased anxiety developed in relation to safety concerns about being alone and fears of intruders at night.&nbsp; Her fatigue, in turn, negatively impacts her studies.</p><p>An adjustment disorder involves emotional or behavioral symptoms (eg, anxiety, depression, disturbance of conduct) developing <strong>within 3 months</strong> of an <strong>identifiable stressor</strong> and lasting no longer than 6 months once the stressor ceases.&nbsp; Symptoms of adjustment disorder are distressing and <strong>impairing</strong> but <strong>do not meet criteria for another psychiatric disorder</strong> (ie, symptoms are insufficient in number, severity, or duration for another specific diagnosis).&nbsp; Stressors can be single or multiple; in this case, they are multiple (eg, moving away from home, living alone for the first time, starting college, feeling academic stress).</p><p><strong>(Choice A)</strong>&nbsp; Acute stress disorder (ASD) involves exposure to a severe and life-threatening traumatic event, intrusive reminders of the trauma (eg, flashbacks, nightmares, memories), dissociative symptoms (eg, altered sense of reality), and/or avoidance behavior.&nbsp; Duration is &#8805;3 days and &lt;1 month.&nbsp; In adjustment disorder, the stressor can be of any severity.&nbsp; This patient lacks both the traumatic stressor and intrusive symptoms required for an ASD diagnosis.</p><p><strong>(Choice C)</strong>&nbsp; Although this patient&#39;s sleep disturbance, fatigue, and tension are also seen in generalized anxiety disorder (GAD), her monthlong history of symptoms is insufficient for this diagnosis.&nbsp; GAD is characterized by excessive, uncontrollable worry about multiple issues (eg, school, family, finances, health) for &#8805;6 months.&nbsp; Patients typically worry about minor matters and experience a chronic course.</p><p><strong>(Choice D)</strong>&nbsp; This patient&#39;s worrisome thoughts are time consuming and distressing; however, she does not describe them as intrusive, which would be typical of obsessive-compulsive disorder (OCD).&nbsp; In addition, she does not display the repetitive, ritualistic compulsive behaviors characteristic of OCD (eg, she checks the doors only once rather than repeatedly in a compulsive manner).</p><p><strong>(Choice E)</strong>&nbsp; This patient&#39;s new, acute-onset symptoms in response to a stressor cannot be explained by a personality disorder alone.&nbsp; Paranoid personality disorder involves a lifelong pattern of pervasive distrust and suspiciousness across a wide range of interpersonal contexts.</p><p><strong>Educational objective:</strong><br>Adjustment disorder is characterized by the development of emotional or behavioral symptoms in response to an identifiable stressor.&nbsp; The diagnosis is appropriate when the patient does not meet the criteria for another psychiatric disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 396,
            "topic": "Adjustment disorders",
            "titleId": 396,
            "title": "Adjustment disorders",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "2",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute stress disorder",
                    "choiceNumber": 1,
                    "correctTaken": 279,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 2,
                    "correctTaken": 2752,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 741,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obsessive-compulsive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 571,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Paranoid personality disorder",
                    "choiceNumber": 5,
                    "correctTaken": 641,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1885,2257,true,-1,1*375,606,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31315203",
                    "mediaDataId": 0,
                    "title": "Adjustment disorder: current developments and future directions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31315203",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29107817",
                    "mediaDataId": 0,
                    "title": "Adjustment disorder: a diagnosis whose time has come.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29107817",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 149,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 5072,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 544,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 11008,
            "questionIndex": 12147,
            "questionText": "<p>A 35-year-old woman comes to the office due to anxiety; she is accompanied by her husband.&nbsp; The patient describes having several panic attacks while driving over a suspension bridge.&nbsp; She suddenly felt faint and shaky, and had to stop the car in the middle of the bridge and get assistance.&nbsp; The patient moved to the suburbs 7 months ago, requiring that she now drive to work.&nbsp; Since having the panic attacks, she has taken an alternate route to work that requires her to drive miles out of her way to avoid bridges.&nbsp; She avoids traveling to the city when possible and has anxiety for days beforehand if a planned trip necessitates taking a bridge.&nbsp; The patient has a history of mitral valve prolapse and asthma.&nbsp; She drinks a glass of wine on weekends and 3 or 4 cups of coffee daily.&nbsp; Blood pressure is 110/60 mm Hg and pulse is 88/min.&nbsp; Auscultation reveals a late systolic click and a grade 2/6 late systolic murmur.&nbsp; Mental status examination shows an anxious mood and tense affect.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t39200\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Specific phobia</strong></p></td></tr><tr><td style=\"width: 23%;\"><p align=\"center\"><strong>History &amp;<br />clinical features</strong></p></td><td style=\"width: 77%;\"><ul><li>Marked anxiety about a <strong>specific </strong>object or situation (the phobic stimulus) for &gt;6 months</li><li>Common types: fear of flying, heights, animals, injections, blood</li><li>Avoidance behavior (eg, avoiding bridges &amp;&nbsp;elevators, refusing work requiring travel)</li><li>Common (10% of population)</li><li>Usually develops in childhood, often after traumatic event</li></ul></td></tr><tr><td style=\"width: 23%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width: 77%;\"><ul><li>Cognitive-behavioral therapy with exposure (first-line)</li><li>Short-acting benzodiazepines (limited role, may help acutely if therapist unavailable or insufficient time)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s marked anxiety about driving over bridges (the <strong>specific phobic stimulus</strong>) and resulting <strong>avoidance behavior</strong> are characteristic of a <strong>specific phobia</strong>.&nbsp; Common phobic fears include animals, insects, heights, water, driving, flying, blood, and injections.&nbsp; This patient was likely able to avoid driving over bridges while living in the city but has become symptomatic since her move.</p><p>The degree of phobic anxiety varies with proximity to the feared object or situation and can reach the level of a full or limited panic attack, as in this patient.&nbsp; In contrast to panic disorder, <strong>panic attacks</strong> in specific phobia are always <strong>triggered by</strong> the <strong>phobic stimulus</strong> and do not occur unexpectedly.&nbsp; <strong>Cognitive-behavioral therapy</strong> that includes exposure (in vivo, imaginal, virtual reality) is the first-line treatment.</p><p><strong>(Choice A)</strong>&nbsp; Although this patient has mitral valve prolapse and a history of asthma, these conditions are an unlikely cause of her anxiety symptoms, which are clearly triggered by a specific situation.&nbsp; A previously reported association of mitral valve prolapse and panic disorder has not been substantiated.</p><p><strong>(Choice B)</strong>&nbsp; This patient&#39;s avoidance behavior is a consequence of her bridge phobia.&nbsp; Avoidant personality disorder is a pervasive pattern of social inhibition, feelings of inadequacy, and hypersensitivity to negative evaluation.</p><p><strong>(Choice C)</strong>&nbsp; Generalized anxiety disorder is characterized by excessive anxiety about multiple issues, whereas this patient&#39;s anxiety is specific to her fear of driving across bridges.</p><p><strong>(Choice D)</strong>&nbsp; A diagnosis of panic disorder requires that at least some panic attacks occur spontaneously with no trigger and are not limited to a specific situation.&nbsp; Patients with a specific phobia may experience anxiety that reaches the level of a panic attack when exposed to the phobic stimulus.</p><p><strong>(Choice F)</strong>&nbsp; Excessive caffeine consumption can result in increased generalized anxiety but would not explain this patient&#39;s anxiety and avoidance in response to a specific phobic stimulus.</p><p><strong>Educational objective:</strong><br>Specific phobia is a common anxiety disorder characterized by a clinically significant fear of a specific object or situation, leading to avoidance behavior.&nbsp; Exposure-based cognitive-behavioral therapy is the treatment of choice.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17208,
            "topic": "Specific phobia",
            "titleId": 17208,
            "title": "Specific phobia",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anxiety due to a general medical condition",
                    "choiceNumber": 1,
                    "correctTaken": 106,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Avoidant personality disorder",
                    "choiceNumber": 2,
                    "correctTaken": 16,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 96,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic disorder with agoraphobia",
                    "choiceNumber": 4,
                    "correctTaken": 1350,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Specific phobia",
                    "choiceNumber": 5,
                    "correctTaken": 15157,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Substance-induced anxiety disorder",
                    "choiceNumber": 6,
                    "correctTaken": 100,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2124,2411,true,-1,1*736,836,true,-1,1*1272,1389,true,-1,1*148,161,true,-1,1*341,399,true,-1,1*410,573,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19716991",
                    "mediaDataId": 0,
                    "title": "Specific phobias.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19716991",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 110,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 16932,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 90,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 625,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 19725,
            "questionIndex": 21214,
            "questionText": "<p>A 5-year-old boy is brought to the office by his aunt for evaluation of behavioral concerns.&nbsp; The patient was placed with the aunt 4 months ago due to physical abuse and neglect by his parents.&nbsp; His teacher is concerned that he does not follow directions, rarely participates during group activities, and does not respond to praise.&nbsp; Last week, the patient hit a classmate after being asked to share the book he was reading.&nbsp; The aunt says, &#x22;He seems to get upset for no reason at times and usually starts throwing and breaking things.&nbsp; I&#39;m trying my best and want him to know he&#39;s loved, but it feels like nothing I do helps.&#x22;&nbsp; Vital signs are within normal limits; growth curves are tracking adequately and consistently.&nbsp; The patient is sitting on the floor playing with various toys.&nbsp; Physical examination shows no abnormalities.&nbsp; He makes eye contact and answers questions briefly before turning away to play by himself.&nbsp; Affect is indifferent with constricted range.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T71060\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Reactive attachment disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p><p align=\"center\"><strong>(some evidence</strong></p><p align=\"center\"><strong>&lt;5 years)</strong></p></td><td><ul><li>Insufficient care (eg, neglect, abuse, inconsistent caregiving)</li><li>Does not seek or respond to comfort</li><li>Poor social responsiveness, limited positive affect</li><li>Unexplained irritability/fear/sadness even during safe encounters</li></ul></td></tr><tr><td><p align=\"center\"><strong>Associated features</strong></p></td><td><ul><li>Toileting &amp; sleep difficulties</li><li>Anxiety, aggression, hyperactivity/impulsivity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Differential diagnosis</strong></p></td><td><ul><li>Adjustment disorder, posttraumatic stress disorder</li><li>Global developmental delay, intellectual disability</li><li>Autism spectrum disorder</li><li>Anxiety disorders (eg, social anxiety disorder, selective mutism)</li><li>Depressive disorders</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Early intervention promoting:<ul style=\"list-style-type:circle;\"><li>safe, stable &amp; enriching environment</li><li>consistent, responsive caregiving</li></ul></li><li>Psychological services (eg, parenting skills, individual/family counseling)</li></ul></td></tr></tbody></table></div><p>This child&#39;s history of physical abuse and neglect, social withdrawal, lack of response to positive affirmation, and emotional outbursts are consistent with <strong>reactive attachment disorder (RAD)</strong>.&nbsp; RAD arises when the normal developmental process of emotional bonding to a primary caregiver is interrupted by inconsistent or <strong>inadequate care</strong> (eg, abuse, neglect, frequent moves between foster homes, prolonged institutionalization).</p><p>Children with RAD often appear socially and emotionally inhibited.&nbsp; They <strong>do not seek</strong> reassurance <strong>or respond to</strong> the <strong>comfort</strong> that most children crave.&nbsp; Other symptoms may include a lack of positive emotions (eg, constricted affect, as in this patient) and episodes of unexpected irritability or aggression in seemingly safe encounters (eg, hitting classmate, throwing objects).&nbsp; Symptoms of RAD can improve with consistent and nurturing caregiving.</p><p><strong>(Choice A)</strong>&nbsp; Although autism spectrum disorder (ASD) also presents with deficits in social and emotional reciprocity, this child does not display the repetitive motor mannerisms or restricted fixated interests required for the diagnosis of ASD.&nbsp; His extensive history of abuse and neglect, coupled with observations of his ability to make eye contact, respond to the physician, and play with a variety of toys, make RAD more likely than ASD.</p><p><strong>(Choice B)</strong>&nbsp; Disinhibited social engagement disorder (DSED) is another possible outcome of severe neglect or abuse.&nbsp; Unlike RAD, where children are emotionally distant, children with DSED display overfamiliarity (even with adults they do not know) and a lack of appropriate boundary setting.</p><p><strong>(Choice C)</strong>&nbsp; It is expected for young children to be anxious or hesitant when moving to a new environment.&nbsp; However, a lack of response to comfort, generalized social disengagement, and aggressive behavior should not be dismissed as normal.&nbsp; Early intervention in RAD can result in significant improvement in behavioral symptoms.</p><p><strong>(Choice D)</strong>&nbsp; Oppositional defiant disorder is characterized by deliberately disobedient and hostile behavior&mdash; often vindictive in nature&mdash; toward authority figures.&nbsp; It would not explain this child&#39;s social withdrawal from both peers and adults, indifference to praise, and lack of response to comfort.</p><p><strong>Educational objective:</strong><br>Reactive attachment disorder occurs in the context of early abuse or neglect and is characterized by emotional withdrawal and a lack of seeking or responding to comfort from caregivers.&nbsp; Unexplained irritability, fear, or aggression may occur even during safe encounters.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 25309,
            "topic": "Reactive attachment disorder",
            "titleId": 25309,
            "title": "Reactive attachment disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autism spectrum disorder",
                    "choiceNumber": 1,
                    "correctTaken": 1062,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disinhibited social engagement disorder",
                    "choiceNumber": 2,
                    "correctTaken": 3330,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal situational reaction",
                    "choiceNumber": 3,
                    "correctTaken": 3713,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oppositional defiant disorder",
                    "choiceNumber": 4,
                    "correctTaken": 1763,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reactive attachment disorder",
                    "choiceNumber": 5,
                    "correctTaken": 10715,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "371,417,true,-1,1*1422,1649,true,-1,1*2007,2159,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30014775",
                    "mediaDataId": 0,
                    "title": "Reactive attachment disorder and attachment theory from infancy to adolescence: review, integration, and expansion.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30014775",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 117,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 20583,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 575,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 11045,
            "questionIndex": 12186,
            "questionText": "<p>A 32-year-old physician comes to the office due to insomnia for the past 6 weeks.&nbsp; He says, &#x22;I feel restless at night, and I can&#39;t get any sleep.&nbsp; I&#39;ve tried reading boring books and drinking herbal teas, but nothing seems to help.&#x22;&nbsp; The patient feels his lack of sleep has made it difficult to focus and started drinking 2 cups of coffee before his shifts &#x22;to get through the day.&#x22;&nbsp; He previously worked in the emergency department but switched to doing shifts at an urgent care clinic a month ago.&nbsp; The patient says, &#x22;I was seeing a lot of gunshot wounds at the hospital.&nbsp; Compared to my old job, this one is much calmer, but I still feel anxious a lot of the time.&#x22;&nbsp; He still thinks about patients he treated and what he could have done differently to save them.&nbsp; The patient says, &#x22;The world has just gotten too dangerous, and I feel like medicine can&#39;t keep up with it.&#x22;&nbsp; He drinks 3-4 beers on the weekends and does not use tobacco or illicit drugs.&nbsp; Medical history is noncontributory.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 130/80 mm Hg, pulse is 84/min, and respirations are 16/min.&nbsp; Physical examination is unremarkable.&nbsp; The patient appears tired and speaks in a low volume.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35882\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Posttraumatic stress disorder</strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Exposure to life-threatening trauma</li><li>Nightmares, flashbacks, intrusive memories</li><li>Avoidance of reminders, dissociation</li><li>Emotional detachment, negative mood, decreased interest in activities</li><li>Sleep disturbance, hypervigilance, irritability</li><li>Duration &gt;1 month</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Treatment</strong></p></td><td><ul><li>Trauma-focused cognitive-behavioral therapy</li><li>Antidepressants (SSRIs, SNRIs)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRIs</strong> = serotonin-norepinephrine reuptake inhibitors; <strong>SSRIs</strong> = selective serotonin<br />reuptake inhibitors.</p></td></tr></tbody></table></div><p>This patient&#39;s sleep disturbance, impaired concentration, and persistent anxiety are most likely due to <strong>posttraumatic stress disorder (PTSD)</strong> (related to trauma exposure in the emergency department).&nbsp; His avoidance of reminders of trauma (ie, stopped working in the emergency department), self-blame, and negative beliefs about the world are also characteristic of the disorder.&nbsp; Other common PTSD symptoms include nightmares, flashbacks, irritability, dissociation, emotional detachment, exaggerated startle response, and hypervigilance.</p><p>First-line treatment of PTSD includes <strong>trauma-focused cognitive-behavioral psychotherapy</strong> and antidepressant medication.&nbsp; <strong>Selective serotonin reuptake inhibitors</strong>, such as paroxetine, and <strong>serotonin-norepinephrine reuptake inhibitors</strong> have the best evidence.&nbsp; Although anxiety and severe insomnia are common PTSD symptoms, benzodiazepines such as lorazepam are not effective in PTSD <strong>(Choice B)</strong>.&nbsp; Benzodiazepines particularly should be avoided in patients with a comorbid substance use disorder.</p><p><strong>(Choice A)</strong>&nbsp; Although caffeinated beverages may exacerbate insomnia and anxiety, advising this patient to discontinue caffeine without addressing the underlying cause of his insomnia is insufficient.&nbsp; However, the patient could be advised to gradually taper caffeine use in conjunction with treatment for PTSD.</p><p><strong>(Choice C)</strong>&nbsp; Melatonin has been used in the treatment of insomnia associated with shift work but is not effective for PTSD.&nbsp; The alpha-adrenergic receptor blocker prazosin has been helpful for some patients with PTSD-related nightmares and sleep disturbance.</p><p><strong>(Choice E)</strong>&nbsp; Reassurance with close follow-up may be indicated for some patients with milder cases of acute stress disorder (symptoms present &lt;1 month).&nbsp; However, this patient has had persistent symptoms for at least 6 weeks that are causing significant distress and impairment.&nbsp; Early treatment of PTSD may prevent the development of chronic functional impairment.</p><p><strong>Educational objective:</strong><br>Trauma-focused cognitive-behavioral psychotherapy and selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors are first-line treatments for posttraumatic stress disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17235,
            "topic": "Post traumatic stress disorder",
            "titleId": 17235,
            "title": "Post traumatic stress disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Advise the patient to discontinue caffeine use",
                    "choiceNumber": 1,
                    "correctTaken": 2091,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe low-dose lorazepam",
                    "choiceNumber": 2,
                    "correctTaken": 1643,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe melatonin",
                    "choiceNumber": 3,
                    "correctTaken": 3318,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe paroxetine",
                    "choiceNumber": 4,
                    "correctTaken": 12843,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance and follow-up in 2 weeks",
                    "choiceNumber": 5,
                    "correctTaken": 400,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2125,2478,true,-1,1*1980,2113,true,-1,1*1310,1545,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26894318",
                    "mediaDataId": 0,
                    "title": "Pharmacotherapies for posttraumatic stress disorder: a meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26894318",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21798109",
                    "mediaDataId": 0,
                    "title": "Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21798109",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 234,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 20296,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 747,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 14736,
            "questionIndex": 16157,
            "questionText": "<p>A 34-year-old woman comes to the office with her husband due to behavioral changes over the past 6 weeks.&nbsp; The husband says, &#x22;She&#39;s not an angry person, but ever since she was in a car accident, little things seem to set her off.&nbsp; She yells and honks at people for not using their turn signals and gets upset when we have to wait for a table at restaurants.&#x22;&nbsp; The patient describes difficulty sleeping due to thoughts &#x22;swirling&#x22; in her head and feeling panicked every time she wakes up.&nbsp; She does not use illicit substances or take any medications.&nbsp; The patient sustained a wrist fracture in a motor vehicle collision 2 months ago; medical history is otherwise unremarkable.&nbsp; Family history is significant for a brother diagnosed with bipolar disorder.&nbsp; Vital signs and physical examination, including neurological examination, are within normal limits.&nbsp; On mental status examination, the patient appears restless and tired.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35882\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Posttraumatic stress disorder</strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Exposure to life-threatening trauma</li><li>Nightmares, flashbacks, intrusive memories</li><li>Avoidance of reminders, dissociation</li><li>Emotional detachment, negative mood, decreased interest in activities</li><li>Sleep disturbance, hypervigilance, irritability</li><li>Duration &gt;1 month</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Treatment</strong></p></td><td><ul><li>Trauma-focused cognitive-behavioral therapy</li><li>Antidepressants (SSRIs, SNRIs)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRIs</strong> = serotonin-norepinephrine reuptake inhibitors; <strong>SSRIs</strong> = selective serotonin<br />reuptake inhibitors.</p></td></tr></tbody></table></div><p>This patient&#39;s recent onset of behavioral changes following a traumatic event (motor vehicle collision) is suggestive of <strong>posttraumatic stress disorder (PTSD)</strong>.&nbsp; Extreme irritability, sleep disturbance, anxiety/panic, and intense psychological distress in response to reminders of the event are characteristic.&nbsp; Angry outbursts with little or no provocation may also occur, as seen in this patient.&nbsp; Other common symptoms of PTSD include nightmares, flashbacks, emotional detachment, and avoidance.</p><p>Treatment of PTSD consists of <strong>psychotherapy</strong> and/or pharmacotherapy with a <strong>serotonergic antidepressant</strong>.&nbsp; Trauma-focused <strong>cognitive-behavioral psychotherapy</strong> (CBT) is commonly first-line treatment, although other forms of psychotherapy (eg, eye movement desensitization and reprocessing, interpersonal therapy, mindfulness-based stress reduction) may also be used.&nbsp; CBT helps the patient emotionally process the trauma and recognize and correct maladaptive thought patterns while also targeting avoidance behaviors with exposure techniques (eg, in vivo or imaginal exposure).</p><p><strong>(Choices A and B)</strong>&nbsp; Serotonergic antidepressants (eg, sertraline, venlafaxine) are first-line pharmacotherapy for PTSD.&nbsp; Buspirone is an antianxiety medication that is used in generalized anxiety disorder, not PTSD.&nbsp; Antipsychotics (eg, quetiapine) may be used as augmentation to an antidepressant in treatment-resistant cases.</p><p><strong>(Choice C)</strong>&nbsp; Although this patient has new-onset behavioral changes, there is no indication to obtain a brain MRI because she does not appear to be delirious or psychotic and has no findings suggestive of underlying neuropathology (eg, normal neurological examination).</p><p><strong>(Choice D)</strong>&nbsp; Reassurance and short-term alprazolam would not adequately treat PTSD.&nbsp; Benzodiazepines (eg, lorazepam) have not shown efficacy in PTSD and carry the risk of abuse and dependence.&nbsp; Without targeted treatment (ie, psychotherapy and/or pharmacotherapy), PTSD can result in prolonged disability due to social and occupational impairment.</p><p><strong>(Choice F)</strong>&nbsp; Group therapy can provide support to the patient but would not adequately target her PTSD symptoms.&nbsp; Trauma-focused cognitive-behavioral therapy is the most effective form of psychotherapy and should be offered as first-line treatment.</p><p><strong>(Choice G)</strong>&nbsp; Lithium is a mood stabilizer used to treat bipolar disorder.&nbsp; Although hypomanic/manic episodes may present with irritability and anger rather than euphoria, this patient lacks other manic symptoms (eg, increased energy, decreased need for sleep, grandiosity, pressured speech).&nbsp; Her behavioral changes following a traumatic event are more likely due to PTSD.</p><p><strong>Educational objective:</strong><br>Trauma-focused cognitive-behavioral therapy is the first-line treatment of posttraumatic stress disorder.&nbsp; It combines cognitive therapy and exposure techniques to help the patient process the trauma and decrease avoidance behaviors.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17235,
            "topic": "Post traumatic stress disorder",
            "titleId": 17235,
            "title": "Post traumatic stress disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Begin buspirone",
                    "choiceNumber": 1,
                    "correctTaken": 575,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Begin quetiapine",
                    "choiceNumber": 2,
                    "correctTaken": 260,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain MRI of the brain",
                    "choiceNumber": 3,
                    "correctTaken": 3157,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance and prescribe short-term alprazolam",
                    "choiceNumber": 4,
                    "correctTaken": 1125,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend cognitive-behavioral therapy",
                    "choiceNumber": 5,
                    "correctTaken": 11234,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer for group therapy",
                    "choiceNumber": 6,
                    "correctTaken": 352,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start lithium",
                    "choiceNumber": 7,
                    "correctTaken": 288,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1118,1376,true,-1,1*1802,1913,true,-1,1*2194,2529,true,-1,1*2851,2946,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29169664",
                    "mediaDataId": 0,
                    "title": "Long-term efficacy of psychotherapy for posttraumatic stress disorder: a meta-analysis of randomized controlled trials.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29169664",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25749748",
                    "mediaDataId": 0,
                    "title": "Psychological mechanisms of effective cognitive-behavioral treatments for PTSD.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25749748",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 71,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16991,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 665,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 2359,
            "questionIndex": 2359,
            "questionText": "<p>An 8-year-old boy is brought to the office by his mother due to behavioral concerns.&nbsp; The patient&#39;s teacher reports that, for the past 4 weeks, he has been &#x22;distant with peers and distracted.&#x22;&nbsp; On a few occasions, he was found sitting in the hallway after asking to use the restroom.&nbsp; The patient has also had frequent stomachaches, resulting in 3 missed days of school in the past month.&nbsp; His mother says he usually follows the rules but received detention a month ago for abruptly leaving the classroom when the new class pet, a snake, was introduced to the students.&nbsp; She also states that although the patient has &#x22;never loved school,&#x22; he was a good student and used to enjoy some subjects, such as math.&nbsp; She has noticed no change of behavior when he is at home or with friends on weekends.&nbsp; When seen alone, the patient says, &#x22;I don&#39;t like my class.&nbsp; Can I be in a different one?&#x22;&nbsp; He has no significant medical history.&nbsp; Vital signs are within normal limits.&nbsp; Height and weight are tracking consistently at the 70th percentile.&nbsp; Physical examination shows no abnormalities.&nbsp; Which of the following is the most appropriate management for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This child&#39;s abrupt change in behavior, which is temporally associated with exposure to the new class pet (snake) a month ago (ie, leaving the classroom abruptly, becoming distant and distracted, subsequently avoiding school), with symptoms not observed outside of school, is concerning for a <strong>specific phobia</strong>.</p><p>Specific phobias are characterized by an <strong>intense fear</strong> of a particular object (eg, <strong>animal</strong>) or a particular experience (eg, flying in an airplane).&nbsp; In the absence of the feared object or experience, performance and behavior are normal, as are this patient&#39;s lack of school issues prior to introduction of the class pet and normal behavior at home and on weekends.</p><p>First-line treatment of specific phobia is with <strong>exposure therapy</strong>, a form of cognitive-behavioral therapy that focuses on exposure to the feared object or experience in a graded fashion that helps extinguish the fear response.</p><p><strong>(Choice A)</strong>&nbsp; Teacher and parent rating scales are useful aids in diagnosing attention-deficit hyperactivity disorder (ADHD).&nbsp; ADHD can present with distraction, as in this patient, but this is evident in multiple settings (eg, home, school, extracurricular activities), not only school.</p><p><strong>(Choice C)</strong>&nbsp; Interpersonal psychotherapy is useful for the treatment of depression or relational difficulties with teachers or peers.&nbsp; There is no evidence of pervasive depression or difficulty with relational functioning in this patient, who has had no change in behavior at home or with his friends on weekends.</p><p><strong>(Choice D)</strong>&nbsp; Selective serotonin reuptake inhibitors are used in the treatment of pervasive disorders such as major depression, generalized anxiety, and social anxiety disorder.&nbsp; These medications are not considered first-line treatment for specific phobia.</p><p><strong>(Choice E)</strong>&nbsp; Social skills training can help in managing behaviors that interfere with communication and relationships but would not effectively target the anxiety and avoidance behavior associated with specific phobia.</p><p><strong>Educational objective:</strong><br>Specific phobia is characterized by intense fear and avoidance behavior related to a specific object or experience.&nbsp; It is best treated with exposure therapy, a form of cognitive-behavioral therapy that includes graded exposure to the feared object or experience.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17208,
            "topic": "Specific phobia",
            "titleId": 17208,
            "title": "Specific phobia",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Attention-deficit hyperactivity disorder rating scales",
                    "choiceNumber": 1,
                    "correctTaken": 117,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exposure therapy",
                    "choiceNumber": 2,
                    "correctTaken": 3221,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Interpersonal therapy",
                    "choiceNumber": 3,
                    "correctTaken": 997,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selective serotonin reuptake inhibitor",
                    "choiceNumber": 4,
                    "correctTaken": 130,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Social skills training",
                    "choiceNumber": 5,
                    "correctTaken": 536,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "261,339,true,-1,1*1539,1784,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30060873",
                    "mediaDataId": 0,
                    "title": "Specific phobias.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30060873",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 81,
            "othersAvgTimeSpent": 82,
            "notes": null,
            "peopleTaken": 5001,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 516,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 10792,
            "questionIndex": 11921,
            "questionText": "<p>A 15-year-old girl is brought to the office by her mother for evaluation of moodiness and behavioral concerns over the past year.&nbsp; Her mother says, &#x22;She always stays out past curfew.&nbsp; I&#39;ve already tried grounding her, but she doesn&#39;t seem to care.&nbsp; When I ask her to do household chores, she gets extremely annoyed and slams her bedroom door in my face.&#x22;&nbsp; The patient is failing multiple classes at school and blames her grades on &#x22;boring teachers&#x22; and being unfairly penalized for handing in assignments late.&nbsp; A few months ago, the patient was sent to the principal&#39;s office after refusing to put away her cell phone during a test.&nbsp; When the principal said her phone would be confiscated, she started arguing and impulsively cursed at him, resulting in suspension from school.&nbsp; Family history is significant for bipolar disorder in the patient&#39;s maternal aunt and depression in her sister.&nbsp; Physical examination shows no abnormalities.&nbsp; On mental status examination, the patient is irritable and sarcastic, frequently interrupting when her mother is speaking.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41614\"><table class=\"table-default-style table-footer-only-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Oppositional defiant disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p>Pattern of angry/irritable mood, argumentative/defiant behavior, or vindictiveness for &ge;6 months</p><ul><li>Argues with adults, defies authority figures, refuses to follow rules</li><li>Deliberately annoys others</li><li>Blames others for own mistakes or misbehavior</li><li>Easily annoyed, angry, resentful, or vindictive</li><li>Not due to another mental disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Parent management training</li><li>Psychotherapy (anger management, social skills training)</li><li>No pharmacotherapy for ODD but assess for comorbid ADHD &amp; treat if present</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ADHD</strong> = attention deficit hyperactivity disorder; <strong>ODD</strong> = oppositional defiant disorder.</p></td></tr></tbody></table></div><p>This patient&#39;s <strong>pattern</strong> of <strong>defiance of rules</strong> and <strong>authority figures</strong>, <strong>irritable mood</strong>, and <strong>blaming</strong> failures on <strong>others</strong> is suggestive of <strong>oppositional defiant disorder</strong> (ODD).&nbsp; For a diagnosis of ODD, the oppositional behaviors must be excessive compared to normative, age-appropriate behaviors and observed during interactions with individuals other than siblings.</p><p>ODD should also be differentiated from conduct disorder, which is characterized by more severe and aggressive behaviors (eg, physical aggression or cruelty toward people or animals, destruction of property, stealing, lying) <strong>(Choice C)</strong>.&nbsp; However, ODD can precede the development of conduct disorder, and it increases the risk of adult antisocial behavior, impaired impulse control, substance abuse, anxiety, and depression.</p><p>Treatment of ODD consists of management programs in which parents are trained to reward prosocial behavior and use brief, nonaversive consequences for misbehavior.&nbsp; Individual or group psychotherapy focusing on anger management, problem-solving, and social skills is also beneficial.</p><p><strong>(Choice A)</strong>&nbsp; This patient&#39;s behavior represents a general pattern of oppositional behavior rather than a response to a specific psychosocial stressor.&nbsp; In addition, adjustment disorder is not diagnosed when symptoms are better explained by a more specific disorder, such as ODD.</p><p><strong>(Choice B)</strong>&nbsp; A diagnosis of bipolar disorder requires distinct episodes of major depression and mania/hypomania, which are not seen in this patient.&nbsp; This patient&#39;s moodiness is more likely related to annoyance at adult rules and demands.&nbsp; Angry/irritable mood is a key feature of ODD.</p><p><strong>(Choice D)</strong>&nbsp; Intermittent explosive disorder is characterized by failure to control aggressive impulses and presents with recurrent, physical, or verbal outbursts.&nbsp; These patients do not display generalized moodiness, argumentative and intentionally defiant behavior, as in ODD.</p><p><strong>(Choice E)</strong>&nbsp; Although some adolescents may occasionally challenge rules and authority in the process of asserting their independence, this patient&#39;s behavior is persistent and impairing.&nbsp; School suspension, significant academic dysfunction, and chronic parent-child communication/relationship concerns differentiate this patient&#39;s behavior from normal adolescent development.</p><p><strong>Educational objective:</strong><br>Oppositional defiant disorder is characterized by a pervasive pattern of argumentative and defiant behavior toward authority figures.&nbsp; It does not involve the more severe violations of basic rights of others seen in conduct disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 325,
            "topic": "Oppositional defiant disorder",
            "titleId": 325,
            "title": "Oppositional defiant disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "6",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with mixed disturbance of emotions and conduct",
                    "choiceNumber": 1,
                    "correctTaken": 42,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar disorder",
                    "choiceNumber": 2,
                    "correctTaken": 44,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Conduct disorder",
                    "choiceNumber": 3,
                    "correctTaken": 1835,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intermittent explosive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 246,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal adolescent behavior",
                    "choiceNumber": 5,
                    "correctTaken": 736,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oppositional defiant disorder",
                    "choiceNumber": 6,
                    "correctTaken": 14124,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1006,1230,true,-1,1*2287,2552,true,-1,1*152,166,true,-1,1*264,309,true,-1,1*487,561,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29238235",
                    "mediaDataId": 0,
                    "title": "Oppositional defiant disorder: current insight.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29238235",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27035043",
                    "mediaDataId": 0,
                    "title": "Common questions about oppositional defiant disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27035043",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 17027,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 576,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 8904,
            "questionIndex": 8923,
            "questionText": "<p>A 13-year-old boy is brought to the office by his mother due to behavioral problems at school.&nbsp; The patient started at a new school 2 months ago after his family moved to the area for his father&#39;s job.&nbsp; His teachers report that he is fidgety in the classroom and has difficulty completing assignments on time.&nbsp; His mother states that he has always been a good student, but his grades have been declining over the past year, despite spending 3-4 hours on homework every night.&nbsp; The patient states that assignments have been taking longer to complete because he must rewrite them until his handwriting is &#x22;just right.&#x22;&nbsp; He worries that if he does not achieve this, his father will lose his job and the family will have to move again.&nbsp; The patient has had no change in sleep or appetite.&nbsp; He does not feel sad or depressed but describes feeling anxious.&nbsp; Physical examination shows no abnormalities, and results of routine laboratory evaluation are within normal range.&nbsp; Which of the following is the most appropriate management for this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33713\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Obsessive-compulsive disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li><strong>Obsessions </strong><ul style=\"list-style-type:circle;\"><li>Recurrent, intrusive, anxiety-provoking thoughts, urges, or images</li></ul></li><li><strong>Compulsions</strong><ul style=\"list-style-type:circle;\"><li>Response to obsessions with repeated behaviors or mental acts</li><li>Behaviors not connected realistically with preventing feared event</li></ul></li><li>Time-consuming (&gt;1 hr/day) or causing significant distress or impairment</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Selective serotonin reuptake inhibitor</li><li>Cognitive-behavioral therapy (exposure &amp; response prevention)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s time-consuming obsession with getting his handwriting &#x22;just right&#x22; and compulsive rewriting that is performed to prevent a feared event are consistent with <strong>obsessive compulsive disorder</strong> (OCD).&nbsp; OCD is a chronic condition that often begins in childhood or adolescence.&nbsp; Patients frequently have high levels of chronic anxiety because they struggle to suppress distressing, intrusive obsessions.&nbsp; Compulsions are intended to prevent a feared event from occurring and are usually not connected to the event in a realistic way (eg, the ability for handwriting appearance to prevent the father from losing his job).</p><p>First-line treatment for OCD includes <strong>selective serotonin reuptake inhibitors (SSRIs)</strong> and/or <strong>cognitive-behavioral therapy (CBT)</strong> based on exposure and response prevention.&nbsp; The SSRIs fluoxetine, fluvoxamine, and sertraline have been shown to be safe and effective in the treatment of pediatric OCD.&nbsp; CBT is the most effective form of psychotherapy and involves exposing patients to thoughts, images, and situations that make them anxious and preventing the accompanying compulsion.</p><p><strong>(Choice A)</strong>&nbsp; Buspirone is an antianxiety medication that is used in the treatment of generalized anxiety disorder (GAD), which would not explain this patient&#39;s obsessions and compulsions. &nbsp;OCD can be associated with chronic anxiety but is not necessarily accompanied by GAD.</p><p><strong>(Choice B)</strong>&nbsp; Dialectical behavior therapy focuses on treating emotional dysregulation and self-harm behaviors in borderline personality disorder (eg, unstable relationships, impulsivity).&nbsp; It has no demonstrated efficacy for OCD.</p><p><strong>(Choice D)</strong>&nbsp; Methylphenidate is a stimulant medication used primarily in attention deficit hyperactivity disorder.&nbsp; This patient&#39;s fidgeting and difficulty completing assignments are likely due to his anxiety related to the intrusive obsessions and compulsions.&nbsp; A stimulant would risk worsening his anxiety.</p><p><strong>(Choice E)</strong>&nbsp; CBT is the psychotherapy of choice for OCD.&nbsp; Psychodynamic psychotherapy, which focuses on unconscious conflicts and developing insight, does not include the targeted behavioral exposure techniques aimed at decreasing compulsive behaviors.</p><p><strong>(Choice F)</strong>&nbsp; Reassurance and follow-up would not adequately address this patient&#39;s symptoms that are causing increasing distress and academic dysfunction.&nbsp; OCD requires pharmacological treatment and/or structured psychotherapy with a CBT-trained therapist.</p><p><strong>Educational objective:</strong><br>First-line treatment of pediatric obsessive-compulsive disorder includes selective serotonin reuptake inhibitors and/or cognitive-behavioral psychotherapy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17181,
            "topic": "Obsessive compulsive disorder",
            "titleId": 17181,
            "title": "Obsessive compulsive disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Buspirone",
                    "choiceNumber": 1,
                    "correctTaken": 449,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dialectical behavior therapy",
                    "choiceNumber": 2,
                    "correctTaken": 2796,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fluoxetine",
                    "choiceNumber": 3,
                    "correctTaken": 9726,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methylphenidate",
                    "choiceNumber": 4,
                    "correctTaken": 498,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Psychodynamic psychotherapy",
                    "choiceNumber": 5,
                    "correctTaken": 5732,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and close follow-up",
                    "choiceNumber": 6,
                    "correctTaken": 1243,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "231,369,true,-1,1*450,481,true,-1,1*892,1107,true,-1,1*1280,1588,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25398447",
                    "mediaDataId": 0,
                    "title": "Obsessive-compulsive disorder in children and adolescents.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25398447",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 114,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 20444,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 723,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 2496,
            "questionIndex": 2496,
            "questionText": "<p>A 22-year-old woman comes to the emergency department for acute onset of nausea and diarrhea.&nbsp; By the time the patient is seen, the abdominal distress has resolved, but she remains agitated and is certain &#x22;there is something really wrong with me.&#x22;&nbsp; Over the past 2 months, the patient has had 4 similar episodes during which she experienced a sudden sinking feeling in her stomach, accompanied by nausea, sweating, rapid heart rate, and shortness of breath.&nbsp; On 2 occasions, these symptoms were also accompanied by diarrhea.&nbsp; She has become increasingly fearful of leaving her home and tearfully reports, &#x22;I am going to lose my job.&#x22;&nbsp; The patient works as a receptionist and has called in sick 5 times in the past 4 weeks because she fears having an episode at work.&nbsp; She does not use illicit drugs.&nbsp; Medical history is unremarkable.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 121/77 mm Hg, pulse is 87/min, and respirations are 14/min.&nbsp; Physical examination is within normal limits and laboratory results are unremarkable.&nbsp; While awaiting discharge, the patient suddenly feels nauseous again.&nbsp; Her breath becomes shallow and rapid.&nbsp; She sweats profusely and says, &#x22;My heart is pounding&#8230;going to die.&#x22;&nbsp; Which of the following is the most appropriate immediate step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33491\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Panic disorder</strong></p></td></tr><tr><td style=\"width: 10%;\"><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td style=\"width: 90%;\"><ul><li>Recurrent &amp; unexpected panic attacks with &ge;4 of the following:<ul style=\"list-style-type:circle;\"><li>Chest pain, palpitations, shortness of breath, choking</li><li>Trembling, sweating, nausea, chills</li><li>Dizziness, paresthesia</li><li>Derealization, depersonalization</li><li>Fear of losing control or of dying</li></ul></li><li>Worry about additional attacks, avoidance behavior</li></ul></td></tr><tr><td style=\"width: 10%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width: 90%;\"><ul><li>First-line/maintenance: SSRI/SNRI &amp;/or cognitive-behavioral therapy</li><li>Acute distress: benzodiazepines</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRI</strong> = serotonin norepinephrine reuptake inhibitor; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>The presence of recurrent episodes of abdominal distress, diaphoresis, shortness of breath, racing heart, and severe anxiety in an otherwise healthy young adult with a negative medical workup is suggestive of panic disorder.&nbsp; <strong>Panic disorder</strong> involves both panic attacks and persistent concern about additional attacks and/or a change in behavior to avoid having another attack.&nbsp; Panic disorder may present with a wide array of physical symptoms, with some patients coming to the emergency department with fears that they may be very ill (eg, having a heart attack) or dying.</p><p>The <strong>long-term treatment</strong> of panic disorder may include <strong>antidepressants</strong>, such as selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors, and/or <strong>cognitive-behavioral therapy</strong>; however, both interventions require weeks to take effect and would not alleviate this patient&#39;s immediate symptoms and marked distress <strong>(Choices B and C)</strong>.&nbsp; <strong>Benzodiazepines</strong> (eg, lorazepam) can provide <strong>rapid relief</strong> of panic attacks and can also be used in the short term while waiting for an SSRI to take effect.&nbsp; Due to the risks of misuse and addiction, they should be prescribed cautiously in patients with a history of a substance use disorder.</p><p><strong>(Choice A)</strong>&nbsp; Buspirone is an anxiolytic used in the treatment of generalized anxiety disorder.&nbsp; It is not effective in the management of acute anxiety and is not used to treat panic disorder.</p><p><strong>(Choices E and F)</strong>&nbsp; This patient&#39;s history of recurrent episodes of nausea that resolve spontaneously is consistent with panic attacks, and her physical examination and laboratory results do not point to an alternative explanation.&nbsp; The proton pump inhibitor omeprazole may be used in the treatment of conditions such as gastroesophageal reflux disease.&nbsp; Ondansetron is a 5-HT<font size=\"2\"><sub>3</sub></font> receptor antagonist antiemetic that is used in patients with persistent nausea.</p><p><strong>(Choice G)</strong>&nbsp; The nonselective beta-blocker propranolol is sometimes used for performance anxiety but there is no evidence of benefit in panic attacks.</p><p><strong>Educational objective:</strong><br>Benzodiazepines provide rapid relief of anxiety and are indicated for the management of acutely symptomatic and functionally impaired patients with panic disorder.&nbsp; Antidepressants and cognitive-behavioral therapy are preferred for long-term treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 19090,
            "topic": "Panic disorder",
            "titleId": 19090,
            "title": "Panic disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Buspirone",
                    "choiceNumber": 1,
                    "correctTaken": 188,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cognitive-behavioral therapy",
                    "choiceNumber": 2,
                    "correctTaken": 958,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fluoxetine",
                    "choiceNumber": 3,
                    "correctTaken": 2211,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lorazepam",
                    "choiceNumber": 4,
                    "correctTaken": 11557,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Omeprazole",
                    "choiceNumber": 5,
                    "correctTaken": 28,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ondansetron",
                    "choiceNumber": 6,
                    "correctTaken": 136,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Propranolol",
                    "choiceNumber": 7,
                    "correctTaken": 1950,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "63,123,true,-1,1*369,468,true,-1,1*2459,2598,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25955736",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of generalized anxiety disorder and panic disorder in adults.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25955736",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25225023",
                    "mediaDataId": 0,
                    "title": "Pharmacological treatment of panic disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25225023",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 65,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 17028,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 406,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 4905,
            "questionIndex": 4905,
            "questionText": "<p>A 28-year-old man comes to the office due to anxiety.&nbsp; The patient was recently promoted at work, requiring a move from the 2nd to the 15th floor of his office building.&nbsp; He says, &#x22;Every time I have to take the elevator to my new office, my heart starts pounding and I can&#39;t catch my breath.&nbsp; I am having panic attacks on a daily basis.&#x22;&nbsp; The patient is distracted at work, spending at least an hour worrying about leaving the building.&nbsp; At night he needs 2-3 hours to fall asleep due to worries about his work performance.&nbsp; The patient has had similar episodes in the past and notes that he has been fearful of heights since adolescence, when he learned that his cousin suffered severe injuries from a fall.&nbsp; He has no other medical or psychiatric history.&nbsp; Which of the following is the most appropriate treatment for this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T39200\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Specific phobia</strong></p></td></tr><tr><td style=\"width: 23%;\"><p align=\"center\"><strong>History &amp;<br>clinical features</strong></p></td><td style=\"width: 77%;\"><ul><li>Marked anxiety about a <strong>specific</strong> object or situation (the phobic stimulus) for &gt;6 months</li><li>Common types: fear of flying, heights, animals, injections, blood</li><li>Avoidance behavior (eg, avoiding bridges &amp; elevators, refusing work requiring travel)</li><li>Common (10% of population)</li><li>Usually develops in childhood, often after traumatic event</li></ul></td></tr><tr><td style=\"width: 23%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width: 77%;\"><ul><li>Cognitive-behavioral therapy with exposure (first-line)</li><li>Short-acting benzodiazepines (limited role, may help acutely if therapist unavailable or insufficient time)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s <strong>fear of heights</strong> is consistent with the diagnosis of <strong>specific phobia</strong>, in which he fears a specific object or situation (phobic stimulus).&nbsp; The first-line <strong>treatment</strong> for specific phobia is cognitive-behavioral therapy (CBT), which involves exposure to the phobic stimulus in a controlled setting.</p><p>Exposure is typically performed in a gradual manner (systematic desensitization), which results in decreased anxiety over time through habituation and extinction.&nbsp; Although in vivo exposure is optimal, imaginal and virtual reality exposure are also effective and may be more feasible.&nbsp; <strong>Exposure therapy</strong> has been shown to be superior to pharmacologic treatment in specific phobia.</p><p><strong>(Choice A)</strong>&nbsp; Pharmacotherapy is not a first-line treatment for specific phobia.&nbsp; Medication (most commonly benzodiazepines [eg, alprazolam]) is appropriate when behavioral therapy is unavailable or the phobic stimulus is infrequently encountered.&nbsp; The risks for dependence, rebound anxiety, and cognitive impairment when using benzodiazepines generally outweigh the benefits.</p><p><strong>(Choice B)</strong>&nbsp; Dialectical behavior therapy is useful for patients who struggle with emotion regulation and distress tolerance and is commonly used to treat borderline personality disorder.</p><p><strong>(Choice D)</strong>&nbsp; Mirtazapine is an atypical antidepressant used in the treatment of major depressive disorder.</p><p><strong>(Choice E)</strong>&nbsp; The selective serotonin reuptake inhibitor sertraline is a first-line treatment for panic disorder and generalized anxiety disorder (GAD), not specific phobia.&nbsp; This patient does not have the spontaneous, unprovoked panic attacks required for the diagnosis of panic disorder.&nbsp; His anxiety is specific to the repercussions of his phobia on his work performance and is not characteristic of the diffuse anxiety seen in GAD.</p><p><strong>(Choice F)</strong>&nbsp; Trauma-focused psychotherapy is a form of CBT used to treat posttraumatic stress disorder (PTSD).&nbsp; This patient does not describe intrusive symptoms (eg, flashbacks, nightmares), pervasive hyperarousal, and negative thoughts related to his cousin&#39;s fall, which would be expected in PTSD.&nbsp; His recent onset of anxiety in response to the phobic stimulus of riding the elevator is characteristic of specific phobia.</p><p><strong>Educational objective:</strong><br>Specific phobia is characterized by a marked fear of a specific object or situation.&nbsp; Cognitive-behavioral therapy using exposure techniques is the preferred treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17208,
            "topic": "Specific phobia",
            "titleId": 17208,
            "title": "Specific phobia",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alprazolam as needed",
                    "choiceNumber": 1,
                    "correctTaken": 440,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dialectical behavior therapy",
                    "choiceNumber": 2,
                    "correctTaken": 323,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exposure therapy",
                    "choiceNumber": 3,
                    "correctTaken": 12439,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mirtazapine",
                    "choiceNumber": 4,
                    "correctTaken": 56,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline",
                    "choiceNumber": 5,
                    "correctTaken": 2423,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trauma-focused psychotherapy",
                    "choiceNumber": 6,
                    "correctTaken": 1257,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "410,573,true,-1,1*883,1044,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30060873",
                    "mediaDataId": 0,
                    "title": "Specific phobias.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30060873",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31551840",
                    "mediaDataId": 0,
                    "title": "Inferiority or even superiority of virtual reality exposure therapy in phobias?â€”A systematic review and quantitative meta-analysis on randomized controlled trials specifically comparing the efficacy of virtual reality exposure to gold standard&#160;in vivo exposure in agoraphobia, specific phobia, and social phobia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31551840",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 52,
            "othersAvgTimeSpent": 43,
            "notes": null,
            "peopleTaken": 16950,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 409,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 8892,
            "questionIndex": 8909,
            "questionText": "<p>A 28-year-old woman comes to the office due to panic attacks.&nbsp; She was promoted at work 7 months ago and has experienced severe anxiety, trembling, sweating, chest tightness, and shortness of breath when giving presentations or meeting new clients.&nbsp; The patient says, &#x22;I have been anxious around people since I was a teenager, but it is getting worse.&nbsp; It&#39;s very embarrassing.&nbsp; I know everyone can see that I&#39;m extremely nervous in meetings and will think I&#39;m incompetent.&nbsp; I&#39;m afraid I&#39;ll make a fool of myself.&nbsp; The last time I had to speak, I became so anxious that I couldn&#39;t breathe and almost passed out.&#x22;&nbsp; The patient is becoming increasingly concerned that she will lose her job, which is resulting in poor sleep.&nbsp; She drinks 2-3 glasses of wine on weekends and does not use illicit substances.&nbsp; Physical examination is unremarkable.&nbsp; On mental status examination, she is visibly anxious throughout the interview and avoids eye contact with the physician.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38988\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p style=\"margin-left: 0.5in; text-align: center;\"><strong>Differential diagnosis of DSM-5 anxiety disorders </strong></p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Social anxiety disorder<br />(social phobia) </strong></p></td><td><p style=\"margin-left:.1in;\">Anxiety restricted to social &amp; performance situations, fear of scrutiny &amp; embarrassment</p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Panic disorder </strong></p></td><td><p style=\"margin-left:.1in;\">Recurrent, unexpected panic attacks</p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Specific phobia </strong></p></td><td><p style=\"margin-left:.1in;\">Excessive anxiety about a specific object or situation (phobic stimulus)</p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Generalized anxiety disorder </strong></p></td><td><p style=\"margin-left:.1in;\">Chronic multiple worries, anxiety, tension</p></td></tr></tbody></table></div><p>This patient&#39;s severe anxiety related to <strong>fears of negative evaluation</strong> and embarrassment in <strong>social and performance situations</strong> is consistent with <strong>social anxiety disorder (SAD)</strong>.&nbsp; Her history suggests that she has been socially anxious since adolescence and that the demands of her new job have exacerbated her condition.&nbsp; Her persistent anxiety and poor eye contact during interaction with the physician are also characteristic of the disorder.&nbsp; According to DSM-5, patients whose symptoms occur only in performance-related situations are specified as having the performance-only subtype of SAD.</p><p>SAD related to discrete performance situations may be mistaken for a specific phobia.&nbsp; When fears are related to being publically scrutinized, embarrassed, or negatively judged in a social context (as in this patient), the appropriate diagnosis is SAD.&nbsp; Having a specific phobia is characterized by the fear of a specific object or situation (eg, flying, heights, animals) rather than the fear of negative evaluation in a social situation <strong>(Choice E)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Generalized anxiety disorder is characterized by multiple, uncontrollable worries (eg, health, finances, relationships, family) whereas this patient&#39;s anxiety is restricted to fears of negative evaluation in social and performance situations and its potential consequences (eg, losing her job).</p><p><strong>(Choice B)</strong>&nbsp; SAD may present with panic symptoms triggered by a feared social situation.&nbsp; However, to make a diagnosis of panic disorder, unexpected panic attacks are required with the fear related to the panic symptoms themselves.&nbsp; This patient&#39;s panic symptoms are always triggered by a fear of embarrassment and humiliation in social and performance situations.</p><p><strong>(Choice D)</strong> In somatic symptom disorder, patients have excessive anxiety that is focused around physical symptoms.&nbsp; In contrast, this patient&#39;s physical symptoms are manifestations of the severe anxiety she feels in social situations.</p><p><strong>Educational objective:</strong><br>Social anxiety disorder (SAD) is characterized by a fear of social situations and anxiety about embarrassment.&nbsp; In the performance-only subtype, anxiety occurs only in performance-related situations.&nbsp; SAD should be differentiated from panic disorder (unexpected panic attacks) and specific phobia (stimulus not related to social anxiety).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24454,
            "topic": "Social anxiety disorder",
            "titleId": 24454,
            "title": "Social anxiety disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 1,
                    "correctTaken": 995,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic disorder",
                    "choiceNumber": 2,
                    "correctTaken": 1516,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Social anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 13432,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Somatic symptom disorder",
                    "choiceNumber": 4,
                    "correctTaken": 19,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Specific phobia",
                    "choiceNumber": 5,
                    "correctTaken": 1102,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28591542",
                    "mediaDataId": 0,
                    "title": "Social anxiety disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28591542",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24395386",
                    "mediaDataId": 0,
                    "title": "Social anxiety disorder in DSM-5.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24395386",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 36,
            "othersAvgTimeSpent": 47,
            "notes": null,
            "peopleTaken": 17064,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 299,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 11124,
            "questionIndex": 12270,
            "questionText": "<p>A 42-year-old man comes to the office accompanied by his wife for evaluation of mood changes.&nbsp; The patient&#39;s wife states that he has been restless and irritable since returning from a work trip.&nbsp; While staying in a hotel 2 weeks ago, the patient was unable to leave his room on the 8th floor after an earthquake caused debris to block the door.&nbsp; He had no cell phone or internet access during this time and remained in his room for 8 hours before the arrival of first responders.&nbsp; His wife says he refuses to talk about the earthquake and has started sleeping in the living room to have access to multiple exit routes &#x22;in case something happens.&#x22;&nbsp; The patient has been working from home since he returned and is scheduled to leave for another work trip next week.&nbsp; He says, &#x22;I keep waking up from nightmares, but I&#39;m sure I&#39;ll get over this on my own.&nbsp; I don&#39;t feel the need to talk about what happened because I know that getting back to my usual routine will help take my mind off of it.&#x22;&nbsp; On mental status examination, the patient is cooperative and provides brief responses to questions.&nbsp; Although he states that his mood is &#x22;okay,&#x22; he appears withdrawn.&nbsp; Which of the following is the most appropriate initial step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33515\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute stress disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Duration &ge;3 days &amp; &le;1 month</li><li>Exposure to actual or threatened trauma</li><li>Symptoms from following categories:<ul style=\"list-style-type:circle;\"><li>Avoidance of internal memories or external reminders</li><li>Intrusion (eg, nightmares, flashbacks)</li><li>Dissociation (eg, amnesia for event, derealization)</li><li>Arousal (eg, insomnia, hypervigilance, startle)</li><li>Negative mood</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Trauma-focused, brief CBT</li><li>Consider medication for insomnia, intense anxiety</li><li>Monitor for PTSD (symptom duration &gt;1 month)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CBT</strong> = cognitive-behavioral therapy; <strong>PTSD</strong> = posttraumatic stress disorder.</p></td></tr></tbody></table></div><p>This patient&#39;s presentation is suggestive of <strong>acute stress disorder </strong>(ASD), given his 2-week history of mood changes, <strong>nightmares</strong>, and <strong>hypervigilance</strong> following exposure to a <strong>traumatic event</strong>.&nbsp; In addition to experiencing arousal and intrusive symptoms, patients may experience dissociation and <strong>avoidance</strong> (eg, avoidance of reminders and talking about the trauma).&nbsp; Although ASD will remit in some individuals without intervention, treatment designed to alleviate symptoms and prevent development of posttraumatic stress disorder (PTSD) (diagnosed when symptoms persist for &#8805;4 weeks) can also be beneficial.</p><p>Trauma-focused cognitive-behavioral therapy (CBT), not medication, is the first-line treatment.&nbsp; However, referring for individual therapy a patient who is not ready to engage in treatment is premature and unlikely to be well received.&nbsp; This patient is not seeking therapy and prefers not to talk about the trauma at this point <strong>(Choice E)</strong>.&nbsp; The best <strong>initial approach</strong> is to provide education on common <strong>physical and emotional responses to trauma</strong> (eg, avoidance, hypervigilance) and the course of ASD.&nbsp; <strong>Normalizing</strong> the stress response, while explaining that symptoms may remit but can also cause persistent distress and impairment, would be helpful.&nbsp; Recommendations for further treatment can be provided at follow-up if necessary.</p><p><strong>(Choice A)</strong>&nbsp; This patient&#39;s preference not to talk at this time should be respected.&nbsp; Discussing the trauma in detail, which is typically conducted as part of trauma-focused CBT, could be undertaken when the patient is ready.</p><p><strong>(Choice B)</strong>&nbsp; This patient prefers to continue working.&nbsp; Encouraging him to take a temporary leave from work would likely reinforce the patient&#39;s avoidance, potentially worsening the course of ASD.</p><p><strong>(Choice C)</strong>&nbsp; Although some patients with ASD have spontaneous resolution of symptoms, others may develop PTSD and more persistent disability.&nbsp; This patient should be educated about the range of symptoms in ASD and what to do if his symptoms persist.</p><p><strong>(Choice D)</strong>&nbsp; Selective serotonin reuptake inhibitors (SSRIs) such as paroxetine are used to treat PTSD when CBT is unavailable or if the patient prefers medication.&nbsp; There is a lack of evidence for the use of SSRIs in ASD.</p><p><strong>Educational objective:</strong><br>The initial approach to patients with acute stress disorder is to educate them on the range of reactions to trauma.&nbsp; Trauma-focused cognitive-behavioral therapy can be beneficial for patients with severe and persistent symptoms.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17235,
            "topic": "Post traumatic stress disorder",
            "titleId": 17235,
            "title": "Post traumatic stress disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "6",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ask the patient to share his experience of the earthquake in detail",
                    "choiceNumber": 1,
                    "correctTaken": 855,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Encourage the patient to take a temporary leave from work",
                    "choiceNumber": 2,
                    "correctTaken": 166,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance that his symptoms will likely resolve without intervention",
                    "choiceNumber": 3,
                    "correctTaken": 536,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend trial of paroxetine",
                    "choiceNumber": 4,
                    "correctTaken": 1343,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer for individual psychotherapy",
                    "choiceNumber": 5,
                    "correctTaken": 5972,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Review common physical and emotional responses to trauma",
                    "choiceNumber": 6,
                    "correctTaken": 8106,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2349,2585,true,-1,1*391,511,true,-1,1*1188,1284,true,-1,1*1285,1423,true,-1,1*1688,1916,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30315408",
                    "mediaDataId": 0,
                    "title": "The current evidence for acute stress disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30315408",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21941180",
                    "mediaDataId": 0,
                    "title": "Immediate and early behavioral interventions for the prevention of acute and posttraumatic stress disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21941180",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 79,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16978,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 529,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 3384,
            "questionIndex": 3384,
            "questionText": "<p>A 15-year-old girl is brought to the office by her mother due to hair loss.&nbsp; The patient was cast in the lead role of the school play a month ago and has been wearing hats and wigs to stay in character.&nbsp; A few days ago, her mother noticed several bald spots on the patient&#39;s scalp.&nbsp; The patient does well in school and enjoys rehearsals.&nbsp; She does not use alcohol or illicit drugs.&nbsp; Menarche was at age 13; menstruation occurs every 4-6 weeks and typically lasts 5-7 days.&nbsp; Vital signs are normal.&nbsp; BMI is 22 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows a 3 &times; 5 cm area of patchy hair loss in the right parietal region surrounded by several areas of uneven hair growth.&nbsp; Eyebrows are sparse.&nbsp; Scalp and skin examination shows no scaling or erythema.&nbsp; Physical examination is otherwise unremarkable.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32007\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Trichotillomania (hair-pulling disorder)</strong></p></td></tr><tr><td style=\"width: 16%;\"><p align=\"center\"><strong>Features</strong></p></td><td style=\"width: 84%;\"><ul><li>Recurrent hair pulling resulting in hair loss</li><li>Repeated attempts to decrease/stop hair pulling</li><li>Not due to a medical/dermatological condition (eg, alopecia areata)</li><li>Not due to another mental disorder (eg, body dysmorphic disorder)</li></ul></td></tr><tr><td style=\"width: 16%;\"><p align=\"center\"><strong>Examination<br />findings</strong></p></td><td style=\"width: 84%;\"><ul><li>Irregular patches of hair loss</li><li>Hair shafts of variable lengths</li><li>Noninflammatory, nonscarring</li></ul></td></tr><tr><td style=\"width: 16%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width: 84%;\"><ul><li>Cognitive-behavioral therapy (habit reversal therapy)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s irregular, patchy hair loss, with areas of uneven hair and the absence of other findings, is most consistent with a diagnosis of <strong>trichotillomania</strong>, a behavioral disorder characterized by compulsive hair pulling.&nbsp; Commonly affected sites include the scalp, eyebrows, and eyelids, with presentation of asymmetric, <strong>irregular areas of hair loss</strong> and/or absent eyebrows (eg, sparse eyebrows in this patient) and eyelashes.&nbsp; Examination shows <strong>hairs of different lengths</strong> due to traumatic breakage at various points.&nbsp; Erythema (characteristic of tinea capitis) and total hair loss (as seen in alopecia areata) are not present.</p><p>Hair pulling may be an automatic behavior (without full awareness) or preceded by tension followed by relief.&nbsp; The prevalence of trichotillomania is estimated to be 1%-2% and is much more common in children and adolescent girls.&nbsp; Because patients with trichotillomania feel out of control and embarrassed, they may avoid work, school, or public places and try to hide the hair loss (eg, wearing hats, wigs).&nbsp; Patients who also ingest hair (trichophagia) may develop trichobezoars that can lead to abdominal pain and bowel obstruction.</p><p><strong>(Choice A)</strong>&nbsp; In alopecia areata, patches are circular, smooth, and completely devoid of hair, whereas in trichotillomania, patches are irregular, typically with broken hairs of varying lengths.</p><p><strong>(Choice B)</strong>&nbsp; Androgenetic alopecia in females (also known as female-pattern hair loss) occurs in adult women and is characterized by progressive hair thinning at the vertex and frontal hairline.</p><p><strong>(Choice C)</strong>&nbsp; Discoid lupus erythematosus, the most common form of chronic, cutaneous lupus erythematosus, is characterized by discrete, erythematous, and scaling plaques.</p><p><strong>(Choice D)</strong>&nbsp; Telogen effluvium is characterized by diffuse thinning of the hair rather than discrete patches of hair loss.&nbsp; It results from premature shedding and is often triggered by stress (eg, major illness or surgery, malnutrition, emotional trauma).</p><p><strong>(Choice E)</strong>&nbsp; Tinea capitis is a fungal infection of the scalp and most commonly seen in children.&nbsp; It presents with scaly, erythematous patches and alopecia, with black dots representing broken hairs within follicles.</p><p><strong>(Choice F)</strong>&nbsp; Traction alopecia is a type of hair loss resulting from prolonged tension on the hair due to hairstyles that stretch the hair (eg, braiding).&nbsp; It would not explain this patient&#39;s sparse eyebrows, and hair loss in the frontal and temporal scalp is most common.</p><p><strong>Educational objective:</strong><br>Trichotillomania is a behavioral disorder characterized by recurrent hair pulling.&nbsp; It results in irregular patches of hair loss with broken hair shafts of differing lengths.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 20502,
            "topic": "Anxiety",
            "titleId": 20502,
            "title": "Anxiety",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "7",
            "userAnswer": "7",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alopecia areata",
                    "choiceNumber": 1,
                    "correctTaken": 2547,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Androgenetic alopecia",
                    "choiceNumber": 2,
                    "correctTaken": 165,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discoid lupus erythematosus",
                    "choiceNumber": 3,
                    "correctTaken": 29,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Telogen effluvium",
                    "choiceNumber": 4,
                    "correctTaken": 576,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tinea capitis",
                    "choiceNumber": 5,
                    "correctTaken": 943,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Traction alopecia",
                    "choiceNumber": 6,
                    "correctTaken": 3655,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trichotillomania",
                    "choiceNumber": 7,
                    "correctTaken": 12570,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "126,172,true,-1,1*1525,1650,true,-1,1*712,810,true,-1,1*846,914,true,-1,1*1007,1115,true,-1,1*1855,1889,true,-1,1*1976,2037,true,-1,1*2220,2463,true,-1,1*2692,2952,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27581696",
                    "mediaDataId": 0,
                    "title": "Trichotillomania.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27581696",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24636654",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of alopecia in children.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24636654",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 60,
            "othersAvgTimeSpent": 43,
            "notes": null,
            "peopleTaken": 20485,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1194,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 13697,
            "questionIndex": 15087,
            "questionText": "<p>A 22-year-old man comes to the office for follow-up regarding anxiety.&nbsp; The patient was referred for treatment by the student health service due to severe anxiety accompanied by sweaty palms and shaky voice, as well as blushing when meeting new people and giving oral presentations.&nbsp; He was diagnosed with social anxiety disorder and started on fluoxetine 2 weeks ago.&nbsp; Today, the patient reports that his anxiety in social situations has not improved and that he has started to feel uncharacteristically tense and jittery, &#x22;like I&#39;ve had too much coffee.&#x22;&nbsp; He says, &#x22;If anything, my anxiety is worse than before, and I feel anxious most of the time.&#x22;&nbsp; The patient now has difficulty falling asleep.&nbsp; He has no significant medical history.&nbsp; The patient does not use illicit drugs.&nbsp; Vital signs are stable, and physical examination is unchanged from the initial presentation.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Selective serotonin reuptake inhibitors (SSRIs)</strong> are often a first-line treatment for depressive and anxiety disorders given their efficacy, tolerability, and general safety in overdose.&nbsp; Common <strong>early adverse effects</strong>&nbsp;include nausea, diarrhea, headache, <strong>increased anxiety</strong>, and insomnia or somnolence.&nbsp; These effects usually occur in the first few weeks of treatment initiation or dose increase and diminish or resolve over time.</p><p>This patient&#39;s worsening anxiety, with&nbsp;jitteriness, insomnia, and new-onset anxiety in nonsocial situations, most likely reflects the <strong>stimulating effects</strong> of fluoxetine.&nbsp; The mechanism may be due to SSRI-induced activation of&nbsp;presynaptic 5HT1A (leading to inhibition of serotonin release and a net&nbsp;<em>decrease</em> in serotonin levels) before the full effects of the medication (net <em>increase</em> in serotonin levels) are seen.&nbsp; The most appropriate next step is a <strong>temporary dose reduction</strong> with the goal of improving tolerability; dose increases may subsequently be reattempted.</p><p>Patients with <strong>anxiety disorders</strong> are especially sensitive to the activating effects of antidepressants and should generally be started at lower doses than those typically used to treat depression (eg, half the normal starting dose), with a gradual increase to a therapeutic level over several weeks.</p><p><strong>(Choices A, B, and F)</strong>&nbsp; Compared to benzodiazepenes, buspirone (an anxiolytic that acts on the serotonergic system)&nbsp;is associated with a lower risk of dependence and fewer side effects but also has weaker anxiolytic effects; it is useful as augmentation therapy when anxiety is not well controlled with SSRIs.&nbsp; Because this patient&#39;s increased anxiety and insomnia are most likely from fluoxetine, adding buspirone or zolpidem (a hypnotic medication used in insomnia) is not indicated, and a higher fluoxetine dose would likely exacerbate his symptoms.</p><p><strong>(Choices D and E)</strong>&nbsp; Because it may take several weeks for the full effect of an SSRI to be seen, switching to another medication after 2 weeks would be premature without first attempting dose reduction.&nbsp; Bupropion is an activating antidepressant that could further increase anxiety and insomnia.&nbsp; Benzodiazepines (eg, clonazepam) are not preferred as long-term monotherapy due to risks of abuse and dependence.&nbsp; These drugs are sometimes prescribed adjunctively for extreme anxiety in the first weeks of treatment but should be tapered and discontinued once the antidepressant takes effect.</p><p><strong>Educational objective:</strong><br>Activating effects (eg, anxiety, insomnia) are possible early adverse effects of selective serotonin reuptake inhibitors but frequently improve with time.&nbsp; Patients with anxiety disorders are more sensitive to activating adverse effects and may benefit from a temporary dose reduction or initiation at a lower-than-normal dose.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 20929,
            "topic": "Selective serotonin reuptake inhibitors",
            "titleId": 20929,
            "title": "Selective serotonin reuptake inhibitors",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add buspirone",
                    "choiceNumber": 1,
                    "correctTaken": 2183,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Add zolpidem",
                    "choiceNumber": 2,
                    "correctTaken": 1901,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decrease dose of fluoxetine",
                    "choiceNumber": 3,
                    "correctTaken": 6996,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue fluoxetine and start bupropion",
                    "choiceNumber": 4,
                    "correctTaken": 2373,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue fluoxetine and start clonazepam",
                    "choiceNumber": 5,
                    "correctTaken": 1554,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase dose of fluoxetine",
                    "choiceNumber": 6,
                    "correctTaken": 1951,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "271,330,true,-1,1*627,1021,true,-1,1*1022,1320,true,-1,1*1343,1629,true,-1,1*2284,2462,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26576188",
                    "mediaDataId": 0,
                    "title": "Antidepressant efficacy and side-effect burden: a quick guide for clinicians.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26576188",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23726508",
                    "mediaDataId": 0,
                    "title": "Side effects of antidepressants during long-term use in a naturalistic setting.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23726508",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 88,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16958,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 716,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 11246,
            "questionIndex": 12401,
            "questionText": "<p>A 57-year-old woman comes to the office with intermittent headaches, shoulder and neck pain, fatigue, and insomnia.&nbsp; The headaches sometimes interfere with the patient&#39;s ability to concentrate at work.&nbsp; The symptoms are not new but have worsened over the past 8 months due to the stress of starting a new job and placing her elderly mother in an assisted living facility.&nbsp; The patient lies awake at night worrying about her mother, her own health problems, and the finances of her 2 adult children, who are having difficulty supporting themselves.&nbsp; During the day, she is tired due to poor sleep and worries about her job performance.&nbsp; The patient has a history of hypertension, irritable bowel syndrome, and tension headaches.&nbsp; She drinks 1 or 2 glasses of wine before bedtime a few times per week to help her relax and fall asleep.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 130/80 mm Hg, pulse is 88/min, and respirations are 16/min.&nbsp; Examination shows sweaty palms and mild, diffuse abdominal tenderness; no other abnormalities are noted.&nbsp; Complete blood count, chemistry panel, TSH, urinalysis, and ECG are normal.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34083\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Generalized anxiety disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>DSM-5 criteria</strong></p></td><td><ul><li>Excessive worry, anxiety (multiple issues) &ge;6 months</li><li>Difficult to control</li><li>&ge;3 of the following symptoms:<ul style=\"list-style-type:circle;\"><li>Restlessness or feeling on edge</li><li>Fatigue</li><li>Difficulty concentrating</li><li>Irritability</li><li>Muscle tension</li><li>Sleep disturbance</li></ul></li><li>Significant distress or impairment</li><li>Not due to substances, another mental disorder, or medical condition</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Cognitive-behavioral therapy</li><li>SSRI or SNRI</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRI</strong> = serotonin-norepinephrine reuptake inhibitor; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>This patient&#39;s pain, <strong>insomnia</strong>, <strong>fatigue</strong>, and poor concentration are consistent with <strong>generalized anxiety disorder (GAD)</strong>.&nbsp; Although <strong>excessive worry</strong> about <strong>multiple issues</strong> is the key symptom in GAD, patients frequently come to their primary care provider with <strong>somatic symptoms</strong>, including fatigue and physical symptoms related to <strong>muscular tension</strong> (eg, headaches; neck, shoulder, and back pain).&nbsp; Other physical manifestations of anxiety commonly seen in GAD include trembling, sweating, and gastrointestinal symptoms.</p><p>GAD typically has a lifelong, chronic course, with symptom severity increasing during periods of stress, as in this patient.&nbsp; GAD is effectively treated with a <strong>serotonergic antidepressant</strong>, <strong>cognitive-behavioral therapy</strong> (CBT), or a combination of the two.</p><p><strong>(Choice A)</strong>&nbsp; Benzodiazepines are generally reserved for patients whose GAD symptoms persist despite treatment with a serotonergic antidepressant.&nbsp; These drugs are also less preferred in patients who have used alcohol to self-medicate.&nbsp; Supportive psychotherapy can be helpful but is not as effective as CBT.</p><p><strong>(Choice C)</strong>&nbsp; An imaging study would be low yield in this patient, who has a known history of tension headaches, a common physical manifestation of GAD, and no focal neurological signs on examination.</p><p><strong>(Choice D)</strong>&nbsp; Pheochromocytoma may cause anxiety.&nbsp; However, it is a rare disease that typically presents with paroxysmal symptoms and would not explain this patient&#39;s chronic anxiety about multiple issues.</p><p><strong>(Choice E)</strong>&nbsp; Acute intermittent porphyria can result in autonomic arousal (eg, tachycardia, hypertension, sweating) as well as anxiety, but these symptoms tend to occur in acute attacks accompanied by neuropathy (eg, weakness, numbness) and severe abdominal pain.</p><p><strong>(Choices F and G)</strong>&nbsp; Reassurance that serious medical illness has been ruled out and regularly scheduled visits are appropriate interventions for patients with somatic symptom disorder.&nbsp; In contrast to the generalized worries seen in GAD, patients with somatic symptom disorder have anxiety that specifically revolves around their somatic symptoms with the fear that they have a serious medical illness.&nbsp; This patient&#39;s somatic symptoms are a manifestation of GAD and should improve with effective treatment.</p><p><strong>Educational objective:</strong><br>Generalized anxiety disorder is characterized by excessive and persistent worry about multiple issues.&nbsp; Patients frequently come to their primary care provider with insomnia, fatigue, and physical symptoms related to muscular tension.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 18230,
            "topic": "Generalized anxiety disorder",
            "titleId": 18230,
            "title": "Generalized anxiety disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Begin clonazepam and supportive psychotherapy",
                    "choiceNumber": 1,
                    "correctTaken": 836,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Begin escitalopram and recommend cognitive-behavioral therapy",
                    "choiceNumber": 2,
                    "correctTaken": 11854,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain noncontrast CT scan of the head and neck",
                    "choiceNumber": 3,
                    "correctTaken": 323,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain urinary fractionated catecholamines and metanephrines",
                    "choiceNumber": 4,
                    "correctTaken": 1330,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain urinary porphobilinogens",
                    "choiceNumber": 5,
                    "correctTaken": 429,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassure the patient that serious medical illness has been ruled out",
                    "choiceNumber": 6,
                    "correctTaken": 557,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schedule monthly visits to monitor symptoms",
                    "choiceNumber": 7,
                    "correctTaken": 700,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "867,932,true,-1,1*991,1055,true,-1,1*1321,1542,true,-1,1*2031,2282,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "106",
                    "mediaDataId": 0,
                    "title": "Generalized anxiety disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27523095",
                    "mediaDataId": 0,
                    "title": "The network structure of major depressive disorder, generalized anxiety disorder and somatic symptomatology.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27523095",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25955736",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of generalized anxiety disorder and panic disorder in adults.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25955736",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 125,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 16029,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1486,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 13711,
            "questionIndex": 15101,
            "questionText": "<p>A 44-year-old woman comes to the office due to worsening anxiety.&nbsp; Prior to starting her new job 3 months ago, the patient had not suffered from anxiety or any other psychiatric condition.&nbsp; She experiences the demands of her new job as overwhelming and disproportionate to the support and resources she has available at work.&nbsp; Around the same time that she started her new job, the patient began to suffer sudden episodes of palpitations, sweating, pounding headache, and panicky feelings that have recurred every few days for no apparent reason.&nbsp; The patient was also recently diagnosed with hypertension that has only slightly improved with antihypertensive medication.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 184/86 mm Hg, pulse is 91/min, and respirations are 14/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The patient appears anxious, mildly tremulous, and diaphoretic on examination.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>14.2 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>180,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>4,100/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>136 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>3.8 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Chloride</td><td>102 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td>24 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>10 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.8 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>190 mg/dL</td></tr></tbody></table><p>Which of the following is the most likely explanation for this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41083\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Pheochromocytoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Arises from neuroendocrine cells in <strong>adrenal medulla</strong></li><li>25% inherited:<ul style=\"list-style-type:circle;\"><li><em>VHL</em> gene (von Hippel-Lindau)</li><li><em>RET</em> gene (multiple endocrine neoplasia type 2)</li><li><em>NF1</em> gene (neurofibromatosis)</li></ul></li></ul><ul><li>Symptoms result from <strong>increased catecholamine secretion</strong></li></ul></td></tr><tr><td><p align=\"center\"><strong>Symptoms</strong></p></td><td><ul><li>Headache</li><li>Tachycardia/palpitations</li><li>Sweating</li><li>Hypertension</li></ul></td></tr><tr><td><p align=\"center\"><strong>Rule of 10s</strong></p></td><td><ul><li>10% bilateral</li><li>10% extraadrenal (paragangliomas)</li><li>10% malignant</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p>Elevated urinary &amp; plasma catecholamines &amp; metanephrines</p></td></tr></tbody></table></div><p>This patient&#39;s <strong>episodic headache</strong>, <strong>diaphoresis</strong>, <strong>tachycardia/palpitations</strong>, and <strong>anxiety symptoms</strong> in the setting of new-onset, drug-resistant <strong>hypertension</strong> and hyperglycemia with normal BMI are consistent with a diagnosis of <strong>pheochromocytoma</strong>.&nbsp; Signs and symptoms of pheochromocytoma are caused by catecholamine excess.&nbsp; However, only 50% of patients with pheochromocytoma are symptomatic, and even in symptomatic individuals, the diagnosis is frequently missed due to the intermittent nature of symptoms.</p><p>Pheochromocytoma is most commonly diagnosed at age 30-50 and is associated with the autosomal dominant disorders of von Hippel-Lindau syndrome, multiple endocrine neoplasia type 2, and neurofibromatosis type 1.&nbsp; Measurements of urinary and/or plasma fractionated metanephrines and catecholamines are used to make the diagnosis.&nbsp; Physicians must have a high index of suspicion for pheochromocytoma as it may be <strong>misdiagnosed</strong> as a psychiatric disorder in otherwise asymptomatic patients.</p><p><strong>(Choice A)</strong>&nbsp; Acute intermittent porphyria is an autosomal dominant disorder of heme synthesis that presents with episodic abdominal pain, tachycardia, and peripheral neuropathy.</p><p><strong>(Choice B)</strong>&nbsp; Carcinoid syndrome is most commonly associated with intestinal neuroendocrine tumors and presents with intermittent diarrhea and skin flushing; it is sometimes associated with pulmonary and/or tricuspid valvular disease.</p><p><strong>(Choices C and F)</strong>&nbsp; Patients with generalized anxiety disorder and panic disorder may have similar psychiatric and sympathetically driven somatic symptoms (eg, palpitations, diaphoresis) as those found in pheochromocytoma; however, severe, drug-resistant hypertension, hyperglycemia, and episodic pounding headache are not associated with either condition.</p><p><strong>(Choice D)</strong>&nbsp; Although hyperthyroidism may present with palpitations, diaphoresis, tremulousness, and anxiety, it is not associated with pounding headache, is not typically episodic, and is accompanied by additional signs/symptoms such as weight loss, heat intolerance, and diarrhea.</p><p><strong>(Choice E)</strong>&nbsp; An insulinoma is a pancreatic tumor that secretes insulin and is associated with episodes of hypoglycemia and resultant cognitive dysfunction, palpitations, diaphoresis, and tremor.&nbsp; It is not associated with drug-resistant hypertension, hyperglycemia, or episodic headache.</p><p><strong>Educational objective:</strong><br>Pheochromocytoma is an adrenal tumor that presents with episodic headache, hypertension, tachycardia/palpitations,&nbsp;and diaphoresis and may be accompanied by anxiety and panic attacks.&nbsp; Given the risks associated with a missed medical diagnosis, physicians must maintain a high index of suspicion for underlying medical causes of psychiatric symptoms.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 25336,
            "topic": "Anxiety due to another medical condition",
            "titleId": 25336,
            "title": "Anxiety due to another medical condition",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "7",
            "userAnswer": "7",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute intermittent porphyria",
                    "choiceNumber": 1,
                    "correctTaken": 112,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Carcinoid syndrome",
                    "choiceNumber": 2,
                    "correctTaken": 486,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 791,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperthyroidism",
                    "choiceNumber": 4,
                    "correctTaken": 1992,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insulinoma",
                    "choiceNumber": 5,
                    "correctTaken": 183,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic disorder",
                    "choiceNumber": 6,
                    "correctTaken": 4435,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pheochromocytoma",
                    "choiceNumber": 7,
                    "correctTaken": 13090,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "615,729,true,-1,1*993,1202,true,-1,1*1221,1289,true,-1,1*127,231,true,-1,1*378,411,true,-1,1*462,476,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29217652",
                    "mediaDataId": 0,
                    "title": "Initial clinical presentation and spectrum of pheochromocytoma:  a study of 94 cases from a single center.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29217652",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27888488",
                    "mediaDataId": 0,
                    "title": "Phaeochromocytoma and paraganglioma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27888488",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 92,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 21089,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 780,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 18512,
            "questionIndex": 19983,
            "questionText": "<p>A 61-year-old attorney comes to the office with his wife for follow-up.&nbsp; Two months ago, the patient experienced an acute myocardial infarction while presenting a case in court and went into cardiac arrest.&nbsp; He was resuscitated in the emergency department, and a drug-eluting stent was placed.&nbsp; The patient recovered without complications and was discharged.&nbsp; He recently returned to work part-time, although his wife thinks he needs more time to rest.&nbsp; She states that he has been very stressed for the past month and worries that he is overworking.&nbsp; The patient has been sleeping restlessly and frequently wakes up startled and diaphoretic.&nbsp; While practicing a case presentation a few days ago, he had to stop and sit down because he felt overwhelmed.&nbsp; The patient plans to &#x22;take things slowly&#x22; and has asked his partner to cover upcoming court appearances.&nbsp; He has had no chest pain, palpitations, shortness of breath, or syncope.&nbsp; Medications include metoprolol, simvastatin, aspirin, and ticagrelor.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows no abnormalities.&nbsp; ECG reveals no acute changes.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35882\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Posttraumatic stress disorder</strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Exposure to life-threatening trauma</li><li>Nightmares, flashbacks, intrusive memories</li><li>Avoidance of reminders, dissociation</li><li>Emotional detachment, negative mood, decreased interest in activities</li><li>Sleep disturbance, hypervigilance, irritability</li><li>Duration &gt;1 month</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Treatment</strong></p></td><td><ul><li>Trauma-focused cognitive-behavioral therapy</li><li>Antidepressants (SSRIs, SNRIs)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRIs</strong> = serotonin-norepinephrine reuptake inhibitors; <strong>SSRIs</strong> = selective serotonin<br />reuptake inhibitors.</p></td></tr></tbody></table></div><p>This patient&#39;s monthlong history of feeling stressed and overwhelmed, experiencing sleep disturbance with possible nightmares, and engaging in avoidance behavior following an acute myocardial infarction (MI) and cardiac arrest is suggestive of <strong>posttraumatic stress disorder</strong> (PTSD).</p><p>Life-threatening medical events, such as acute MI, may be experienced as traumatic and result in PTSD in some patients.&nbsp; Symptoms include feelings of helplessness or horror in response to the cardiac event, reexperiencing of the event (eg, intrusive thoughts, <strong>nightmares</strong>, or flashbacks of the MI, cardiac arrest, or medical procedures), psychologic distress (eg, feeling overwhelmed)&nbsp;and physiologic reactivity when reminded of the event, and <strong>avoidance</strong> of activities or places related to the trauma (eg, this patient avoiding returning to the courtroom, where he had a cardiac arrest).&nbsp; The development of PTSD following acute MI is associated with increased risk of recurrence of cardiac events and mortality.</p><p>Trauma-focused <strong>cognitive-behavioral therapy</strong> (CBT) is the preferred initial treatment for PTSD.&nbsp; CBT combines cognitive techniques to help correct maladaptive thoughts about the trauma and exposure-based techniques to target avoidance behaviors and help the patient process the trauma emotionally.&nbsp; Pharmacotherapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI) is an alternate option that is generally safe in patients with cardiovascular disease.</p><p><strong>(Choice A)</strong>&nbsp; The hypothetical association of beta blockers with depression has not been substantiated by rigorous studies, and there is no evidence that beta blockers exacerbate symptoms of PTSD.&nbsp; In addition, beta blockers provide known survival benefit following acute MI; therefore, discontinuing metoprolol is not indicated.</p><p><strong>(Choice B)</strong>&nbsp; SSRI and SNRI antidepressants are first-line pharmacotherapy for PTSD.&nbsp; Mirtazapine, a sedating antidepressant, may help with restless sleep, but it has not demonstrated efficacy in the treatment of PTSD.</p><p><strong>(Choice C)</strong>&nbsp; Echocardiography is commonly performed several months after acute MI to evaluate for a persistent reduction in left ventricular ejection fraction; however, this patient had no complications at the time of MI and has no new symptoms to suggest heart failure.</p><p><strong>(Choice D)</strong>&nbsp; Although this patient can be reassured that his cardiac condition is stable, it would be inappropriate to defer treatment of his PTSD, which causes significant distress and increases his risk for recurrent cardiovascular events.</p><p><strong>Educational objective:</strong><br>Life-threatening medical events may be experienced as traumatic and result in posttraumatic stress disorder.&nbsp; Trauma-focused cognitive-behavioral therapy is the preferred initial treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17235,
            "topic": "Post traumatic stress disorder",
            "titleId": 17235,
            "title": "Post traumatic stress disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Discontinue metoprolol",
                    "choiceNumber": 1,
                    "correctTaken": 48,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate mirtazapine",
                    "choiceNumber": 2,
                    "correctTaken": 209,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain an echocardiogram",
                    "choiceNumber": 3,
                    "correctTaken": 288,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassure the patient and follow up in a month",
                    "choiceNumber": 4,
                    "correctTaken": 244,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend cognitive-behavioral therapy",
                    "choiceNumber": 5,
                    "correctTaken": 4192,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2358,2563,true,-1,1*1387,1510,true,-1,1*1808,2018,true,-1,1*312,329,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27566327",
                    "mediaDataId": 0,
                    "title": "Post-traumatic stress disorder and cardiovascular disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27566327",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25749748",
                    "mediaDataId": 0,
                    "title": "Psychological mechanisms of effective cognitive-behavioral treatments for PTSD.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25749748",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25545708",
                    "mediaDataId": 0,
                    "title": "Post-traumatic stress disorder among cardiac patients: prevalence, risk factors, and considerations for assessment and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25545708",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 175,
            "othersAvgTimeSpent": 85,
            "notes": null,
            "peopleTaken": 5073,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 614,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 14455,
            "questionIndex": 15864,
            "questionText": "<p>A 17-year-old girl comes to the office due to &#x22;disturbing images&#x22; she has seen over the past year.&nbsp; She says, &#x22;I&#39;d be standing in the kitchen helping my mother chop vegetables, and terrible images of stabbing her in the back with a knife would pop into my head.&#x22;&nbsp; The patient is overwhelmed with anxiety each time this occurs, resulting in putting the knife down and running out of the kitchen.&nbsp; She describes counting down from 5 to 1 several times to try to &#x22;get rid&#x22; of the thoughts, but this has not been helpful.&nbsp; The patient has no medical history, and physical examination is unremarkable.&nbsp; Mental status examination shows a tense and anxious affect; she becomes tearful when discussing how she would never want to hurt her mother.&nbsp; She reports no depressed mood or suicidal ideation.&nbsp; Which of the following is the most appropriate management for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T33713\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Obsessive-compulsive disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li><strong>Obsessions</strong><ul style=\"list-style-type:circle;\"><li>Recurrent, intrusive, anxiety-provoking thoughts, urges, or images</li></ul></li><li><strong>Compulsions</strong><ul style=\"list-style-type:circle;\"><li>Response to obsessions with repeated behaviors or mental acts</li><li>Behaviors not connected realistically with preventing feared event</li></ul></li><li>Time-consuming (&gt;1 hr/day) or causing significant distress or impairment</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Selective serotonin reuptake inhibitor</li><li>Cognitive-behavioral therapy (exposure &amp; response prevention)</li></ul></td></tr></tbody></table></div><p><strong>Obsessive-compulsive disorder (OCD)</strong> is diagnosed by the presence of obsessions, compulsions, or both&mdash;with most patients having a combination.</p><p><strong>Obsessions</strong> are characterized by involuntary, intrusive distressing thoughts, images, or urges and are managed through suppression or neutralization with a compulsion.&nbsp; <strong>Compulsions</strong> are repetitive, unyielding external (eg, hand washing) or mental (eg, repeated counting) acts designed to <strong>protect against the obsession</strong> or <strong>reduce distress or anxiety</strong>.&nbsp; In some cases, obsessions in OCD include unwelcome violent urges or images, as seen in this patient who has images of stabbing her mother in the back with a knife, followed by her compulsion of repeatedly counting from 5 to 1 to neutralize the thought.</p><p>First-line treatment for OCD includes exposure and response prevention (a type of cognitive-behavioral therapy) and pharmacotherapy with a <strong>serotonergic antidepressant</strong>.&nbsp; All <strong>selective serotonin reuptake inhibitor (SSRI)</strong> antidepressants (eg, fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, escitalopram) and the tricyclic antidepressant clomipramine are effective.&nbsp; SSRIs are preferred as initial treatment due to their superior adverse-effect profile.</p><p><strong>(Choices A and C)</strong>&nbsp; Aripiprazole (a second-generation antipsychotic) and haloperidol (a first-generation antipsychotic) are not indicated as monotherapy in OCD.&nbsp; Antipsychotics are sometimes used as augmentation in patients with inadequate response to SSRIs.</p><p><strong>(Choices B and D)</strong>&nbsp; Although anxiety is a prominent feature of OCD, anxiolytic medications such as buspirone and lorazepam do not treat obsessions and compulsions.&nbsp; Buspirone has a role in the pharmacotherapy of generalized anxiety disorder.&nbsp; Lorazepam is used in anxiety disorders and the short-term management of acute anxiety, but it carries risks of misuse and withdrawal.</p><p><strong>Educational objective:</strong><br>Treatment of obsessive-compulsive disorder consists of serotonergic antidepressants and cognitive-behavioral therapy based on exposure and response prevention.&nbsp; Selective serotonin reuptake inhibitors are first-line medications.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17181,
            "topic": "Obsessive compulsive disorder",
            "titleId": 17181,
            "title": "Obsessive compulsive disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aripiprazole",
                    "choiceNumber": 1,
                    "correctTaken": 5434,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Buspirone",
                    "choiceNumber": 2,
                    "correctTaken": 781,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Haloperidol",
                    "choiceNumber": 3,
                    "correctTaken": 1266,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lorazepam",
                    "choiceNumber": 4,
                    "correctTaken": 549,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline",
                    "choiceNumber": 5,
                    "correctTaken": 9076,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "969,1223,true,-1,1*1546,1687,true,-1,1*1849,1945,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25150568",
                    "mediaDataId": 0,
                    "title": "Pharmacological treatment of obsessive-compulsive disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25150568",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25681005",
                    "mediaDataId": 0,
                    "title": "Obsessive-compulsive disorder (OCD): practical strategies for pharmacological and somatic treatment in adults.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25681005",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 41,
            "notes": null,
            "peopleTaken": 17106,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1001,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 4285,
            "questionIndex": 4285,
            "questionText": "<p>A 25-year-old woman is brought to the emergency department by coworkers following a 15-minute episode of chest pain, shortness of breath, and sweating that started while she was giving a presentation.&nbsp; She is very anxious and says, &#x22;It happened so suddenly; my heart was pounding, and I felt like I was going to pass out.&#x22;&nbsp; The patient first had a similar episode 3 months ago prior to giving a presentation at work and has had a number of episodes since then&mdash;while socializing with friends, before taking a flight to visit her parents, and while relaxing at home with her roommate.&nbsp; Now she constantly worries about having another episode.&nbsp; The patient is extremely anxious about speaking in public and has called in sick twice to avoid giving presentations, fearing that the symptoms will recur.&nbsp; She has a history of a benign childhood heart murmur, asthma, and hypothyroidism.&nbsp; Medications include levothyroxine and an albuterol inhaler that she uses infrequently.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 130/85 mm Hg, pulse is 98/min, and respirations are 18/min.&nbsp; Examination shows mild end-expiratory wheezing over the left lower lobe and no other abnormalities.&nbsp; White blood cell count is 9,800/mm<font size=\"2\"><sup>3</sup></font> and TSH level is 4.2 &micro;U/mL.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33491\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Panic disorder</strong></p></td></tr><tr><td style=\"width: 10%;\"><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td style=\"width: 90%;\"><ul><li>Recurrent &amp; unexpected panic attacks with &ge;4 of the following:<ul style=\"list-style-type:circle;\"><li>Chest pain, palpitations, shortness of breath, choking</li><li>Trembling, sweating, nausea, chills</li><li>Dizziness, paresthesia</li><li>Derealization, depersonalization</li><li>Fear of losing control or of dying</li></ul></li><li>Worry about additional attacks, avoidance behavior</li></ul></td></tr><tr><td style=\"width: 10%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width: 90%;\"><ul><li>First-line/maintenance: SSRI/SNRI &amp;/or cognitive-behavioral therapy</li><li>Acute distress: benzodiazepines</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRI</strong> = serotonin norepinephrine reuptake inhibitor; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>This patient&#39;s abrupt onset of intense episodes of anxiety accompanied by chest pain, shortness of breath, sweating, and dizziness is suggestive of <strong>panic disorder</strong>.&nbsp; Diagnosis requires that at least some of these panic attacks are untriggered or <strong>unexpected</strong> (eg, at home, relaxing with friends) and the presence of &#8805;1 months of <strong>worry about future attacks</strong> or change in behavior (eg, <strong>avoidance</strong>).</p><p>Panic attacks may also be a symptom of other anxiety disorders; however, in these cases the panic attacks&nbsp;are always specifically triggered by a feared object or situation (eg, being away from home alone in agoraphobia; being in social or performance situations in social anxiety disorder) <strong>(Choices A and F)</strong>.&nbsp; The key difference is that in panic disorder, at least some attacks are unexpected and followed by persistent worry about future attacks.</p><p><strong>(Choice B)</strong>&nbsp; Anxiety disorder due to another medical condition is diagnosed when the panic attacks are a direct physiological consequence of another medical condition (eg, hyperthyroidism, arrhythmias, asthma).&nbsp; This patient&#39;s thyroid condition is stable and her asthma attacks are infrequent and not consistently related to her panic attacks.&nbsp; Her mild wheezing on examination is more likely a consequence than a cause of her panic.</p><p><strong>(Choice C)</strong>&nbsp; Generalized anxiety disorder is characterized by &#8805;6 months of persistent worry about multiple issues and does not feature unexpected panic attacks.&nbsp; Patients with panic disorder may exhibit some degree of chronic anxiety, but this is due to fears of having additional attacks, not excessive anxiety about everyday issues.</p><p><strong>(Choice D)</strong>&nbsp; Medication-induced anxiety disorder is diagnosed when panic symptoms are directly caused by exposure to a medication (eg, overmedication with albuterol or levothyroxine, precipitating panic).&nbsp; However, this patient&#39;s TSH level is normal and she is using albuterol infrequently, making these unlikely causes of her recurrent attacks.</p><p><strong>Educational objective:</strong><br>Panic disorder involves recurrent unexpected panic attacks, fears of future attacks, and avoidance behavior.&nbsp; Diagnosis requires differentiation from other anxiety disorders that may include triggered panic attacks and ruling out medical causes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 19090,
            "topic": "Panic disorder",
            "titleId": 19090,
            "title": "Panic disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Agoraphobia",
                    "choiceNumber": 1,
                    "correctTaken": 259,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anxiety disorder due to another medical condition",
                    "choiceNumber": 2,
                    "correctTaken": 691,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 572,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication-induced anxiety disorder",
                    "choiceNumber": 4,
                    "correctTaken": 554,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic disorder",
                    "choiceNumber": 5,
                    "correctTaken": 13432,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Social anxiety disorder, performance only",
                    "choiceNumber": 6,
                    "correctTaken": 1568,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "879,957,true,-1,1*1269,1407,true,-1,1*2186,2519,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": true,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25955736",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of generalized anxiety disorder and panic disorder in adults.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25955736",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29320381",
                    "mediaDataId": 0,
                    "title": "A brief interview to detect&#160;panic&#160;attacks and&#160;panic disorder&#160;in&#160;emergency department&#160;patients with cardiopulmonary complaints.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29320381",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 109,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 17076,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 473,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 4141,
            "questionIndex": 4141,
            "questionText": "<p>A 28-year-old man comes to the office with a 6-month history of extreme nervousness, irritability, restlessness, muscle tension, and insomnia.&nbsp; He fears making mistakes in his job as an attorney and often worries that he has said something wrong.&nbsp; The patient dreads the possibility of not being offered a position as a partner in the law firm despite frequent reassurance from his superiors.&nbsp; As a result, he finds himself unable to concentrate or perform his duties efficiently.&nbsp; The patient is also engaged and spends sleepless nights thinking about the responsibilities of married life.&nbsp; He worries that he will not be a good husband or father.&nbsp; The patient does not drink alcohol or use recreational substances.&nbsp; He is reluctant to start psychotherapy due to his busy schedule.&nbsp; Which of the following medications is most appropriate for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T108875\" style=\"overflow-x:auto;\" tid=\"2793\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Generalized anxiety disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>DSM-5-TR criteria</strong></p></td><td><ul><li>Excessive worry, anxiety (multiple issues) &#8805;6 months</li><li>Difficult to control</li><li>3 or more of the following symptoms:<ul style=\"list-style-type:circle;\"><li>Restlessness/feeling on edge</li><li>Fatigue</li><li>Difficulty concentrating</li><li>Irritability</li><li>Muscle tension</li><li>Sleep disturbance</li></ul></li><li>Significant distress or impairment</li><li>Not due to substances, another mental disorder, or medical condition</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>First-line<ul style=\"list-style-type:circle;\"><li>Cognitive-behavioral therapy</li><li>SSRIs or SNRIs</li></ul></li><li>Second-line<ul style=\"list-style-type:circle;\"><li>Benzodiazepines</li><li>Buspirone</li></ul></li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRIs</strong> = serotonin-norepinephrine reuptake inhibitors; <strong>SSRIs</strong> = selective serotonin reuptake inhibitors.</p></td></tr></tbody></table></div><p>This patient&#39;s 6-month history of excessive worry and anxiety, restlessness, irritability, difficulty concentrating, muscle tension, and sleep disturbance is consistent with <strong>generalized anxiety disorder (GAD)</strong>.&nbsp; In GAD, the anxiety is chronic, excessive, and difficult to control; as a result, it causes significant distress or impairment.</p><p>Treatment of GAD includes <strong>cognitive-behavioral therapy</strong>, <strong>medication</strong>, or a combination of both.&nbsp; Preferred initial medications for GAD include selective serotonin reuptake inhibitors <strong>(SSRIs)</strong> or serotonin-norepinephrine reuptake inhibitors <strong>(SNRIs)</strong> such as venlafaxine.&nbsp; No antidepressant has been shown to be a superior treatment, so medication selection is based on the adverse effect profile and the patient&#39;s treatment history.&nbsp; SSRIs/SNRIs are also effective in treating depression, a common comorbidity.</p><p>Benzodiazepines (eg, diazepam, lorazepam) are effective but considered second-line treatments due to the risks for misuse, dependence, and tolerance and the potential for withdrawal syndromes and rebound effects with abrupt discontinuation <strong>(Choices B and C)</strong>.&nbsp; Benzodiazepines can be used when antidepressants are ineffective or poorly tolerated but should be avoided in patients with a history of substance use or significant comorbid depression.&nbsp; They can also be used as an adjunct to manage acute anxiety while waiting for SSRIs or SNRIs to take effect.</p><p>Buspirone, a nonbenzodiazepine anxiolytic, has been used to treat GAD in patients without comorbid depression or panic symptoms.&nbsp; Although it has a slower onset of action and weaker anxiolytic effects than benzodiazepines, it can be helpful in patients with a high risk for benzodiazepine misuse.</p><p><strong>(Choice A)</strong>&nbsp; Bupropion is a norepinephrine dopamine reuptake inhibitor that is sometimes used off-label in the management of GAD; however, it has greater potential for more severe adverse effects (eg, worsened anxiety, increased restlessness) compared to preferred first-line serotonergic agents.</p><p><strong>(Choice D)</strong>&nbsp; The beta blocker propranolol is an effective treatment of the performance subtype of social anxiety disorder, but it is not used in the treatment of GAD.</p><p><strong>(Choice E)</strong>&nbsp; Second-generation antipsychotics, such as quetiapine, should not be used as first-line treatment for GAD.&nbsp; They are sometimes prescribed when a patient&#39;s condition is resistant to treatment, but they have significant adverse effects (eg, sedation, metabolic effects).</p><p><strong>(Choice G)</strong>&nbsp; Zolpidem is a sedative-hypnotic medication that could target this patient&#39;s insomnia but would not address his other GAD symptoms.</p><p><strong>Educational objective:</strong><br>Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors (eg, venlafaxine) are first-line medication options for the treatment of generalized anxiety disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 18230,
            "topic": "Generalized anxiety disorder",
            "titleId": 18230,
            "title": "Generalized anxiety disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bupropion",
                    "choiceNumber": 1,
                    "correctTaken": 581,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diazepam",
                    "choiceNumber": 2,
                    "correctTaken": 70,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lorazepam",
                    "choiceNumber": 3,
                    "correctTaken": 131,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Propranolol",
                    "choiceNumber": 4,
                    "correctTaken": 110,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quetiapine",
                    "choiceNumber": 5,
                    "correctTaken": 74,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Venlafaxine",
                    "choiceNumber": 6,
                    "correctTaken": 4004,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Zolpidem",
                    "choiceNumber": 7,
                    "correctTaken": 116,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "477,502,true,-1,1*1709,2007,true,-1,1*2008,2304,true,-1,1*2821,2832,true,-1,1*2895,3046,true,-1,1*2317,2600,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33343351",
                    "mediaDataId": 0,
                    "title": "Comparative remission rates and tolerability of drugs for generalised anxiety disorder: a systematic review and network meta-analysis of double-blind randomized controlled trials.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33343351",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 71,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 5086,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 550,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 10691,
            "questionIndex": 11811,
            "questionText": "<p>A 33-year-old woman comes to the office due to poor sleep for the past 2 months.&nbsp; The patient says, &#x22;Most nights, I wake up around 2 AM in a state of panic&mdash;my heart is racing and it&#39;s hard to fall back asleep.&nbsp; I can barely stay awake at work, and it takes me twice as long to finish assignments because I need to reread everything.&#x22;&nbsp; The patient lives alone and works as a computer programmer.&nbsp; She filed for divorce 3 months ago due to her husband&#39;s substance use and violent behavior toward her.&nbsp; The patient drinks a glass of wine at bedtime to help her fall asleep and does not use illicit drugs.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination and laboratory evaluation are unremarkable.&nbsp; On mental status examination, she appears tired and her mood is depressed and anxious.&nbsp; The patient jumps when a nearby door slams closed.&nbsp; At one point, she appears to stare into space and does not respond to her name for a few moments.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35882\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Posttraumatic stress disorder</strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Exposure to life-threatening trauma</li><li>Nightmares, flashbacks, intrusive memories</li><li>Avoidance of reminders, dissociation</li><li>Emotional detachment, negative mood, decreased interest in activities</li><li>Sleep disturbance, hypervigilance, irritability</li><li>Duration &gt;1 month</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Treatment</strong></p></td><td><ul><li>Trauma-focused cognitive-behavioral therapy</li><li>Antidepressants (SSRIs, SNRIs)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRIs</strong> = serotonin-norepinephrine reuptake inhibitors; <strong>SSRIs</strong> = selective serotonin<br />reuptake inhibitors.</p></td></tr></tbody></table></div><p>This patient&nbsp;with a history of exposure to intimate partner violence has several features suggestive of <strong>posttraumatic stress disorder (PTSD)</strong>, including <strong>sleep disturbance</strong> (poor sleep,&nbsp;panicked awakening), <strong>dissociation&nbsp;</strong>(eg, momentarily staring and unresponsive), <strong>negative mood</strong>, and hypervigilance/<strong>increased startle response</strong>&nbsp;(eg, when nearby door slams).&nbsp; Other characteristic features of PTSD include flashbacks, intrusive memories, and avoidance of reminders of the traumatic event.</p><p>Patients with PTSD commonly experience depressed mood, irritability, and anxiety and frequently have classic mood symptoms such as insomnia, fatigue, and impaired concentration.&nbsp; Patients may be <strong>reluctant to disclose trauma</strong>, so physicians must remain alert to signs and symptoms of PTSD and provide further assessment and treatment.&nbsp; Trauma-focused cognitive-behavioral therapy and antidepressants are first-line treatments.</p><p><strong>(Choice A)</strong>&nbsp; Adjustment disorder develops within 3 months of an identifiable stressor and causes significant distress.&nbsp; However, it&nbsp;is not diagnosed when the stressor is of a traumatic nature (rather than a common occurrence) and when the patient has a constellation of symptoms (eg, dissociation, hypervigilance) suggestive of a more specific disorder (eg, PTSD).</p><p><strong>(Choice B)</strong>&nbsp; Depersonalization/derealization (ie, feeling detached from one&#39;s body, experiencing surroundings as unreal) is considered part of PTSD and is not diagnosed as a separate disorder when PTSD is present.&nbsp; The specifier, &#x22;with dissociative symptoms,&#x22; can be added to the PTSD diagnosis when such symptoms are persistent.</p><p><strong>(Choice C)</strong>&nbsp; Although generalized anxiety disorder (GAD) is also characterized by anxiety, sleep disturbance, and impaired concentration, these patients worry about a multitude of everyday events.&nbsp; In addition, a duration of 6 months is required for diagnosis of GAD.</p><p><strong>(Choice D)</strong>&nbsp; Major depressive disorder would not explain this patient&#39;s panicked awakening, heightened startle response, or dissociation.&nbsp; Negative mood states, decreased interest in activities, and emotional detachment are common features of PTSD.</p><p><strong>(Choice E)</strong>&nbsp; Patients with panic disorder experience unprovoked panic attacks at any time during the day or night.&nbsp; This patient&#39;s nighttime panic symptoms are more likely due to nightmares related to PTSD.</p><p><strong>Educational objective:</strong><br>Patients with posttraumatic stress disorder (PTSD) commonly have symptoms of sleep disturbance, impaired concentration, and negative mood.&nbsp; A history of trauma, dissociative symptoms, and increased startle response are clues for PTSD.<span class=\"psgexrpt\"> </span></p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17235,
            "topic": "Post traumatic stress disorder",
            "titleId": 17235,
            "title": "Post traumatic stress disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "6",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 1,
                    "correctTaken": 555,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Depersonalization/derealization disorder",
                    "choiceNumber": 2,
                    "correctTaken": 169,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic disorder",
                    "choiceNumber": 5,
                    "correctTaken": 137,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Posttraumatic stress disorder",
                    "choiceNumber": 6,
                    "correctTaken": 3890,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1435,1788,true,-1,1*2747,2838,true,-1,1*722,776,true,-1,1*798,868,true,-1,1*312,329,true,-1,1*194,311,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29063485",
                    "mediaDataId": 0,
                    "title": "The dissociative subtype of post-traumatic stress disorder: research update on clinical and neurobiological features.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29063485",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26711508",
                    "mediaDataId": 0,
                    "title": "New developments in intimate partner violence and management of its mental health sequelae.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26711508",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25084856",
                    "mediaDataId": 0,
                    "title": "Post-traumatic stress disorder: theory and treatment update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25084856",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 154,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 5052,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 77,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 434,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 10766,
            "questionIndex": 11894,
            "questionText": "<p>A 32-year-old man with no significant medical history comes to the office with concerns about recurrent episodes of sudden heart pounding, shortness of breath, chest pain, dizziness, shaking, and tingling in his extremities over the past several months.&nbsp; The episodes last about 10 minutes and are associated with feelings of unreality and detachment from his body.&nbsp; The patient fears having episodes while at work or driving and worries that he may have a heart condition or a serious undiagnosed disease.&nbsp; He has seen other physicians, who performed extensive medical workups but found nothing wrong.&nbsp; His worry has progressively worsened, and he now feels anxious all the time.&nbsp; The patient does not use alcohol or illicit drugs.&nbsp; Routine laboratory testing, ECG, and physical examination show no abnormalities.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t33491\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Panic disorder</strong></p></td></tr><tr><td style=\"width: 10%;\"><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td style=\"width: 90%;\"><ul><li>Recurrent &amp; unexpected panic attacks with &ge;4 of the following:<ul style=\"list-style-type:circle;\"><li>Chest pain, palpitations, shortness of breath, choking</li><li>Trembling, sweating, nausea, chills</li><li>Dizziness, paresthesia</li><li>Derealization, depersonalization</li><li>Fear of losing control or of dying</li></ul></li><li>Worry about additional attacks, avoidance behavior</li></ul></td></tr><tr><td style=\"width: 10%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width: 90%;\"><ul><li>First-line/maintenance: SSRI/SNRI &amp;/or cognitive-behavioral therapy</li><li>Acute distress: benzodiazepines</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRI</strong> = serotonin norepinephrine reuptake inhibitor; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div></p><p>The <strong>unexpected</strong> and <strong>abrupt onset</strong> of symptoms in this otherwise healthy patient with repeated <strong>negative</strong> medical <strong>workups</strong> is suggestive of <strong>panic disorder</strong>.&nbsp; Patients with panic disorder frequently have <strong>cardiorespiratory</strong> symptoms and may fear they are having a heart attack and repeatedly seek medical care.&nbsp; Other symptoms may include <strong>gastrointestinal</strong> distress, <strong>paresthesias</strong>, and <strong>dissociative</strong> symptoms such as derealization and depersonalization.&nbsp; Patients typically develop anticipatory anxiety about subsequent attacks and may develop chronic anxiety.&nbsp; They may reasonably become preoccupied with their symptoms and fears of having an undiagnosed condition, making it difficult to differentiate panic disorder from a somatic symptom disorder.</p><p><strong>(Choice A)</strong>&nbsp; Conversion disorder (functional neurological symptom disorder) involves development of a neurological symptom that is inconsistent with recognized neurological disease.</p><p><strong>(Choice B)</strong>&nbsp; This patient&#39;s feelings of derealization and depersonalization are associated symptoms of his panic attacks.&nbsp; Depersonalization/derealization disorder should not be diagnosed when the symptoms occur only during panic attacks that are part of panic disorder.</p><p><strong>(Choice C)</strong>&nbsp; In factitious disorder, patients intentionally falsify symptoms in order to assume the sick role.</p><p><strong>(Choice D)</strong>&nbsp; This patient has become chronically anxious because he fears recurrent panic attacks.&nbsp; His anxiety is restricted to fears surrounding his panic symptoms, and he does not have the excessive worries about multiple issues required for a diagnosis of generalized anxiety disorder.</p><p><strong>(Choice E)</strong>&nbsp; In illness anxiety disorder, patients experience excessive anxiety about having or acquiring a serious illness and have few or no somatic symptoms.&nbsp; This patient has multiple somatic symptoms, and he is concerned that they are due to a medical illness because he has not yet been accurately diagnosed.&nbsp; Illness anxiety disorder is not diagnosed when the illness-related preoccupation is better explained by another mental disorder, such as panic disorder.</p><p><strong>(Choice G)</strong>&nbsp; Multiple physical symptoms, high health care use, and a preoccupation with symptoms are seen in both panic disorder and somatic symptom disorder.&nbsp; However, in somatic symptom disorder, physical symptoms are persistent over time.&nbsp; This patient&#39;s acute physical symptoms are characteristic of panic disorder and do not persist between panic attacks.</p><p><strong>Educational objective:</strong><br>Patients with panic disorder may be misdiagnosed with a somatic symptom disorder due to preoccupation with unexplained symptoms and a history of high health care use.&nbsp; The recurrent abrupt onset of characteristic physical symptoms that resolve within minutes should raise clinical suspicion for panic disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 19090,
            "topic": "Panic disorder",
            "titleId": 19090,
            "title": "Panic disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Conversion disorder",
                    "choiceNumber": 1,
                    "correctTaken": 184,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Depersonalization/derealization disorder",
                    "choiceNumber": 2,
                    "correctTaken": 1667,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Factitious disorder",
                    "choiceNumber": 3,
                    "correctTaken": 73,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 4,
                    "correctTaken": 426,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Illness anxiety disorder",
                    "choiceNumber": 5,
                    "correctTaken": 1221,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic disorder",
                    "choiceNumber": 6,
                    "correctTaken": 12041,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Somatic symptom disorder",
                    "choiceNumber": 7,
                    "correctTaken": 1348,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2785,2986,true,-1,1*2368,2625,true,-1,1*2173,2199,true,-1,1*2290,2317,true,-1,1*899,940,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "15842183",
                    "mediaDataId": 0,
                    "title": "Understanding and treating panic disorder in the primary care setting.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/15842183",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19763206",
                    "mediaDataId": 0,
                    "title": "Panic disorder subtypes: deceptive somatic impersonators.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19763206",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 70,
            "othersAvgTimeSpent": 43,
            "notes": null,
            "peopleTaken": 16960,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 496,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 18546,
            "questionIndex": 20017,
            "questionText": "<p>A 28-year-old woman comes to the office for follow-up of an 8-month history of anxiety, nightmares, and flashbacks after returning from a military deployment.&nbsp; She has been taking sertraline for the past 6 months and completed a course of cognitive-behavioral therapy recently.&nbsp; The patient reports her symptoms have mostly improved, and she no longer has intrusive thoughts or flashbacks related to her time in a combat zone.&nbsp; She says, &#x22;My mood feels lighter, and I&#39;ve started spending more time with friends and family.&nbsp; I can&#39;t seem to sleep through the night though.&nbsp; I&#39;m still having scary dreams about my time in the army.&#x22;&nbsp; She drinks a glass of wine twice a week and does not use tobacco or illicit drugs.&nbsp; Medical history is noncontributory.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows no abnormalities.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t67244\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Posttraumatic stress disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>DSM-5</strong></p></td><td><ul><li>Exposure to life-threatening trauma</li><li><strong>Intrusion symptoms:</strong> nightmares, flashbacks</li><li><strong>Avoidance symptoms:</strong> avoids distressing thoughts, feelings &amp; external reminders of the event</li><li><strong>Negative mood &amp; cognitions:</strong> persistent horror, anger, guilt, negative beliefs about self &amp; the world, decreased interest in activities, emotional detachment, amnesia for event</li><li><strong>Arousal symptoms:</strong> sleep disturbance, hypervigilance, impaired concentration</li><li>Duration: more than 1 month</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Trauma-focused cognitive-behavioral therapy</li><li>Antidepressants (SSRIs, SNRIs)</li><li>Prazosin for nightmares</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRIs</strong> = serotonin-norepinephrine reuptake inhibitors;<strong> SSRIs</strong> = selective serotonin reuptake inhibitors.</p></td></tr></tbody></table></div><p>First-line treatment for <strong>posttraumatic stress disorder (PTSD)</strong> includes trauma-focused cognitive behavioral psychotherapy and pharmacotherapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI).&nbsp; This patient&#39;s symptoms of PTSD have improved with psychotherapy and sertraline, but she continues to experience <strong>distressing nightmares</strong>.</p><p>Meta-analyses have shown that <strong>prazosin</strong>, an <strong>alpha-1 adrenergic receptor antagonist</strong>, is effective for treatment of PTSD-related nightmares and is particularly helpful as an adjunct to SSRI or SNRI treatment.&nbsp; Prazosin is thought to <strong>reduce nightmare frequency</strong> by decreasing the adrenergic hyperactivity found in many patients with PTSD.&nbsp; Prazosin is administered at bedtime and requires titration to reduce the risk of effects on blood pressure (eg, orthostasis).</p><p><strong>(Choice A)</strong>&nbsp; Benzodiazepines (eg, clonazepam) are not effective in the treatment of PTSD-related nightmares and carry risks of addiction and dependence.&nbsp; They should particularly be avoided in patients with an active substance use disorder.</p><p><strong>(Choice B)</strong>&nbsp; There is no evidence that psychodynamic psychotherapy can effectively target PTSD-related nightmares.&nbsp; Exposure-based cognitive-behavioral therapy (CBT) is the therapy of choice for PTSD; CBT techniques to target nightmares specifically include image rehearsal therapy, in which nightmares are rewritten with a positive outcome.</p><p><strong>(Choice D)</strong>&nbsp; This patient&#39;s PTSD symptoms have improved significantly on sertraline.&nbsp; There is no evidence that paroxetine is more effective in treating nightmares than other SSRIs, and switching antidepressants could risk worsening other PTSD symptoms.</p><p><strong>(Choice E)</strong>&nbsp; This patient is benefiting from sertraline, and tapering risks relapse.</p><p><strong>Educational objective:</strong><br>Prazosin, an alpha-1 adrenergic receptor antagonist, is effective for the treatment of posttraumatic stress disorder&ndash;related nightmares.&nbsp; It is particularly helpful as an adjunct to selective serotonin reuptake inhibitor or serotonin norepinephrine reuptake inhibitor treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17235,
            "topic": "Post traumatic stress disorder",
            "titleId": 17235,
            "title": "Post traumatic stress disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add clonazepam",
                    "choiceNumber": 1,
                    "correctTaken": 1875,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend psychodynamic psychotherapy",
                    "choiceNumber": 2,
                    "correctTaken": 2145,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start prazosin",
                    "choiceNumber": 3,
                    "correctTaken": 11472,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Switch to paroxetine",
                    "choiceNumber": 4,
                    "correctTaken": 927,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Taper sertraline",
                    "choiceNumber": 5,
                    "correctTaken": 706,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2518,2654,true,-1,1*602,625,true,-1,1*2017,2157,true,-1,1*1322,1576,true,-1,1*430,449,true,-1,1*466,488,true,-1,1*265,412,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31855732",
                    "mediaDataId": 0,
                    "title": "Comparative efficacy of imagery rehearsal therapy and prazosin in the treatment of trauma-related nightmares in adults: A meta-analysis of randomized controlled trials",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31855732",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 62,
            "othersAvgTimeSpent": 43,
            "notes": null,
            "peopleTaken": 17125,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 523,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 15071,
            "questionIndex": 16495,
            "questionText": "<p>A 31-year-old woman comes to the office for a 6-week postpartum visit.&nbsp; The patient is accompanied by her husband who says, &#x22;We haven&#39;t been getting much sleep since the baby was born, but he&#39;s healthy and doing well.&nbsp; My wife is doing a great job&mdash;I&#39;m just worried she&#39;s too overwhelmed.&#x22;&nbsp; Her husband shares that she spends hours every night reading about breastfeeding and baby formula instead of sleeping.&nbsp; The patient says, &#x22;Lots of things get passed on to the baby in breast milk.&nbsp; I don&#39;t want him to get exposed to something bad or hurt him in some way.&#x22;&nbsp; She wears sterile surgical gloves when preparing formula and showers every time before breastfeeding.&nbsp; The patient washes fruits and vegetables 3 times to &#x22;get all the pesticides out&#x22; and does not eat at restaurants anymore from fear of getting food poisoning.&nbsp; She does not drink alcohol or use illicit drugs.&nbsp; Medical history is insignificant.&nbsp; Physical examination is within normal limits.&nbsp; The patient appears tired and anxious; she has no suicidal ideation.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33713\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Obsessive-compulsive disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li><strong>Obsessions </strong><ul style=\"list-style-type:circle;\"><li>Recurrent, intrusive, anxiety-provoking thoughts, urges, or images</li></ul></li><li><strong>Compulsions</strong><ul style=\"list-style-type:circle;\"><li>Response to obsessions with repeated behaviors or mental acts</li><li>Behaviors not connected realistically with preventing feared event</li></ul></li><li>Time-consuming (&gt;1 hr/day) or causing significant distress or impairment</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Selective serotonin reuptake inhibitor</li><li>Cognitive-behavioral therapy (exposure &amp; response prevention)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s new onset of time-consuming, intrusive obsessions (ie, excessive preoccupation about contamination of breast milk, obsessional fears of harming the baby) and associated compulsive behaviors (excessive washing and showering) are consistent with <strong>obsessive-compulsive disorder</strong> (OCD).&nbsp; Pregnancy and the <strong>postpartum period</strong> are associated with <strong>increased risk</strong> for new onset, recurrence, or exacerbation of OCD.&nbsp; As in this case, the obsessional thoughts and compulsions often relate to the health and safety of the baby (eg, fears of contaminating and harming the baby, excessive washing).</p><p>New mothers with OCD may be reluctant to disclose their symptoms and come to clinical attention only when a partner or family member becomes concerned.&nbsp; Mild cases of postpartum OCD are treated with cognitive-behavioral therapy; management of moderate to severe cases may include a serotonergic antidepressant after consideration of the risks of pharmacotherapy versus the risks of untreated OCD.</p><p><strong>(Choice A)</strong>&nbsp; Adjustment disorder with anxiety is characterized by emotional or behavioral disturbances within 3 months of the onset of a stressor (eg, childbirth).&nbsp; However, this patient&#39;s time-consuming, intrusive thoughts&nbsp;and compulsions make OCD a more likely diagnosis.&nbsp; Adjustment disorder&nbsp;is not diagnosed when the criteria for a more specific mental disorder (eg, OCD) are met.</p><p><strong>(Choice B)</strong>&nbsp; Generalized anxiety disorder is characterized by multiple worries about everyday events lasting &#8805;6 months and would not explain this patient&#39;s compulsive behaviors.</p><p><strong>(Choice C)</strong>&nbsp; This patient&#39;s mood is anxious, and she does not have other key depressive symptoms (eg, decreased interest, impaired concentration, feelings of worthlessness/guilt, decreased appetite).</p><p><strong>(Choice E)</strong>&nbsp; It may be difficult to differentiate delusions seen in postpartum psychosis from the obsessions seen in OCD.&nbsp; However, this patient does not have other psychotic symptoms (eg, hallucinations, disorganized speech or behavior) that would be seen in postpartum psychosis.&nbsp; Her compulsive checking and cleaning behaviors are characteristic of OCD.</p><p><strong>(Choice F)</strong>&nbsp; Specific phobia is characterized by severe anxiety upon exposure to a specific situation or object, typically leading to avoidance of the feared stimulus (eg, heights, needles).&nbsp; It would not explain this patient&#39;s compulsive behaviors.</p><p><strong>Educational objective:</strong><br>Pregnancy and the postpartum period are associated with increased risk for new onset, recurrence, or exacerbation of obsessive-compulsive disorder.&nbsp; Obsessions and compulsions frequently center around fears of contaminating and harming the baby.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17181,
            "topic": "Obsessive compulsive disorder",
            "titleId": 17181,
            "title": "Obsessive compulsive disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with anxiety",
                    "choiceNumber": 1,
                    "correctTaken": 1045,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 2,
                    "correctTaken": 194,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 3,
                    "correctTaken": 10,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obsessive-compulsive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 2514,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Postpartum psychosis",
                    "choiceNumber": 5,
                    "correctTaken": 623,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Specific phobia",
                    "choiceNumber": 6,
                    "correctTaken": 537,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2247,2592,true,-1,1*1232,1476,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26246310",
                    "mediaDataId": 0,
                    "title": "Obsessive-compulsive disorder in the postpartum period: diagnosis, differential diagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26246310",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24421066",
                    "mediaDataId": 0,
                    "title": "Obsessive-compulsive disorder and female reproductive cycle events: results from the OCD and reproduction collaborative study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24421066",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23656845",
                    "mediaDataId": 0,
                    "title": "Risk of obsessive-compulsive disorder in pregnant and postpartum women: a meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23656845",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 108,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 5013,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 338,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 3839,
            "questionIndex": 3839,
            "questionText": "<p>A 27-year-old man comes to the office due to anxiety and poor sleep that has been worsening over the last year.&nbsp; He worries that he will say something stupid or embarrassing at his weekly staff meeting, and so he has particular difficulty falling asleep for 2 or 3 nights leading up to it.&nbsp; He says, &#x22;It&#39;s just so difficult for me to relax at those meetings even though I am always well prepared.&#x22;&nbsp; Although the patient&#39;s work performance is good, he recently turned down a promotion because he worried that he would be required to interact more regularly with clients.&nbsp; He is experiencing no depression, difficulty concentrating, or appetite disturbance.&nbsp; The patient previously used alcohol daily to calm his nerves when meeting new people but now limits alcohol to 2 drinks twice a week.&nbsp; Medical history is insignificant.&nbsp; Blood pressure is 130/80 mm Hg, pulse is 82/min, and respirations are 16/min.&nbsp; On mental status examination, the patient sighs frequently and has a tense appearance and poor eye contact.&nbsp; He is reluctant to consider psychotherapy and requests medication to help him relax.&nbsp; Which of the following is the most appropriate pharmacotherapy?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T34093\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Social anxiety disorder (social phobia)</strong></p></td></tr><tr><td><p style=\"text-align: center;\"><strong>Diagnosis</strong></p></td><td><ul><li>Marked anxiety about &#8805;1 social situations for &#8805;6 months</li><li>Fear of scrutiny by others, humiliation, embarrassment</li><li>Social situations avoided or endured with intense distress</li><li>Marked impairment (social, academic, occupational)</li><li>Subtype specifier: performance only</li></ul></td></tr><tr><td><p style=\"text-align: center;\"><strong>Treatment</strong></p></td><td><ul><li>SSRI/SNRI</li><li>Cognitive-behavioral therapy</li><li>Beta blocker or benzodiazepine for performance-only subtype</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRI</strong> = serotonin-norepinephrine reuptake inhibitor; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>This patient&#39;s extreme anxiety in social situations and fears of scrutiny and negative evaluation are consistent with <strong>social anxiety disorder</strong>.&nbsp; The patient&#39;s fear of saying something embarrassing and his anticipatory anxiety about interacting with coworkers and meeting new people (both work-related and social) are characteristic of the disorder.&nbsp; His refusal of a job promotion that requires more social interaction is an example of the resulting <strong>functional impairment</strong>.&nbsp; Self-medication of social anxiety with alcohol is a common complication of the disorder.</p><p>Selective serotonin reuptake inhibitors <strong>(SSRIs)</strong> (eg, sertraline) and serotonin-norepinephrine reuptake inhibitors <strong>(SNRIs)</strong> are used as <strong>first-line medication</strong> for social anxiety disorder.&nbsp; Cognitive-behavioral therapy is considered a first-line nonpharmacological treatment.</p><p><strong>(Choice A)</strong>&nbsp; Bupropion, a norepinephrine and dopamine reuptake inhibitor, has limited evidence for the treatment of social anxiety disorder and is not considered first-line pharmacotherapy.&nbsp; It is used in major depressive disorder or&nbsp;tobacco dependence.</p><p><strong>(Choice B)</strong>&nbsp; Buspirone, an antianxiety medication that targets serotonin receptors, is indicated for the treatment of generalized anxiety disorder (GAD), not social anxiety disorder.&nbsp; Patients with GAD have chronic anxiety surrounding multiple issues (eg, work, finances, safety) rather than anxiety exclusively focused on social interactions, as seen in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Benzodiazepines, such as lorazepam, have a role in the treatment of the performance-only type of social anxiety disorder (eg, public speaking).&nbsp; They are less preferred in patients who have anxiety in more generalized nonperformance social situations, such as meeting new people and regular interactions with coworkers and clients.&nbsp; In addition, benzodiazepines are generally avoided in patients with a history of self-medication with alcohol, as in this case.</p><p><strong>(Choice D)</strong>&nbsp; Beta blockers (eg, propranolol) can be used for the performance-only subtype of social anxiety disorder.&nbsp; They are used on an as-needed basis and are most useful for patients with prominent physiological symptoms such as tachycardia or tremor.</p><p><strong>Educational objective:</strong><br>Social anxiety disorder is characterized by anxiety and fear of scrutiny in social situations, resulting in avoidance, distress, and social-occupational dysfunction.&nbsp; The preferred pharmacological treatment is a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24454,
            "topic": "Social anxiety disorder",
            "titleId": 24454,
            "title": "Social anxiety disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bupropion",
                    "choiceNumber": 1,
                    "correctTaken": 228,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Buspirone",
                    "choiceNumber": 2,
                    "correctTaken": 1451,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lorazepam",
                    "choiceNumber": 3,
                    "correctTaken": 965,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Propranolol",
                    "choiceNumber": 4,
                    "correctTaken": 5686,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline",
                    "choiceNumber": 5,
                    "correctTaken": 8579,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "80,135,true,-1,1*1018,1106,true,-1,1*1391,1451,true,-1,1*1568,1631,true,-1,1*1644,1815,true,-1,1*2012,2155,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29048739",
                    "mediaDataId": 0,
                    "title": "Pharmacotherapy for social anxiety disorder (SAnD).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29048739",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22436306",
                    "mediaDataId": 0,
                    "title": "The evidence-based pharmacotherapy of social anxiety disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22436306",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 93,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 16910,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 512,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 13772,
            "questionIndex": 15166,
            "questionText": "<p>A 28-year-old woman comes to the office for a preventive visit.&nbsp; She is getting married in a few weeks and has been increasingly anxious due to last-minute details and preparation.&nbsp; For the past 3 weeks, the patient has had difficulty falling and remaining asleep as she is &#x22;too excited about the wedding.&#x22;&nbsp; She notes that her dress required alterations and is pleased she &#x22;didn&#39;t have to go on a diet.&#x22;&nbsp; She states that anxiety has not been an issue for her in the past and asks if there is a medication that could help her feel more relaxed and get some sleep.&nbsp; Medical history is insignificant; the patient takes no medications or supplements.&nbsp; She drinks alcohol infrequently on social occasions and does not use illicit drugs.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 120/80 mm Hg, pulse is 100/min and regular, and respirations are 16/min.&nbsp; Physical examination shows mild hand tremors with sweaty palms and is otherwise normal.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s anxiety, sleep disturbances, weight loss, tremors, sweating, and increased heart rate are consistent with <strong>hyperthyroidism</strong>.&nbsp; The first step in evaluating hyperthyroidism is measurement of <strong>serum TSH</strong>, which is low in patients with primary hyperthyroidism.&nbsp; Many different disorders cause hyperthyroidism (most commonly Graves disease), and diagnosis of the underlying etiology is necessary for appropriate treatment.</p><p>Differentiating hyperthyroidism from anxiety disorders can be difficult due to overlap in symptoms (eg, <strong>anxiety</strong>, <strong>insomnia</strong>, <strong>sweating</strong>, <strong>palpitations</strong>).&nbsp; Some causes of hyperthyroidism (eg, postpartum and painless thyroiditis) can present with minimal or no thyroid enlargement on examination, making it more challenging to diagnose a thyroid disorder.&nbsp; Signs and symptoms associated with thyroid dysfunction rather than anxiety disorders include unintentional/unexplained <strong>weight loss</strong> (as in this patient), new-onset atrial fibrillation, hypertension, lid lag, and menstrual changes.&nbsp; To avoid misdiagnosis and inappropriate treatment, it is important to assess thyroid functioning in patients with new-onset anxiety symptoms and associated physical symptoms.</p><p><strong>(Choice A)</strong>&nbsp; A serum chemistry would not be warranted as the patient does not report symptoms or have physical examination findings that would suggest electrolyte disturbances or kidney dysfunction.&nbsp; Her constellation of symptoms is more consistent with hyperthyroidism.</p><p><strong>(Choices C, D, E, F, and G)</strong>&nbsp; Measurement of thyroid functioning is necessary before considering psychotherapy and/or psychotropic medication given this patient&#39;s unintentional weight loss and other symptoms suggestive of hyperthyroidism.</p><p><strong>Educational objective:</strong><br>Hyperthyroidism and anxiety disorders have considerable symptom overlap, including sleep disturbances, palpitations, and sweating.&nbsp; Measurement of thyroid functioning is the first step in management of patients with new-onset anxiety and physical symptoms to prevent misdiagnosis and provide appropriate treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 25336,
            "topic": "Anxiety due to another medical condition",
            "titleId": 25336,
            "title": "Anxiety due to another medical condition",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Order serum chemistry",
                    "choiceNumber": 1,
                    "correctTaken": 488,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order thyroid function studies",
                    "choiceNumber": 2,
                    "correctTaken": 12503,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend cognitive-behavioral therapy",
                    "choiceNumber": 3,
                    "correctTaken": 776,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend interpersonal psychotherapy",
                    "choiceNumber": 4,
                    "correctTaken": 154,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start hydroxyzine as needed",
                    "choiceNumber": 5,
                    "correctTaken": 794,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start low-dose lorazepam as needed",
                    "choiceNumber": 6,
                    "correctTaken": 904,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start short course of zolpidem",
                    "choiceNumber": 7,
                    "correctTaken": 1582,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "608,808,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26926973",
                    "mediaDataId": 0,
                    "title": "Hyperthyroidism:  diagnosis and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26926973",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 125,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 17201,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 326,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 14732,
            "questionIndex": 16153,
            "questionText": "<p>A 9-year-old girl is brought to the office by her mother due to behavioral problems at school.&nbsp; The patient was sent home a week ago after she threw a pencil and cried when the teacher criticized her handwriting.&nbsp; Since that time, she has had stomachaches every morning and asks to stay home.&nbsp; Her recent report cards describe her as &#x22;having trouble focusing; easily upset when she makes a mistake.&#x22;&nbsp; The mother says, &#x22;For the past year, she has become increasingly self-conscious and can&#39;t seem to relax.&nbsp; She always thinks that she will say something stupid and that the other kids will laugh at her.&nbsp; When I try to reassure her, she becomes irritable and snaps at me.&#x22;&nbsp; At home, the patient completes her homework and chores without prompting, and her appetite is normal.&nbsp; A few nights a week, she struggles to fall asleep due to concerns that someone might break into the house and insists that her mother check the locks.&nbsp; The patient has no significant medical history, but family history is notable for depression in her mother.&nbsp; Physical examination is normal.&nbsp; The patient is easily distracted by noises outside the room and repeatedly fidgets with her clothing.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t69536\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Generalized anxiety disorder in children</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical&nbsp;features</strong></p></td><td><ul><li>Excessive, uncontrollable worry (multiple issues) &ge;6&nbsp;months</li><li>&ge;1 of the following symptoms:<ul><li>Restlessness; feeling on edge</li><li>Fatigue</li><li>Difficulty concentrating</li><li>Irritability</li><li>Muscle tension</li><li>Sleep disturbance</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Associated&nbsp;features</strong></p></td><td><ul><li>Physical symptoms: stomachaches, headaches</li><li>Perfectionism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Cognitive-behavioral therapy</li><li>SSRIs or SNRIs</li></ul></td></tr><tr><td><p align=\"center\"><strong>Differential&nbsp;diagnosis</strong></p></td><td><ul><li>Adjustment disorder (response to identifiable stressor)</li><li>Obsessive-compulsive disorder (intrusive thoughts; compulsive behaviors)</li><li>Separation anxiety disorder (anxiety focused on separation from caregiver)</li><li>Social anxiety disorder (fears of negative evaluation in social/performance situations)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SNRIs</strong>&nbsp;=&nbsp;serotonin-norepinephrine reuptake inhibitor; <strong>SSRIs</strong>&nbsp;=&nbsp;selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>This patient&#39;s <strong>excessive concern</strong> about <strong>multiple issues</strong> (her work not being good enough, kids laughing at her, intruders in the house), resulting in <strong>irritability</strong> (snapping at her mother, throwing pencils), <strong>difficulty falling asleep</strong>, and <strong>poor concentration</strong>, is suggestive of <strong>generalized anxiety disorder (GAD)</strong>.</p><p>GAD in children can manifest as a need for perfectionism and order; when these are not attainable, coping difficulty is also seen (eg, this patient&#39;s emotional outburst after being criticized at school).&nbsp; Other manifestations include <strong>somatic symptoms</strong> (eg, stomachache, school refusal).</p><p>Although the diagnosis of GAD in adults requires uncontrollable worry accompanied by &#8805;3 additional symptoms (eg, restlessness, fatigue, irritability), only 1 additional symptom is required in children and adolescents.</p><p><strong>(Choice B)</strong>&nbsp; Although this patient fears intruders and asks her mother to check the locks, she does not display the time-consuming (eg, &gt;1 hour a day) intrusive thoughts and/or repetitive, ritualistic behaviors required for a diagnosis of obsessive-compulsive disorder.</p><p><strong>(Choice C)</strong>&nbsp; Obsessive-compulsive personality disorder is characterized by a long-standing, pervasive need for control and order at the expense of efficiency and flexibility.&nbsp; This patient gets upset when she makes mistakes but can complete tasks (eg, homework, chores) on time.&nbsp; Also, personality disorders require stability over time and are not diagnosed during childhood.</p><p><strong>(Choice D)</strong>&nbsp; In oppositional defiant disorder, defiance is willful rather than due to anxiety and is accompanied by a pattern of argumentativeness and vindictive behavior.</p><p><strong>(Choices E and F)</strong>&nbsp; This patient has anxiety about multiple issues, including the quality of her work, whether other children like her, and safety at home.&nbsp; Her anxiety is not centered around separation from her mother, as in separation anxiety disorder, or focused solely on a fear of negative evaluation, as in social anxiety disorder.</p><p><strong>Educational objective:</strong><br>Generalized anxiety disorder presents with excessive concern about a range of issues, which can result in irritability, poor sleep, and trouble concentrating.&nbsp; Children with anxiety commonly experience somatic symptoms.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 18230,
            "topic": "Generalized anxiety disorder",
            "titleId": 18230,
            "title": "Generalized anxiety disorder",
            "topicAttributeId": 330555,
            "topicAttribute": "Anxiety and trauma-related disorders",
            "correctAnswer": "1",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 1,
                    "correctTaken": 11336,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obsessive-compulsive disorder",
                    "choiceNumber": 2,
                    "correctTaken": 1691,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obsessive-compulsive personality disorder",
                    "choiceNumber": 3,
                    "correctTaken": 1582,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oppositional defiant disorder",
                    "choiceNumber": 4,
                    "correctTaken": 189,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Separation anxiety disorder",
                    "choiceNumber": 5,
                    "correctTaken": 259,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Social anxiety disorder",
                    "choiceNumber": 6,
                    "correctTaken": 1999,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "106",
                    "mediaDataId": 0,
                    "title": "Generalized anxiety disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26763675",
                    "mediaDataId": 0,
                    "title": "Generalised anxiety disorder in children and adolescents.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26763675",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 124,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 17056,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}